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ABSTRACT 
 
-Synuclein (-syn) misfolding and aggregation is strongly associated with both idiopathic 
and familial forms of Parkinson disease (PD). Evidence suggests that -syn has an impact on cell 
clearance routes and protein quality control systems, such as the ubiquitin-proteasome system 
(UPS) and autophagy. Recent advances in the key role of the autosomal recessive PARK2/PARKIN 
and PINK1 genes in mitophagy, highlighted this process as a prominent new pathogenic 
mechanism. Nevertheless, the role of autophagy/mitophagy in the pathogenesis of sporadic and 
autosomal dominant familial forms of PD is still enigmatic. The yeast Saccharomyces cerevisiae is a 
powerful “empty room” model that has been exploited to clarify different molecular aspects 
associated with -syn toxicity, which combines the advantage of being an established system for 
aging research. Here, we showed that the heterologous expression of -syn WT or the A53T mutant 
form induced toxicity, additionally the toxic phenotype was more aggravated when the -syn 
expression was induced at the stationary cells growth phase. At this growth phase, it was 
demonstrated that the induction of the toxic -syn variants led to the stimulation of the unfolded 
protein response (UPR), by the activation of the Ire-Hac1 signaling pathway. The activation of this 
pathway is probably responsible by the induction of the ATG6 and ATG8 mRNA levels, linked with 
autophagy and ATG32, ATG33 and DNM1 mRNA levels, which are genes specifically associated with 
mitophagy, suggesting that autophagy and mitophagy are stimulated under -syn-induced toxicity. In 
fact modulation of autophagy, by its inhibition with chloroquine or 3 methyladenine, reverted the -
syn toxic phenotype detected by an extension of in the chronological life span (CLS) of cells 
expressing the -syn WT or A53T mutant forms. Additionally, with the specific method to quantify 
the autophagy or mitophagy activities, the alkaline phosphatase assay, it was confirmed that the 
toxicity due to the heterologous expression of the toxic -syn variants was accompanied by 
exacerbated stimulation of both autophagy and mitophagy. Modulation of mitophagy, by its 
impairment, achieved by deletion of ATG11 or ATG32 resulted in a CLS extension, accompanied by 
physiologic autophagic levels, further implicating mitophagy in the -syn toxicity.  
It is established that reactive oxygen species, particularly superoxide anion (O2
2-), are 
associated with autophagy induction. In the experimented conditions, the stimulation of 
autophagy/mitophagy under -syn expression was accompanied with O2
2- accumulation. 
Nevertheless, cells with impaired mitophagy display lower levels of O2
2-. Thus, the findings do not 
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rule out O2
2- as inducer of autophagy in these conditions. Other molecules that have been associated 
with the regulation of autophagy in higher eukaryotic cells are the sirtuins, particularly the SIRT1. 
Deletion of SIR2, the yeast homologue of SIRT1, essential for -syn-induced toxicity, abolished 
autophagy and mitophagy, thereby rescuing cells from -syn toxicity. These data show that Sir2 
functions as a regulator of autophagy, like its mammalian homologue, SIRT1, but also of mitophagy, 
mediating the ATG32 mRNA levels.  
Caloric restriction (CR) is a physiologic intervention known to promote life span extension, by 
reducing the activity of various signal transduction pathways either directly or through the decrease 
in the activity of nutrient-sensing pathways. Wild type cells submitted to CR experienced a CLS 
extension accompanied by physiological levels of autophagy/mitophagy, independently of the 
expression of -syn toxic variants. In fact, in -syn-induced toxicity conditions, autophagy/mitophagy 
induction was significant lower in comparison with the same cells submitted to non-CR conditions, 
supporting the hypothesis that induction of autophagy/mitophagy are directly related with the -syn-
induced toxicity. CR, like mitophagy abrogation, has the capacity to reduce -syn-induced toxicity. 
The observed high CLS of atg11 and atg32 cells expressing -syn WT or A53T mutant form in 
comparison with the wild type cells submitted to the same conditions, suggested that CR controls 
autophagy/mitophagy independently, or at least partially independent, of the pathways regulating 
mitophagy . Similar results were observed in sir2 cells, in which CR is able to further increase the 
CLS of sir2 cells expressing -syn toxic variants, suggesting that under CR conditions, the activated 
signaling pathways are independent of Sir2. Altogether our work highlights that -syn expression is 
associated with autophagy, particularly mitophagy stimulation mediated by the regulation of ATG32 
by Sir2, an important phenomenon linked to -syn-induced toxicity during aging. These findings 
open new insights to the study of the mechanism associated with PD pathogenesis in higher 
eukaryote organisms.  
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RESUMO 
A acumulação intracelular da proteína α-sinucleina (α-sin) com alterações conformacionais 
leva à formação de agregados que estão associados com as formas idiopática e familiar da doença 
de Parkinson (DP). Evidências sugerem que a α-sin interfere com as vias de degradação proteica e 
com o sistema de controlo de qualidade das proteínas, tais como o sistema ubiquitina-proteasoma e 
a autofagia. Um papel fundamental das proteínas PARK2/PARKIN e PINK1, cujos genes estão 
envolvidos em formas autossómicas recessivas da DP, na regulação da mitofagia, destacam este 
processo como um novo proeminente mecanismo patogénico da DP. No entanto, o papel da 
autofagia/mitofagia na patogénese das formas esporádica e familiar autossómica dominante da DP 
é ainda enigmático. A levedura Saccharomyces cerevisiae é um poderoso modelo, que tem sido 
explorado para esclarecer diferentes aspectos moleculares associados com a toxicidade da α-sin, 
combinando a vantagem de ser um sistema estabelecido para o estudo do envelhecimento. Este 
trabalho demonstra que a expressão heteróloga da α-sin selvagem ou da forma mutante A53T induz 
toxicidade, que é mais evidente quando a expressão da α-sin foi induzida em células envelhecidas 
(pós-mitóticas em fase estacionária de crescimento). A expressão das variantes tóxicas de α-sin 
levou à ativação de uma resposta específica da célula através da via de sinalização Ire-Hac1. A 
activação desta via é, provavelmente, responsável pelo aumento dos níveis de mRNA dos genes 
ATG6 e ATG8, associados com o processo autofágico, e também dos genes ATG32, ATG33 e 
DNM1, especificamente associados com a mitofagia, sugerindo que a autofagia e a mitofagia estão 
implicadas na toxicidade induzida pela expressão de α-sin. De fato, a modulação da autofagia, 
através da sua inibição com cloroquina ou 3 metiladenina reverteu o fenótipo tóxico da α-sin, 
detetado através do aumento da longevidade cronológica das células. Paralelamente, com o auxílio 
de um método específico para a quantificação da atividade autofágica ou mitofágica, confirmou-se 
que a toxicidade devida à expressão heteróloga das variantes tóxicas de α-sin foi acompanhada pela 
estimulação exacerbada do processo autofágico e mitofágico. A modelação da mitofagia, através da 
sua inibição, por deleção dos genes ATG11 ou ATG32, resultou numa extensão da longevidade 
cronológica, acompanhada por níveis autofágicos fisiológicos, implicando a mitofagia na toxicidade 
induzida pela α-sin.  
Está estabelecido que as espécies reactivas de oxigénio, em particular o anião superóxido 
(O2
2-), regulam a indução de autofagia. Nas condições em estudo, a estimulação da 
autofagia/mitofagia em células a expressar α-sin foi acompanhada pela acumulação de O2
2-. No 
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entanto a acumulação de O2
2- não é observada em células incapazes de realizar mitofagia. Assim, 
os resultados não descartam a possibilidade de O2
2- estar a contribuir para a indução da autofagia, 
em condições de toxicidade induzida pela α-sin. Outras moléculas que têm sido associadas com a 
regulação da autofagia, em células eucariotas superiores, são as sirtuinas, particularmente SIRT1. A 
deleção de Sir2 (proteína de levedura homólogo de SIRT1), cujo seu papel foi previamente 
demonstrado como sendo crucial para a toxicidade da α-sin, resultou na supressão da autofagia e 
da mitofagia, e consequentemente numa melhor performance das células. Estes dados mostram, 
pela primeira vez, que Sir2 para além de ser uma molécula reguladora da autofagia, tal como o seu 
homólogo de mamífero, SIRT1, regula também a mitofagia, controlando os níveis de mRNA do gene 
ATG32. 
A restrição calórica (RC) é uma intervenção fisiológica que promove a extensão da 
longevidade, reduzindo diretamente a atividade de várias vias de transdução de sinal, ou diminuindo 
a actividade das vias de sinalização de nutrientes. As células da estirpe selvagem submetidas a RC 
demonstraram uma extensão na longevidade cronológica, acompanhada por níveis fisiológicos de 
autofagia/mitofagia, independentemente da expressão das variantes tóxicas de α-sin. No entanto, 
esta indução foi significativamente menor quando comparada com as mesmas células submetidas a 
condições de não-RC, corroborando a hipótese de que a RC tem a capacidade de reduzir a 
toxicidade induzida por expressão da α-sin. Adicionalmente, células deletadas no gene ATG11 ou 
ATG32, a expressar α-sin selvagem ou a forma mutante A53T, quando sujeitas a RC apresentaram 
uma maior longevidade cronológica em comparação com as células da estirpe selvagem 
submetidos às mesmas condições, o que sugere que a RC tem a capacidade de controlar a 
toxicidade, devido a expressão de α-sin, por mecanismos independentes, ou pelo menos 
parcialmente independentes, dos mecanismos que estão na base da regulação da mitofagia. Os 
mesmos resultados foram observados para as células deletadas no gene SiR2, sugerindo que a RC 
regula a autofagia/mitofagia por vias de sinalização independentes de Sir2. Em suma, o nosso 
trabalho sugere que a expressão de α-sin promove a estimulação da autofagia, particularmente da 
mitofagia, e que esta indução é regulada pelos níveis de mRNA do gene ATG32, através da acção 
da proteína Sir2, um evento relevante ligado à indução da toxicidade de α-sin, durante o 
envelhecimento. Estes resultados abrem novas perspectivas para o estudo de mecanismos 
associados com a patogénese da DP, em organismos eucariotas superiores. 
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OBJECTIVES AND OUTLINE OF THE THESIS 
 
In the last decade, several piece of evidence established a connection between the cell 
clearance routes and protein quality control systems, such as the ubiquitin-proteasome system 
(UPS) and autophagy, and the human physiology. Particularly, deregulation of autophagy is 
emerging as the common basis of numerous pathologies such as neurodegenerative diseases as 
the Parkinson disease (PD), the most common neurodegenerative movement disorder. PD is 
mainly a sporadic disease, nevertheless, monogenic familial forms of the disease, characterized 
by an autosomal dominant or recessive pattern of inheritance have also been identified. One of 
the genes associated with familial PD is the gene that codifies to α-synuclein (α-syn). α-Syn is a 
ubiquitously expressed protein in the brain with an intrinsic ability to bind to lipids and 
membranes. The function of α-syn is still unclear, but it regulates synaptic plasticity, dopamine 
neurotransmission and endoplasmic reticulum-Golgi trafficking, and acts as a molecular 
chaperone. In normal conditions, the soluble forms of α-syn are degraded by chaperone-
mediated autophagy and by UPS, whereas insoluble and aggregated forms, due to 
overexpression or mutations in gene codifying α-syn, inhibit these protein control quality systems 
leading to the pathogenesis of PD associated with an upregulation of autophagy. In addition, 
oxidative stress and mitochondria dysfunction have also been implicated in the pathogenesis of 
PD. It was recently proposed that this could be a consequence of the loss of mitochondria due to 
overactivation of autophagy. Recent advances in the key role of the autosomal recessive 
PARK2/PARKIN and PINK1 genes in mitophagy highlighted this process as a prominent new 
pathogenic mechanism. Nevertheless, the role of autophagy/mitophagy in the pathogenesis of 
sporadic and autosomal dominant familial forms of PD is still enigmatic. The yeast 
Saccharomyces cerevisiae is a powerful “empty room” model that has been exploited to clarify 
different molecular aspects associated with α-syn toxicity, which combines the advantage of being 
an established system for aging research.  
The work reported in this thesis aimed to get new insights on the contribution of 
autophagy/mitophagy for the toxicity induced by the heterologous expression of the human wild-
type α-syn gene and the clinical A53T mutant during yeast chronological life span (CLS).To drive 
the reader through the main achievements, this thesis was organized in four chapters:  
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In chapter 1, a general introduction, mainly centered on the knowledge of the cellular 
quality control systems that mediate cellular proteostasis, with particular emphasis on autophagy, 
will be given. In addition, a revision on the actual acknowledge about the contribution of 
autophagy in particularly for PD pathogenesis will be made. Finally, the impact of aging as a main 
risk factor for neurodegenerative diseases will be discussed. 
In chapter 2, all the materials and methods used in this work are referred.  
In chapter 3, results are presented and discussed in two sections. The results 
presented in the section 3.1 show evidence indicating that α-syn toxicity is associated with 
autophagy and mitophagy in yeast aged cells. The findings on the caloric restriction effects in the 
toxicity induced by the presence of α-syn in aged cells will be also described in section 3.2.  
Finally, chapter 4 comprises an integrative discussion focused on the main 
contributions of the present work combined with future perspectives. 
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1.1 The protein quality control system 
 
Cells encompass millions of proteins, which are packed into different subcellular 
localizations [1]. Proteins are the most abundant molecules in cells and regulate/participate in 
almost all physiological processes on which cells live depends [2]. Inside the cells, a large fraction of 
newly synthesized proteins needs to be efficiently folded in order to be functionally active. The 
protein folding beginnings in the moment that proteins are synthetized in the ribosomes, continues 
through structural intermediates and finished when the native state is reached [3-5]. This statement 
implies that the folding environment in the cells is a critical step to define the cell health, and 
consequently, cells have a hard task of maintaining proper protein homeostasis, also referred to as 
proteostasis [1]. To maintain proteostasis, cells have an adaptive network commonly called protein 
quality control. Protein quality control describes a collection of pathways, which include the 
molecular chaperones, the unfolded protein response (UPR), the ubiquitin-proteasome system (UPS) 
and the lysosomal proteolysis system [6]. Protein quality control system is responsible to maximize 
the protein folding capacity, to minimize the intrinsic and extrinsic protein deregulations and to 
degrade misfolded proteins [7]. Indeed, protein quality control system is viewed as an elaborate 
network of molecular chaperones and protein degradation factors that continually monitor and 
maintain the integrity of the proteome [8], and also as an efficient process due to the functional 
redundancy and capacity of molecular chaperones and clearance machines (the UPS and the 
lysosomal proteolysis system) [9]. Nevertheless, beyond the protein quality control system, 
proteostasis integrates RNA metabolism and processing, protein synthesis, folding, translocation, 
assembly/disassembly, and clearance [10, 11]. In this sense, proteostasis constitute a modular, 
elaborated and integrated, network (Fig. 1) that “governs the life of proteins” from the genesis to 
their decease, being dynamically regulated by several signaling pathways and in response to 
developmental signals, genetic changes, epigenetic marks, environmental stress and aging [10, 11]. 
 
 
 
6 
 
Figure 1. The proteostasis network (PN). In the center (blue font) are described the processes that are responsible for 
the control of the protein homeostasis. The next layer (green font) includes the signaling processes that influence the 
level and activity of the central players. In the outer layer is described the modifiers that influence the players shown in 
the other two layers. From [11]. 
 
 
1.1.1 Molecular chaperones 
 
Molecular chaperones are proteins that have the function of interact, stabilize and help other 
proteins to acquire their functional active conformation [12]. In fact, cells possess a complex 
chaperone network that has the capacity to assure that proteins acquire a stable folded 
conformational state. Molecular chaperones also function as a surveillance mechanism that targets 
the proteins for degradation, when the folding process fail (Fig. 2) [13]. Essentially, chaperones are 
responsible to fold newly synthesized polypeptides and translocate them across membranes, and to 
refold the denatured substrates. Additionally, they also play an important role in targeting misfolded 
proteins for degradation as well as preventing aggregation (Fig. 2) [8]. Eukaryotic cells have two 
distinctly regulated chaperone networks to play these distinct functions: the chaperones that are 
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linked to protein synthesis (CLIPS), which are functionally and physically linked to the translation 
machinery and assist folding of newly translated proteins [14] and the heat shock proteins (HSPs), 
which were first identified in Drosophila melanogaster due to the ability of the fly cells to respond to 
non-permissive heat treatments [15].  
 
 
 
Figure 2. Life-cycle of proteins. 1) and 2) After synthesis, proteins usually fold naturally, but those that fail a proper 
folded conformation are aided by chaperones that are also able to promote the folding of proteins synthesized in the 
endoplasmic reticulum (ER) and cytosol. 3) Unfolding of previously folded proteins is required for their trafficking through 
membranes. The proteins can also suffer damage (4 and 5) that consequently results in their unfolding and/or 
aggregation. In these events, it is necessary the chaperone assistance to refold (4) or disaggregate (5) the impaired 
proteins. When the proteins damage is irreversible, molecular chaperones mediate the protein degradation of the altered 
proteins by the different proteolytic systems (6). From [13]. 
 
 
Chaperones are evolutionary conserved, from bacteria to mammalian, and can be classified, 
according to their molecular weight, in different classes: HSP100, HSP90, HSP70, HSP60, HSP40 
and the small heat shock proteins (sHSP) [7, 12, 13, 16-18]. They are considered stress factors that 
are rapidly induced in response to high temperatures and other stress stimuli, which can operate in 
the cytosol or in different cellular sub-compartments (Fig. 2), contributing to the protection/control of 
different subsets of proteins [7, 12, 13, 16]. Essentially, the vast majority of chaperones recognizes 
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and binds to nascent polypeptide chains and partially folded proteins. The folding process is 
promoted through cycles of substrate binding and release that are regulated by their ATPase activity 
and by cofactor proteins [8]. The heat-shock response is controlled in eukaryotes by specific heat-
shock transcription factors (HSFs) that are expressed and maintained in a non-DNA-binding state 
under non-stressed conditions, resulting in basal transcription levels of their downstream targets. 
Under stress conditions, like the presence of misfolded proteins, the HSFs are activated to a trimeric 
DNA-binding state. Many HSF genes (HSF1, HSF2, and HSF4) are expressed in mammals while D. 
melanogaster, Caenorhabditis elegans and yeast only express HSF1 [19, 20].  
The cells must accomplish and maintain a correct balance between protecting folding 
intermediates, to guarantee that proteins reach the native state, and enforcing the rapid and efficient 
clearance of misfolded species. Alteration in this equilibrium can lead to an imbalance of cellular 
homeostasis. 
 
 
1.1.2 Unfolded protein response (UPR) 
 
Proteins that are synthetize in the endoplasmic must be correctly folded and assembled 
before transit to intracellular organelles and to the cell surface. When the molecular chaperones are 
unable to maintain their vital function, cells can undergo several stress conditions such as 
perturbation in calcium homeostasis or redox status, elevated secretory protein synthesis, 
accumulation of misfolded proteins or carbon source deprivation that lead to the accumulation of 
unfolded or misfolded proteins in the ER lumen, resulting in the activation of the ER stress [21]. 
Under ER stress, two distinct and interconnected mechanisms can be activated in an attempt to 
respond to the presence of misfolded proteins. The first is an ER stress response called the unfolded 
protein response (UPR) that acts by increasing its folding capacity [22]. The second mechanism is 
termed ER-associated degradation (ERAD), which has the capacity of recognize misfolded proteins 
and retrotranslocate those proteins through the ER membrane into the cytosol, to be degraded by 
the ubiquitin-proteasome machinery [23]. 
In the last years, it becomes clear that the UPR pathways are remarkably conserved from 
yeast to mammalian. In yeast, the folding capacity of the ER is only monitored by the conserved 
pathway that is transduced by the yeast Ire1p (inositol-requiring kinase 1) [24] and the mammalian 
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homologues IRE1α [25] and IRE1β [26]. Ire1p is a highly conserved transmembrane kinase that 
contains an unfolded protein sensor domain in the ER lumen connected to an effector domain in the 
cytosol and to a ribonuclease domain [27]. Upon accumulation of misfolded proteins in the ER 
lumen, the Ire1p is activated and consequently promotes the non-conventional splicing of the mRNA 
of HAC1 (a leucine zipper family transcription factor), via its ribonuclease domain [28]. Then the 
spliced Hac1p travels to the nucleus, where it mediates the transcription of UPR targets, such as ER 
chaperones, ERAD machinery and several secretory proteins [29]. Likewise, in mammalian cells the 
Hac1p orthologue, the X-box binding protein 1 (XBP-1), which share few sequence homology with 
Hac1, undergoes also the non-conventional splicing of its transcripts mediate by IRE1 [30]. Similarly, 
in the nucleus, XBP-1 can activate the UPR targets [31].  
Although, it is suggested a conservation of UPR signaling mechanisms, the pathway is far 
more complex in higher eukaryotic cells. Thus, additionally to the IRE1, higher eukaryotes present 
two other UPR sensors, the ER transmembrane kinase PERK and the ER transmembrane 
transcription factor ATF6. PERK contains a lumenal sensor that is strong similar to that of IRE1, but 
presents a dissimilar catalytic domain, consisting of an eIF2α (α subunit of eukaryotic initiation 
factor 2) kinase [29, 32]. Since eIF2α phosphorylation is able to inhibit the general cap-dependent 
translation [32], it is suggested that PERK might associate ER stress with translational control. In 
fact, activation of the PERK by the presence of misfolded proteins results in a generalized inhibition 
of translation [33]. Therefore, in this sense UPR can reduce stress by restricting new protein 
synthesis, giving time to ER to reestablish homeostasis without lose capacity with newly synthetized 
proteins, which must be folded, modified and sorted [32].  
Accumulation of misfolded proteins also activates ATF6, which like Hac1p is a leucine zipper 
DNA binding protein, whose activity is regulated post-transcriptionally. But unlike Hac1p, ATF6 is 
constitutively expresses as a 90 kDa protein with a large lumenal domain and a cytosolic DNA-
binding domain. Under ER stress, ATF6 is processed down to a 50 kDa cytosolic fragment, which 
allows it to enter to the nucleus and mediate UPR targets activation [34-36].  
Hence, UPR acts as a sensitive and flexible pathway that regulates ER activity and adapts 
cells to different physiological conditions. Furthermore, it has the ability to decide the cells fate, 
since when homeostasis fails, the UPR as the capacity of drive cells to death. 
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1.1.3 Proteolytic systems 
 
In all eukaryotic cells, the production and degradation of proteins, commonly known as 
protein turnover, is a constant, ongoing process that is crucial for cellular renewal. In fact, protein 
degradation is important for cell homeostasis. Different rates of proteins turnover are necessary to 
allow their levels to change rapidly in response to external stimuli. Furthermore, beyond the complex 
network of the chaperone system, several proteins are unable to reach their native stable state and 
need to be degraded. In this line, cells have to ensure the proteostasis quality and for that cells 
possess mechanisms that promote the elimination of the non-functional and potential toxic proteins. 
Thus, protein degradation assumes a major role in the regulation of cellular homeostasis in all 
eukaryotic cells, and processes like DNA transcription, repair and cell cycle are coordinately 
controlled with protein degradation [37].  
Cellular protein degradation can occur in different compartments such as cytosol, 
lysosome/vacuole and endoplasmic reticulum. Eukaryotic cells encompass two major pathways - the 
ubiquitin-proteasome pathway (UPS) and the lysosomal proteolysis system - mediated protein 
degradation. UPS is highly selective and recognizes only ubiquitinated substrates, like short-lived 
proteins, while organelles, aggregated proteins and long-lived proteins are usually degraded by the 
lysosomal proteolysis system [38, 39].  
 
 
1.1.3.1 Ubiquitin-proteasome system (UPS) 
 
The UPS is one of the main proteolytic systems that participate in the protein quality control 
system. In fact, UPS is the principal system responsible for the ATP-dependent degradation of short-
lived, misfolded and truncated proteins found in the nucleus, endoplasmic reticulum and cytosol of 
all eukaryotic cells [13, 40]. Degradation of proteins by the UPS is a highly complex process that 
requires the coordinated action of a large number of proteins. These proteins participate in the 
multiple steps of the UPS pathway, being progressively involved in the recognition and the 
conjugation of multiple ubiquitin molecules to the subtract, to produce the poly-ubiquitin chains, and 
in the destruction of these poly-ubiquitylated substrates by the proteolytic machinery, namely by the 
26S proteasome [41, 42].  
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Most of the proteasome subtracts are target for degradation through the linkage of ubiquitin, 
called ubiquitination, which consists on the formation of an isopeptide bond between specific lysines 
of the target protein and ubiquitin. Targets of the ubiquitin system are ubiquitinated by a cascade of 
three enzymes, generally known as E ligases, the E1, ubiquitin-activating enzyme, the E2, ubiquitin-
carrier enzyme and finally the E3 ubiquitin-protein ligase (Fig. 3), which act sequentially to activate 
ubiquitin [13, 43]. Repeated cycles of ubiquitinization produce the poly-ubiquitin chains that are 
recognized to degradation. In fact, the degradation of ubiquitinated proteins requires poly-ubiquitin 
chains of more than 4 ubiquitins [44]. Nevertheless, the ubiquitination of a specific protein could not 
be sufficient to determine its degradation, since mono-ubiquitinated or even poly-ubiquitinated 
proteins can experiment post translational modifications that are related to other various cellular 
functions, including DNA repair or membrane trafficking [45]. 
Multi-ubiquitinated proteins are degraded by the 26S proteasome (Fig. 3), which consists of 
a multicatalytic complex formed by 4 rings containing two types of catalytic subunits (α and β), 
known as 20S, capped on both ends by a multisubunit regulatory complex, the 19S, that is 
composed by chaperones, ATPases and enzymes that allows the substrate recognition and the 
ubiquitin tags removal [13]. Three major types of proteolytic activity have been described in the 
catalytic subunit that were identified as trypsin-like, which performs the cleavage after hydrophobic 
bonds, chymotrypsin-like, which cleaves at basic residues and postglutamylpeptide hydrolase-like or 
caspase-like activities, which cleaves after acidic amino acid [46, 47]. 
After poly-ubiquitinated with at least 4 ubiquitins, the target protein has the possibility to 
bind either directly to the ubiquitin receptors in the 19S regulatory complex of the 26S proteasome 
or to adaptor proteins that contain both polyubiquitin-binding and proteasome-binding domains (Fig. 
3) [48]. Next the target protein is unfolded by unfoldases in the regulatory complex, followed by the 
removal of the polyubiquitin chain by proteasome-associated de-ubiquitylating enzymes (DUBs), and 
then is translocated into the central proteolytic chamber, where it is cleaved into short peptides (Fig. 
3) [13, 49].  
The UPS is an intracellular protein degradation system that is responsible for the protein 
turnover within the cell, playing an important role in a large variety of biological processes including 
regulation of cell cycle, protein misfolding, transcription, replication, mitochondrial biogenesis and 
cell death [41]. Therefore, it is conceivable that deregulation of the UPS function could lead to 
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harmful cellular consequences. In fact, imbalances of the UPS can underlie several diseases such as 
the neurodegenerative disease that will be discussed hereafter. 
 
 
 
Figure 3. The ubiquitin-proteasome system (UPS). 1) The ubiquitination process, which consists in the covalent 
attachment of 4 or more ubiquitins through the coordinated action of the catalytic enzymes, E1, E2 and E3, which act 
sequentially to activate the ubiquitin and ligate it to the substrate presented by the E3. 2) The proteasome, which is 
composed by a catalytic core (the 20S) formed by 4 rings containing two types of catalytic subunits (α and β) and a 
regulatory complex, the 19S. 3) The polyubiquitinated chains are recognized by components of the regulatory subunit. 
Next the deubiquitinases present allow the release of the ubiquitin for recycling, followed by the substrate unfold by 
unfoldases in the regulatory complex. The ATPases in this complex provide the energy required for the injection of the 
substrate protein into the catalytic barrel. From [13]. 
 
 
1.1.3.2 Lysosomal proteolysis system 
 
As above described, the turnover of proteins and of misfolded proteins that can generate 
insoluble forms and aggregates, essentially due to an impairment of the chaperone system and/or 
the overload or deregulation of the UPS, are processed by the lysosomal proteolysis, particularly via 
the autophagic pathway [7, 50, 51]. In higher eukaryotes, lysosomal proteolysis system could be 
divided in three main sub-systems: chaperone-mediated autophagy (CMA), microautophagy and 
macroautophagy. In CMA the target proteins are translocated across the membrane of the lysosome 
complexed with chaperones that allow the recognition by the lysosomal membrane receptor 
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lysosomal-associated membrane protein 2A (LAMP-2A), resulting in the target proteins unfolding and 
degradation (Fig. 4) [52]. In microautophagy, the vacuole membrane invaginates and directly engulfs 
small components of the cytoplasm (Fig. 4) [53, 54]. Macroautophagy, hereafter referred to as 
autophagy, is the most well characterized process of the three. It is a process in which the cellular 
components are sequestered within vesicular structures (autophagosomes) and delivered to the 
vacuole/lysosome for degradation (Fig. 4) [55]. The autophagy molecular mechamism and 
regulation processes will be discussed in more detail hereafter.  
In the yeast Saccharomyces cerevisiae, the lysosomal, which in yeast is vacuolar, proteolysis 
system occurs only by two main sub-systems: macroautophagy (commonly referred as autophagy) 
and microautophagy [53, 54]. Additionally, a similar pathway in many respects to CMA has been 
described in yeast, in which the vacuolar protein import is dependent on cytosolic hsp70 family and 
on protease-sensitive components on the outer surface of vacuoles. Protein degradation by this 
pathway depends on a functional vacuolar ATPase [56]. Nevertheless, this pathway is still poorly 
explored.  
Autophagy (macroautophagy) is a physiological process that is conserved among eukaryotic 
cells, which is crucial to maintain the balance between anabolism and catabolism in order to confer 
the normal growth and development [57]. For instances, autophagy is active at basal levels to 
promote the turnover of long-lived proteins and for the removal of unnecessary or damage 
organelles. On the other hand, the process is induced in response to several stress conditions like 
starvation, heat and oxidative stress, being also associated with cellular development and 
differentiation [58]. Like the UPS, autophagy deregulation causes detrimental cellular consequences, 
being also associated with several diseases. These aspects will be focused hereafter.  
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Figure 4. Lysosomal proteolysis system. three fundamentally different types of lysosomal proteolysis systems: 
macroautophagy (commonly referred as autophagy), microautophagy and chaperone-mediated autophagy, have been 
described. From [59]. 
 
 
1.2 Autophagy (macroautophagy)  
 
Autophagy is an essential, homeostatic process by which cells degrade their own 
components. The most primordial function of autophagy is adaptation to nutrient starvation. 
Nevertheless, it is now established that it also orchestrates diverse pieces of the cellular response 
pathways to other dangerous stimuli [60].  
 
 
1.2.1 Autophagic machinery  
 
The lysosome in mammalian cells or the vacuole in yeast is the organelle responsible for the 
turnover of long-lived proteins, degradation of the misfolded proteins and dysfunctional organelles. In 
mammalian cells this process has been phenomenological observed for a long time, nevertheless 
the molecular autophagic components have been identified in the yeast S. cerevisiae, just in the last 
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decade [61-63]. Over 35 different AuTophaGy-related (ATG) genes have been identified in yeast, and 
many of them have homologues in higher eukaryotic cells [39, 64]. The Atg proteins are divided in 
different groups according to their physiological functions in the autophagic process [65]. 
Conceptually, the autophagy process can be divided into discrete steps: induction, cargo recognition 
(for specific types of autophagy) and packaging, vesicle nucleation, vesicle expansion and 
completion, vesicle fusion with the vacuole, degradation and export of the metabolic building blocks 
(Fig. 5) [66]. The Atg proteins can be included into different functional groups due to their 
participation in the various steps of the pathway: i) the Atg1-Atg13-Atg17 kinase complex, which 
participates in the autophagy induction; ii) the class III phosphatidylinositol 3-kinase (PtdIns3K) 
complex I, integrating Vps34, Vps15, Atg6 and Atg14 that are implicated in the autophagosome 
formation; iii) two ubiquitin-like protein conjugation systems, Atg12 and Atg8, which participate in 
the expansion of autophagosome membranes; iv) Atg9 and its recycling system that potentially 
contributes to the delivery of membranes to the forming autophagosome; and v) the proteins that 
contribute to the last steps of the process (Fig.5) [67]. Furthermore, in yeast, autophagy machinery 
is concentrated at a perivacuolar site, called phagophore assembly site (PAS), and the action of the 
autophagy machinery at the PAS results in the phagophore expansion and autophagosome 
formation (Fig. 5) [68]. 
In yeast, autophagy induction is initiated by the activation of the target of rapamycin (TOR)-
Atg1-Atg13-Atg17 kinase complex, being TOR a negative regulator of the complex [55]. TOR is a 
serine/threonine kinase that in response to amino acids and growth factors coordinates different 
aspects of cell growth, playing a crucial role in the autophagy regulation [69]. Yeast harbors two TOR 
complexes with distinct functions, TOR complex 1 and 2 (TORC1 and TORC2), nevertheless only 
TORC1 has a central role in autophagy regulation [69]. TORC1 regulation is dependent on the 
nutritional conditions. Thus under nutrient rich conditions it is active, promoting autophagy 
inhibition, while under nutrient starvation it is inactive allowing the activation of the autophagy 
pathway [69]. TORC1 directly or indirectly regulates the Atg1-Atg13-Atg17 kinase complex through 
the Atg13 phosphorylation state (Fig. 6A) [70]. Under favorable nutrient conditions, with active 
TORC1 complex, Atg13 is hyperphosphorylate and has low affinity for Atg1 and Atg13. Since Atg17 
is unable to interact with Atg1 without the presence of Atg13 (Fig. 6A) [71-73], the complex is 
blocked and consequently autophagy is inhibited. Upon nutrient deprivation, the TORC1 complex is 
inactive and Atg13 is rapidly dephosphorylated, resulting in the interaction between Atg1 and Atg17, 
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the consequent complex formation and the activation of Atg1 kinase activity. The Atg1 is upregulated 
during autophagy induction, suggesting an important role for Atg1 in the autophagy process [72]. 
 
 
 
Figure 5. Schematic representation of the autophagic pathway in yeast cells. Autophagy can be divided in several steps 
including induction, cargo recognition (for specific types of autophagy) and packaging, vesicle nucleation, vesicle 
expansion and completion, vesicle fusion with the vacuole/lysosome, degradation and export of the metabolic building 
blocks. The Atg proteins can be included into different functional groups due to their participation in the various steps of 
the pathway (see in the text). From [65]. 
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Figure 6. The Atg1 complex as a regulator of autophagy in (A) yeast and (B) mammalian cells. Adapted from [74]. 
 
 
Homologues of Atg1 were identified in various organisms, such as D. melanogaster [75], C. 
elegans [76] and mammalian cells [77, 78], being also involved in the regulation of autophagy. In 
mammalian, the uncoordinated 51-like kinase 1 and 2 (ULK1 and ULK2) appear to be the functional 
similar to yeast Atg1 homologues, since some data already showed that the knockdown of ULK1 and 
ULK2 inhibits autophagy induction [79, 80]. Like in yeast, ULK1 and ULK2 are part of a complex in 
which the mammalian homologue of Atg13, mAtg13, and the mammalian orthologue of Atg17, the 
protein FIP200, are also integrated (Fig. 6B) [80-82]. In conditions that lead to autophagy induction, 
a decrease in mTOR activity results in the dephosphorylation of ULK1, ULK2, and mAtg13. In this 
situation, ULK1 and ULK2 are activated promoting the phosphorylation of mAtg13 and FIP200 (Fig. 
6B) [80, 82]. 
The nucleation and assembly of the initial phagophore membrane requires the PtdIns3K 
complex. In yeast, there are two PtdIns3K complexes that share the only PtdIns3K protein present. 
Each complex contains three common components, Vps34 (the only PtdIns3K protein in yeast), 
Vps15 and Vps30/Atg6 (Fig. 7) [83]. The function of Vps34 is dependent on Vps15, which is 
required for Vps34 membrane association and activity [84]. Additionally, each complex contains 
another specific component, which makes the distinction between the two complexes. Thus, the 
complex I also integrates Atg14 and in the complex II, Vps38 is present (Fig.7). The complex I, 
Vps15-Vps34-Vps30-Atg14, localizes to the PAS and is involved in autophagy and in the cytoplasm-
to-vacuole (cvt) pathway, which is a yeast selective type of autophagy (that will be discussed 
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hereafter) (Fig. 7) [85], while the complex II functions at the endosome and participates in the 
sorting of carboxypeptidase Y (CPY), which is normally transported from the late Golgi to the vacuole 
through the CPY pathway (Fig. 7). 
 
 
 
Figure 7. The two phosphatidylinositol 3-kinase (PtdIns3K) complexes in yeast. Each complex contains three common 
players, Vps15, Vps34 (the PtdIns3K) and Vps30/Atg6. Additionally, another specific component, Atg14 or Vps38 
participates in complex I or complex II, respectively. From [54]. 
 
 
Apparently, the role of PtdIns3K is to produce phosphatidylinositol (3)-phosphate 
(PtdIns(3)P) at the PAS to recruit PtdIns(3)P-binding proteins, which in turn recruit additional 
downstream effectors to the PAS [86, 87]. It is described that PtdIns(3)P recruits Atg18, Atg20, 
Atg21, Atg24 and Atg27 to the PAS [88-90]. On the other hand, Atg24 and possibly Atg20 interact 
with Atg17 [88], and Atg20 interacts with Atg11 [91]. These data suggests that Atg20-Atg24 
complex might interact with the Atg1 kinase complex. 
In contrast to yeast, mammalian cells present two types of PtdIns3K proteins: class I and III. 
Class III PtdIns3K, hVps34, which is similar to the yeast Vps34, generates PtdIns(3)P and plays a 
stimulatory role in autophagy. It also forms a complex with p150, the homologue of Vps15, and with 
its accessory protein Beclin 1 (the homologue of Vps30/Atg6) [92, 93]. Furthermore, the 
orthologues of Atg14 and Vps38 are already identified and designed as Atg14-like protein (Atg14L or 
Barkor) and ultraviolet irradiation resistant-associated gene (UVRAG), respectively [94-96].  
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The role of the enzymatic product of hVps34 is not well understood, however it likely 
participates in diverse phases of the autophagic process contributing to the autophagosomal 
membrane formation [97], to the targeting of PI3P–binding proteins, such as Atg18, to the 
autophagic membrane [98], to the localization of LC3 (Atg8) lipidation [99] and to autophagosomal 
maturation into autolysosomes [100]. Additionally, Beclin 1, a key regulator of autophagy, interacts 
with functionally distinct hVps34-containing protein complexes. Therefore, when complexed with 
Atg14L, the complex plays a role in initiation [94, 101], and when associated with UVRAG/VPS38, 
the complex participates in the maturation of the autophagosome [94, 100]. On other hand, the 
participation of Beclin1 in autophagy is predominantly done by B-cell lymphoma/leukemia-2 (Bcl-2). 
Bcl-2 is an anti-apoptotic protein that inhibits autophagy by binding and sequestering Beclin1 [55]. 
In yeast, the phagophore expansion and nucleation that leads to the autophagosome 
formation also requires the participation of the PtdIns3K complex I (Vpas34-Vps15-Atg6/Vpas30-
Atg14), which together with the Atg1 kinase complex is a platform to recruit two interrelated 
ubiquitin-like conjugation systems, Atg12-Atg5-Atg16 and Atg8-PE (phosphatidylethanolamine) to the 
phagophore (Fig. 8) [102, 103]. 
In yeast, Atg12 is activated by the Atg7 (E1 ubiquitin-activating enzyme) and then by Atg10 
(E2 ubiquitin-conjugating enzyme) staying covalently attached to Atg5 [104]. This conjugation further 
interacts with Atg16 which links the Atg12-Atg5-Atg16 complex into a multimeric structure and 
attaches it to the phagophore [105, 106]. Apparently, the Atg12-Atg5-Atg16 complex has the 
capacity to induce curvature into the growing phagophore through asymmetric recruitment of Atg8-
PE (Fig. 8) [107]. 
In the other conjugation system, Atg8 is first processed by the cysteine protease Atg4. In the 
same way as in the Atg12-Atg5 conjugation system, E1 enzyme Atg7 activates Atg8 and transfers it 
to the E2 enzyme Atg3. Finally, Atg8 is conjugated to the target lipid PE through an amide bond [99, 
108]. In favorable nutritional conditions, Atg8 is cytosolic, although upon autophagy induction, Atg8 
is conjugated with PE being tightly associated with membranes. In fact, Atg8-PE is localized in both 
sides of the phagophore during the autophagic process [109, 110].  
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Figure 8. The two ubiquitin-like protein conjugation systems in yeast required for the phagophore expansion and 
nucleation. From [54]. 
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Contrarily to Atg12-Atg5 conjugation, Atg8-PE association is a reversible process, being 
possible to make the recycling of the Atg8. Once again the Atg4 cysteine protease has the capacity 
of release Atg8 from its target lipid, which is recycled and used in another conjugation reaction, 
allowing the efficient progression of the autophagic process (Fig. 8) [110]. 
The Atg12 and Atg8 conjugation systems are evolutionarily conserved and mammalian 
homologues for each component of the yeast Atg12-Atg5 and Atg8-PE conjugation systems, with 
similar function, have been described [111-113]. In mammalian cells, it is observed the existence of 
at least four Atg8 yeast homologues, MAP1LC3, GATE16, GABARAP and Atg8L. All the refereed 
proteins share a conserved glycine residue near their C terminus, and are conjugated to PE, an 
event similar to the one observed in yeast, catalyzed by Atg4, Atg7 and Atg3 [109, 114-117]. 
MAP1LC3, commonly known as LC3, is the most abundant in the autophagosomal membrane, 
being established as a central marker to assess the autophagosome and autophagic activity [118]. 
Like the yeast Atg8-PE, the mammalian LC3-PE (also named LC3-II) localizes in the membrane outer 
face, and is cleared from the membrane due to a cleavage promoted by Atg4, while the inner 
population remains associated to the vesicle and is delivered into the lysosome where it is degraded 
[109, 110, 119].  
One of the main puzzling questions regarding autophagy process is the origin of the 
autophagosome membrane. During autophagy, the formation of double-membrane vesicles is 
required, and apparently these vesicles do not bud from a pre-existing organelle, rather the vesicles 
are supposed to be form by the expansion of a membrane core, of yet unknown origin, called 
phagophore (Fig. 9) [120-122]. Some evidence indicates that the ER membrane, plasma 
membrane, mitochondrial outer membrane and Golgi complex contribute to the vesicle formation 
[123]. Apparently, in yeast, the phagophore membrane formation occurs at or is organized around 
the PAS [124]. In fact, although the role of the PAS is not entirely understood, it is proposed that it 
serves to facilitate the nucleation and/or expansion of the phagophore, by the recruitment of the 
necessary Atg proteins [103, 120]. Thus, Atg11, which is essential for PAS organization under 
vegetative conditions, and Atg17, which role is critical during starvation, are the initial factors 
responsible for subsequent recruitment of the remaining Atg proteins. Atg17, in addition to the Atg1-
Atg13-Atg17 complex, interacts also with Atg29 and Atg31 and this association is essential for 
recruitment of Atg proteins to the PAS to generate autophagosomes (Fig. 9). Furthermore, Atg1-
Atg13 is also required for PAS organization (Fig. 10) [125]. 
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Figure 9. Schematic representation of the double membrane formation in yeast. From [54]. 
 
 
Another protein that is recruited relatively early to the PAS is Atg9. In fact it is considered a 
“membrane carrier” during the assembly process [121, 126]. During autophagy, Atg9 is present in 
multiple punctate structures, like PAS and subjacent or at the mitochondria surface, and also a 
portion is dispersed to the cytosol being apparently associated with membranes (Fig. 10). The 
cycling of the Atg9 between PAS and the other structures is crucial for the autophagosome 
formation, since it is suggested that the membrane could be transported to the PAS by this shuttling 
process [127, 128]. This travelling, called anterograde movement, involve several Atg proteins (Fig. 
10). Atg11 is essential, particularly for the specific organelles degradation, since its absence blocks 
the transport of Atg9 to PAS [126, 129]. Additionally the efficient movement also involves the 
peripheral membrane protein Atg23 and the type I transmembrane protein Atg27. They form an 
essential interdependent complex with Atg9. Atg9, Atg23 and Atg27 are also found in the PAS and in 
other punctate structures (Fig. 10).  
Another collaborator on the Atg9 anterograde movement is the actin cytoskeleton [126]. 
Particularly, an actin-related protein, Arp2, which is one subunit of the Arp2/3 complex, the 
nucleation factor of branched actin filaments. Hence, the data suggests that Arp2/3 complex brings 
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the power to push the cargo, composed by Atg9 and its associated membranes, from the 
membrane donor to the forming autophagosome (Fig. 10) [126, 130, 131]. 
The above referred recruitment of the two ubiquitin-like conjugation systems, Atg12-Atg5-
Atg16 and Atg8-PE to the phagophore by the PtdIns3K complex I is also assisted by the Atg9. The 
absence of this interaction does not hamper the conjugates formation, nevertheless they completely 
diffuse in the cytosol, losing the punctate localization [132].  
The retrieval of Atg9 from the PAS to the peripheral sites also requires the participation of 
several Atg proteins including the Atg1-atg13 kinase complex, Atg12, Atg18, and the PtdIns3K 
complex I. The absence of any of these players culminates in the accumulation of Atg9 in the PAS 
[128]. In the same way, the retrieval of Atg23 and Atg27 is also coupled to the participation of the 
Atg1-atg13 kinase complex (Fig. 10) [133, 134].  
 
 
 
Figure 10. Cycling of Atg9. During autophagy, Atg9 cycles between the PAS and non-PAS punctate structures, such as 
mitochondria surface, and also a portion is dispersed to the cytosol being apparently associated with membranes. From 
[54]. 
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In mammalian cells there is no evidence for the existence of the PAS. The phagophore 
membranes seem to initiate from the ER [135, 136], together with other cytosolic membrane 
structures, like Golgi and late endosomes [60, 97, 137]. However, colocalization of the Atg proteins 
was also observed, nevertheless in multiple sites, instead of only one place as in yeast cells. The 
data suggests that probably the mammalian cells present multiple PAS [138, 139]. In fact, 
mammalian Atg9 homologue, mAtg9 resides in the transi-Golgi network and late endosomes. 
Deprivation nutrient conditions induce the redistribution of the mAtg9 to peripheral sites, overlapping 
with LC3 positive autophagosomes. Furthermore, like in yeast, the mAtg9 cycling is also dependent 
of the ULK1, since its absence restrings mAtg9 to the transi-Golgi network [139]. 
In yeast, the machinery involved in the autophagosome-vacuole fusion includes the Rab 
family GTPase Ypt7, the NSF homologue Sec18, the SNARE proteins Vam3, Vam7, Vti1, Ykt6, the 
class C Vps/HOPS complex proteins, and two other proteins, Ccz1 and Mon1 [140-142]. The 
autophagosome inner membrane vesicle, called autophagic body, is released to the vacuole lumen, 
after fusion. Upon release into the vacuole, the autophagic body is degraded dependently on 
appropriate vacuole function and on the activity of the resident vacuolar acid hydrolases, like Pep4 
and Prb1, and the lipase Atg15 [143-145]. The resulting molecules from degradation must be 
released back to the cytosol for maintenance of the cellular functions. Apparently, the efflux of the 
molecules across the vacuolar membrane is played by Atg22, a putative amino acid effluxer on the 
vacuolar membrane [146], together with the vacuolar permeases Avt3 and Avt4 [146, 147]. 
In mammalian cells, the autophagosome-lysosome fusion is mediated by the same 
machinery that is involved in the vesicular trafficking pathways, and the fusion event involves the 
lysosomal membrane protein LAMP-2A and the small GTPase Rab7 [148, 149].  
 
 
1.2.2 Selective types of autophagy 
 
Autophagy is commonly recognized as a non-selective process, in which cytosolic 
components are randomly surrounded by the phagophore membrane and included in the 
autophagosome. However, in certain scenarios autophagy plays a biosynthetic role by mediating the 
specific degradation of unnecessary or damage organelles or the trafficking of some molecular 
enzymes [150]. Some types of selective degradation have been detected and explored, like the 
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selective removal of aggregated proteins [151] and of damage organelles, for example mitochondria 
[152, 153], peroxisomes [154] and ER [155].  
 
 
1.2.2.1 The Cytoplasm-to-vacuole (Cvt) pathway  
 
The best described type of selective autophagy is the Cvt pathway that is responsible for the 
specific delivery of at least two hydrolases, α-mannosidase (Ams1) and aminopeptidase I (Ape1), to 
the vacuole, the site where they will be enzymatically processed into their mature form. This pathway 
operates constitutively under growing conditions in S. cerevisiae [61]. In this sense, and contrarily to 
autophagy, the Cvt pathway is a biosynthetic process, however the machinery used during the 
process is almost identical to the one used by bulk autophagy but with the participation of some 
additional factors. The transport of ApeI and Ams1 to the vacuole is dependent of participation of 
Atg19 and Atg11. In fact, Atg11 sequester the complex enzyme-Atg19 and drive it to the PAS, 
suggesting that Atg11 is associated with selective types of autophagy [91, 156].  
 
 
1.2.2.2 Mitophagy  
 
Mitochondria are organelles that have essential functions for the cell, including ATP 
production via oxidative phosphorylation and calcium homeostasis, however their continued 
presence within the cell may sometimes result in cell death. In fact, mitochondria deterioration is 
accomplished with the production of excessive reactive oxygen species (ROS) leading to the release 
of pro-apoptotic proteins, like cytochrome c and apoptosis-inducing factor (AIF), triggering the 
damage of the neighboring mitochondria and the entire cell [157]. Furthermore, if the cellular 
energy intake is low, an excessive number of mitochondria could result in the generation of high 
ROS levels and consequently cellular damage [158]. In this sense, as a quality control system, the 
cells have to proceed with the controlled removal of excessive, unstable or damage mitochondria by 
specific autophagy, mitophagy, supporting the crucial role of mitophagy in cell survival [50, 159, 
160]. 
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In the yeast S. cerevisiae, mitochondria are sequestered, and delivered into the vacuole. 
This process is performed by the core of Atg proteins essential for autophagosome formation, 
nevertheless can occur without nutrient starvation and does not involve the Atg proteins that are 
specific for bulk autophagy (macroautophagy) [161, 162].  
The first protein identified as being involved in mitophagy was the Uth1p [163], an outer 
mitochondrial membrane protein that in coordination with the core of Atg proteins mediate the 
selective removal of mitochondria. Next a second mitophagy-related protein was found, the Aup1 
[164], a putative protein phosphatase present in the mitochondrial intermembrane space. In fact, it 
has recently been proposed that Aup1 regulates mitophagy by regulating the retrograde signaling 
pathway [165]. Nevertheless, later studies did not confirm the need of Uth1p and Aup1p to the 
process of mitochondria elimination [161, 166], however, this could be partially explained by the 
different yeast backgrounds used in the studies or even in the detection methods [160]. In this 
sense, the participation of Uth1p and Aup1p in mitophagy is still matter of controversy.  
More recently, two other proteins were identified as being associated with mitophagy, Atg32 
and Atg33 [161, 166]. Atg32 is a mitochondrial anchored protein that is specific and crucial to 
mitophagy (Fig. 11A), but not for autophagy or other types of selective autophagy, since ATG32 
mutant cells are only competent in the autophagy and Cvt pathways. Atg32 is induced and anchored 
on the outer membrane of damage mitochondria, functioning as a protein receptor that interacts 
with the adaptor protein Atg11, resulting in the mitochondria sequester to the PAS (Fig. 11A). 
Additionally, Atg32 owns an evolutionary conserved motif (WXXI/L) that is crucial for direct binding 
to Atg8, an interaction that is required for mitochondrial recruitment by the phagophore (Fig. 11A) 
[161, 166]. 
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Figure 11. Schematic representation of mitophagy in (A) yeast and (B) mammalian cells. From [160]. 
 
 
However, important questions remains open, particularly the consequences on the 
mitophagy process under the absence of Atg32. Mounting evidence revealed that under determined 
conditions, the lacking of Atg32 did not alter the mitochondrial mass neither the DNA levels, 
suggesting a critical role for Atg32 in the removal of excessive mitochondria [167]. In contrast, in the 
presence of damage mitochondria, Atg32 seems to be critical for mitophagy induction [166].  
Atg33 is an outer mitochondrial membrane protein, which when absent is responsible for 
the blockage of mitophagy during nitrogen starvation and almost completely during the stationary 
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phase, suggesting that it is probably required for the recruitment of aged mitochondria by the PAS 
(Fig 11A) [160]. Nevertheless, further studies are necessary to prove this hypothesis.  
Another pre-requisite that apparently is essential to mitophagy is mitochondrial fission. This 
event is required to remove the damage mitochondria and also to prepare them to fit into the 
autophagosomes. Nevertheless, the fission process must be associated with a concomitant 
mitochondrial dysfunction or even with unclear signals [160]. In yeast, it is still controversial if 
mitophagy is strictly dependent on mitochondria fission and thus alternative pathways for 
mitochondrial quality control by mitophagy must be considered [168].  
In mammalian cells it is well established that loss of mitochondrial membrane potential 
causes mitophagy. Additionally, mitophagy is also triggered during differentiation of specific tissues 
[169, 170]. The process occurs with the participation of ULK1 and ATG7 [171, 172]. Additionally, 
NIX, a BPNIP3-like protein is crucial for the complete mitochondrial removal [169, 170]. In fact, NIX 
has been proposed to be a receptor protein, having the same function as Atg32 in yeast cells. NIX 
also possesses the LC3-interacting region (Fig. 11B) [173, 174]. Nevertheless, in determined 
conditions, mitophagy is also induced in the absence of NIX, suggesting the existence of other 
redundant pathways. Indeed, mounting evidence indicate that PARKIN, an E3 ubiquitin ligase that 
when mutated is linked to autosomal recessive forms of Parkinson disease, is translocate from the 
cytosol to mitochondria in cells submitted to carbonyl cyanide m-chlorophenylhydrazone (CCCP) or 
paraquat treatments. PINK1, a mitochondrial kinase also linked to autosomal recessive forms of 
Parkinson disease, seems to assist the translocation of PARKIN to the damage mitochondria both in 
mammalian cells [175-177] and in D. melanogaster [178]. Furthermore, PINK1 is rapidly degraded 
in healthy mitochondria, whereas it accumulates on the surface of damaged mitochondria (Fig. 11B) 
[179]. Next PARKIN catalyzes poly-ubiquitination of diverse substrates, recruiting the autophagy 
receptor p62/SQSTM1, which that simultaneously binds ubiquitin and LC3/GABARAP proteins (Fig. 
11B) [177]. 
Some evidence propose that NIX is able to interact with PARKIN, inducing its translocation 
for damage mitochondria [180], however further studies are needed to validate this hypothesis  
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1.2.2.3 Other selective types of autophagy.  
 
Both peroxisomes and ribosomes are selectively eliminated via autophagy in yeast cells 
[181]. Peroxisomes are organelles involved in lipid metabolism and in the elimination of peroxides. 
In cells the balance between biogenesis and degradation of peroxisomes is highly regulated, and 
when the peroxisomes population is in excess or damaged, they are committed to degradation by an 
autophagy-related process called pexophagy. Both yeast and mammalian cells use essentially 
macropexophagy (Fig. 12), in which the peroxisomes are delivered into the lysosome or vacuole by 
the engulfment of the autophagosome, but direct engulfment by the vacuole, micropexophagy (Fig. 
12), has also been demonstrated [182]. During macropexophagy, Atg30 is an adaptor that interacts 
with Pex3 and Pex14 (peroxisome proteins), with the selective autophagy adaptor Atg11 and also 
with Atg17 (Fig. 12) [107, 183].  
Ribosomes are also selectively degraded during starvation in a process called ribophagy. 
This process depends on the core of Atg proteins from autophagy [184], and is also dependent on 
the catalytic activity of the ubiquitin protease Ubp3p and its cofactor Bre5p [185], suggesting that 
ubiquitin is involved in this process.  
S. cerevisiae cells are also able to degrade non-essential portions of the nucleus into the 
vacuole in response to starvation conditions, a process called piecemeal microautophagy of the 
nucleus (PMN). In this process patches between the nucleus and the vacuole, the called nucleus-
vacuole junctions (NVJs), are formed by the interaction between Vac8 (vacuolar membrane protein) 
and a nuclear membrane protein Nvj1 [186]. During PMN, part of the NVJ buds resulting in a bleb 
that is released into the vacuole. Besides the already referred specific proteins, PMN requires 
proteins from the autophagy machinery (Fig. 13) [187]. Usually PMN is induced upon nutrient 
starvation, although it does not contribute to cell survival during starvation conditions, it might be 
important concerning the adjustment of determined processes in the nucleus, as for instance 
transcription or ribosome biogenesis (Fig. 13) [188]. 
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Figure 12. Schematic representation of pexophagy (see in the text). From [50]. 
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Figure 13. Schematic representation of piecemeal microautophagy of the nucleus, which allows the degradation of a 
portion of the nucleus (see in the text). From [50]. 
 
 
1.2.3 Transcriptional/translational and post-translational regulation of autophagy 
 
Autophagy genes are regulated at a transcriptional level in response to stress. In fact, 
autophagy induction under starvation conditions greatly stimulates the expression levels of some 
ATG genes. Under starvation, ATG8 levels are extremely high, nevertheless, the transcription 
factor(s) that regulate the expression level of the ATG8 gene are still poorly understood [110], being 
Gln3, a nitrogen catabolite repression-sensitive GATA-type transcription factor, the only regulator 
factor described [119, 189]. On other hand, the ATG14 mRNA levels are increased more than 20-
fold in nitrogen starvation conditions and are also regulated by Gln3, but the relationship between 
the ATG14 mRNA levels and autophagy induction is not established (reviewed in [190]). In addition 
to ATG8 and ATG14, a microarray analysis demonstrated that ATG1, ATG3, ATG4, ATG5, ATG7, 
ATG12 and ATG13 are upregulated under nutrient deprivation conditions [191]. Alongside, under 
amino acid starvation, yeast triggers a general amino acid control in an attempt to induce the 
transcription of several genes. In this response, Gcn4 plays a central role, since it is a transcriptional 
activator of gene expression [192]. Its synthesis is mainly regulated at the translational level, 
particularly by the protein kinase Gcn2 that phosphorylates the only known substrate eIF2α, which 
transcriptionally stimulates autophagy, since the transcription of ATG12, ATG1 and ATG13 was 
found upregulated in these conditions (reviewed in [55]). Recently, it was demonstrated that the life 
span extension induced by the acetylase inhibitor spermidine requires the participation of essential 
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autophagy genes. Indeed, the increased longevity is linked to alterations in the acetylation of nuclear 
histones and to a transcriptional increase of different ATG genes, including ATG7, ATG11 and ATG15 
[193]. Furthermore, as hereafter described, ER stress is also associated with autophagy stimulation 
by upregulating the expression of specific ATG genes [194, 195]. Although, autophagy could be 
transcriptionally regulated, this type of alteration/regulation is not the main mechanism of autophagy 
regulation.  
Stimulation of autophagy in conditions, in which protein synthesis is blocked, for example 
with cycloheximide, results in the formation of abnormally small autophagosomes, suggesting that 
protein synthesis is not directly correlated with induction of autophagy, but it is crucial for the 
generation of normal sized autophagosomes [196]. Furthermore, it is proposed that higher levels of 
Atg8 are necessary to mediate the increased number of membrane fusion events occurring during 
the formation of the large autophagosomes. Indeed, this hypothesis was sustained by the finding 
that deletion of ATG8 results in cells with abnormally small autophagosomes [196, 197]. 
Furthermore, it is also proposed that translational initiation factors, like eIF4GI, that are associated 
with the translation of proteins controlling cell growth and proliferation, block the stimulation of 
autophagy downstream of TOR [198], while eEF-2 (eukaryotic elongation factor-2) kinase and the 
eIF2α kinase signaling pathway that induce translational arrest, positively regulate autophagy [199, 
200].  
Several distinct stimuli and toxic agents can induce a rapid homeostatic autophagy, and 
there is increasing evidence that initially autophagy induction does not require transcriptional 
reprogramming and changes in the expression of the autophagic genes, suggesting that the cells 
have enough Atg proteins levels to rapidly response to cellular injuries. In fact, instead of 
transcriptional reprogramming, autophagy depends on post-translational modifications of proteins, 
including phosphorylation, acetylation and ubiquitination. The autophagic process comprises 
ubiquitin-like modification of Atg12 and Atg8/LC3, and TOR/PKA-dependent phosphorylation of the 
Atg1/ULK kinase complex, as above described. Additionally, in mammalian cells, it was 
demonstrated that several Atg protein, including Atg5, Atg7, Atg8, and Atg12, are acetylated in 
nutrient-rich conditions and in contrast they are deacetylated during starvation. In this sense, 
deacetylation modification of some autophagy players is important for autophagy stimulation [201]. 
Additionally, the deacetylation process is dependent on the NAD-dependent deacetylase SIRT1 (a 
sirtuin family member) [201], which expression is induced by caloric restriction (CR) and direct 
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related with promotion of autophagy and longevity [202]. Furthermore, assays with the acetylase 
inhibitor, spermidine and the deacetylase activator, resveratrol, both inducers of autophagy, showed 
that they induce changes in the acetylation of several proteins linked to the autophagy network. 
Importantly, in the cytoplasm, both agents induce essentially convergent protein deacetylation, 
whereas in the nucleus, acetylation is dominantly triggered by spermidine and resveratrol. Thus it is 
suggested that multiple post-translational modifications of the acetylproteome can probably regulate 
autophagy [203].  
Collectively, the findings suggest that autophagy at basal conditions is regulated by nuclear-
independent responses, however, during time, to maintain an increased autophagic activity, 
transcriptional reprogramming is required.   
 
 
1.2.4 Signaling pathways that regulate autophagy 
 
Autophagy occurs at basal levels in the majority or even all cells, but it can be induced 
under several conditions. Indeed, extracellular stimuli, such as starvation or therapeutic treatment, 
and also intracellular stimuli, including the accumulation of misfolded proteins, have the capacity to 
modulate the autophagic response. Additionally, autophagy is sensitive to nutrient availability and is 
negatively regulated by signaling pathways. In fact, the link between autophagy and nutrient-sensing 
pathways that regulate life span has been demonstrated in many studies. These aspects will be 
explored hereafter. 
 
 
1.2.4.1 Nutrient Signaling 
 
Nutrient starvation is able to rapidly induce the formation of autophagosomes. In yeast and 
mammalian cells, the two main signaling cascades that sense nutrient status and negatively regulate 
autophagy are the TOR and Ras-cAMP-PKA pathways. 
 
TOR complex 1 (TORC1). A key player in the nutrient sensing and in the regulation of cell 
growth and the autophagic process is the TOR kinase. As aforementioned, inhibition of autophagy in 
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yeast cells can be done by TORC1, dependent on the nutritional conditions (Fig. 14). Particularly, 
TORC1 regulates the Atg1 kinase complex by the Atg13 phosphorylation state [71-73].   
Beyond the direct regulation of autophagy by the interaction with the Atg proteins (as above 
described), TOR can also act through its downstream effectors to control autophagy. Under nutrient 
rich conditions, TOR has the capacity of phosphorylate the protein Tap42, which promotes its 
association with PP2A. The association between Tap42-PP2A results in the activation of the catalytic 
subunits of PP2A, a negative regulator of autophagy [204]. PP2A is a phosphatase that acts on 
several TOR substrates, including glutaminase (Gln3). Dephosphorylation of Gln3 by PP2A 
culminates in the activation of the transcription of several genes [205, 206], including ATG8 and 
ATG14 [119, 189], as above referred. On the other hand, under starvation or rapamycin treatment 
TOR becomes inhibited. This inhibition causes dephosphorylation and dissociation of Tap42 from 
PP2A, allowing the PP2A to acquire the capacity of dephosphorylate its targets, leading eventually to 
a variety of anti-proliferative responses and also to the induction of autophagy [204].  
 
Ras/cAMP-dependent protein kinase A (PKA). Besides TORC1, the Ras/PKA also 
regulates autophagy [207]. This pathway plays a key role in cell proliferation, stress response, and 
longevity [208]. In yeast, PKA contains a heterotetramer that is composed by a regulatory subunit 
Bcy1 and three apparently redundant catalytic subunits, Tpk1, Tpk2, and Tpk3. Thus, in response to 
nutrient rich conditions, two redundant Ras GTPases, Ras1 and Ras2, are activated and 
subsequently stimulate adenylate cyclase to produce cAMP. Then cAMP is able to bind to the 
regulatory PKA subunit, Bcy1, allowing its dissociation from the PKA catalytic subunits [209], and 
consequently the activation of PKA. When this activation occurs, the autophagy induced by TOR 
inhibition is suppressed, indicating that PKA is a potent negative regulator of autophagy (Fig. 14) 
[210, 211]. Additionally, it was demonstrated that Atg1, Atg13, Atg18 and Atg21 are PKA 
substrates. Apparently, in the presence of nutrients, PKA phosphorylation promotes the presence of 
Atg1 and dissociated from the PAS, whereas in contrast, during nutrients depletion, Atg1 is 
dephosphorylated and it is localized to the PAS. However, it is still unknown if the phosphorylation of 
these proteins by the PKA is linked to autophagy regulation [211]. 
Additionally, PKA may function in parallel with Sch9 in the control of several physiological 
events, such as growth, cell cycle progression, and glycolysis [208, 212]. Sch9, a serine/threonine 
protein kinase, which is the yeast homologue of Akt and S6K, is also involved in the nutrient sensing. 
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[213]. It is described that Sch9 is a negative regulator for autophagy (Fig. 14), since, hyperactivation 
of Sch9 moderately suppresses autophagy when TOR becomes inactivated by rapamycin. 
Furthermore, Sch9 also cooperates with PKA to regulate autophagy, thus inactivation of both PKA 
and Sch9, independently of TORC1 regulation, triggers autophagy. Additionally, as the inactivation of 
Sch9, PKA and TORC1 has an additive effect, probably the three, at least in part, cooperate in 
parallel in the autophagy regulation (Fig. 14) [210]. The common downstream targets of PKA and 
Sch9 pathways, the stress resistance transcription factors Msn2/Msn4 and the protein kinase 
Rim15, are required for autophagy induced by inactivation of these pathways, but not for autophagy 
induced by inactivation of TORC1 [210]. 
 
 
 
Figure 14. The signaling pathways that regulates autophagy in yeast cells. Adapted from [214]. 
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In yeast, the abrogation of the conserved TOR, Ras/cAMP-dependent protein kinase A (PKA) 
or Sch9 proteins, that integrate the network of nutrient sensing pathways, is known to promote 
longevity (Fig. 14) [214-217]. These signaling pathways are negative regulators of autophagy, 
reinforcing that autophagy and aging are coordinately regulated by a complex network of different 
signaling pathways, with partial overlapping branches and yet undisclosed hierarchic connections. 
 
 
1.2.4.2 Energy sensing 
 
SNF1. Snf1 is the yeast homologue of the mammalian AMP-activated protein kinase 
(AMPK), and functions as an energy sensor that is able to reprogram the cellular metabolism in 
order to restore the normal energy levels essential to sustain cell metabolism and to support a stress 
response. Snf1 is activated in response to glucose depletion in attempt to allow transcription of 
glucose-repressed genes, however its activity increases in aged cells even when glucose is abundant 
(reviewed in [218]).  
It is established a crosstalk between this energy sensing protein and the nutrient-sensing 
players. In fact, Sch9 was shown to be a common downstream target of the intrinsic aging defense 
pathway controlled by Snf1 kinase and the extrinsic nutrient-sensing pathway regulated by TORC1, 
additionally, Snf1 is also regulated by PKA [219]. In contrast to AMPK, Snf1 is negatively regulated 
by TORC1, but it can positively regulate autophagy (reviewed in [218]). The molecular mechanism 
underlying Snf1 regulation of autophagy is still elusive, but appears to be partially dependent on the 
inactivation of TOR kinases [220] and on the direct Atg1 phosphorylation [214]. Apparently, Snf1 is 
associated with the DNA replication stress, and several evidence suggests a strong interconnection 
between DNA replication stress, autophagy and nutrient signaling pathways. Nevertheless, the 
underlying crosstalk between DNA replication stress, autophagy and nutrient sensing pathways and 
the role of snf1 in this crosstalk remains to be elucidated. 
 
 
 
 
37 
1.2.4.2 Stress response 
 
ER stress. As above referred, the ER is the major compartment in the cell that facilitates 
folding of newly synthesized proteins. Several evidence suggests that autophagy is induced by the ER 
stress (Fig. 15), and the signaling mechanisms associated with that regulation are dependent on the 
specific stress conditions and the organism in study. ER stress response is normally activated in an 
attempt to protect the cells from changes that alter the organelle homeostasis. In this sense, 
autophagy can help cells to handle with ER stress, contributing to the elimination of unfolded or 
aggregated proteins or even participating in the mechanisms of ER stress-induced cell death 
(reviewed in [221]). In yeast, chemical induction of ER stress triggers autophagy by the Atg1 kinase 
[139]. In fact, activation of the Ire1-Hac1 arm, particularly Hac1 is capable of inducing the 
expression of several ATG genes, like ATG5, ATG7, ATG8, ATG14 and ATG19 (Fig. 15) [194, 195]. 
Additionally, ER proliferation leads to the formation of autophagosome-like structures that are 
densely and selectively packed with membrane stacks derived from the UPR-expanded ER [155].  
In mammalian, PERK and IRE1 have been implicated as mediators of ER stress-induced 
autophagy. It is demonstrated that the ER stress response to the presence of aggregates in the 
cytosol, particularly PERK or its downstream target eIF2α, upregulates Atg12 expression and 
induces autophagy confirmed by the conversion of LC3-I to LC3-II [194] (Fig. 15).  
Under certain scenarios, when the intensity or duration of the ER damage cannot be 
restored, ER stress can also lead to cell death via both apoptosis and autophagy [222]. Therefore, 
depending on whether pharmacological or genetic inhibition of autophagy improves or prevents cell 
death, stimulation of autophagy induced by ER stress can generate a protective or a cytotoxic 
response.  
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Figure 15. Signaling cascades inducing autophagy upon ER stress. The transmembrane protein Ire1 (in yeast and 
mammalian cells), ATF6 and PERK (mammalian cells) sense the accumulation of unfolded proteins and/or aggregates, 
triggering a general transcriptional response that disturbs the levels of proteins involved in autophagy. From [223]. 
 
 
Oxidative stress. A common intracellular stress that apparently leads to induction of 
autophagy is the formation of ROS, which are essentially generated in mitochondria, as above 
mentioned. The link established between ROS and autophagy induction is via the cysteine protease 
Atg4, responsible for the cleavage of Atg8/LC3 from the autophagosome (as above described). In 
fact, ROS inhibit Atg4 protease activity and promote the lipidation of Atg8/LC3 [224]. Additionally, 
stimulation of autophagy induced by starvation, inhibitors of mitochondrial electron transfer chain or 
even addition of exogenous hydrogen peroxide (H2O2) is correlated with increased superoxide anion 
(O2
2-) production along with H2O2 decrease suggesting that O2
2- is the major ROS involved in 
Autophagy induction 
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autophagy modulation. Furthermore, the scavenging of O2
2- accumulation by overexpression of Sod2 
is able to inhibit autophagy and increases starvation-induced cell death (reviewed in [225]).  
Even though, ROS are involved in autophagy induction, autophagy can also have an impact 
on ROS production. Therefore, it is possible that autophagy induction results in the removal of 
specific proteins, like the detoxifying enzymes, generating a self-sustaining loop, which enhanced 
ROS production by mitochondria that promotes an over-activation of autophagy (reviewed in [225]). 
Therefore, ROS acts as positive regulators of autophagy, while autophagy induction can either 
reduce or increase oxidative stress. 
 
 
1.2.5 Autophagy in cell survival and cell death  
 
Autophagy is a crucial process to maintain cell homeostasis, particularly important in post-
mitotic cells, since they do not have the capacity to get rid of their waste through cell division [226, 
227]. Autophagy is a process that is present at basal levels, in most cells, contributing to the 
turnover of cytoplasmic components. Usually, it is induced during starvation in an attempt to 
maintain the energy homeostasis. Nevertheless, its induction is not only restricted to starvation, the 
autophagy network is likewise involved in the clearance of damage organelles, the degradation of 
intracellular pathogens and also protein aggregates that cannot be removed by the UPS (reviewed in 
[228]).  
An apparent counter intuitive aspect is that besides the autophagy cytoprotective role, it is 
also participating in cell death, probably due to uncontrolled over stimulation of autophagy (reviewed 
in [229]). Autophagic activity above a certain threshold engulfs largely portions of the cytosol and 
organelles, which could result in an irreversible type of cellular atrophy and cause a total collapse of 
cellular functions. In fact, it was shown that during intense autophagic activity, the total area of 
autophagic vacuoles may equal that of the cytosol and organelles outside the vacuole (reviewed in 
[228]). Paradoxically, autophagy has also been implicated in a type of programmed cell death (type 
II PCD), designed by autophagic cell death that is different from apoptosis and necrosis, which was 
first described as a type of cell death with the presence of autophagosomes [230], but they may also 
accumulate as a result of inhibition of the processing of autophagosomes rather than an 
upregulation of autophagy. In this sense, recently new criteria were defined, and then autophagic 
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cell death is characterized by: (i) cell death that occurs without the involvement of the apoptosis 
machinery; (ii) increase of autophagic flux, and not only an increase of the autophagic markers, in 
the dying cells; and (iii) suppression of autophagy via pharmacological inhibition and genetic 
approaches can be able to rescue or prevent cell death [231].  
It is now accepted that autophagy can participate in cell survival under determined 
circumstances and also promotes cell death in other, being context-dependent, depending on 
features such as the nature of the stimuli, the cell type and the presence or activation of other 
autophagy-related factors. Nevertheless, the primordial function of autophagy is associated with a 
rapid cellular rearrangement in an attempt to promote the cell survival. 
 
 
1.2.6 Autophagy and aging 
 
Aging is a complex, continuous and dynamic process that begins immediately after birth and 
ends with death [232]. It is associated with a general and progressive decline of cellular processes 
that ultimately culminate in cell death. Aging, at the molecular level, is characterized by a 
progressive accumulation of damage in DNA, RNA, lipids and proteins. In fact, the most related 
aging symptom at the molecular level is the accumulation of altered proteins, both polypeptide chain 
length and amino acid composition [233, 234]. In this sense, the age-dependent decrease in the 
activity of the quality protein control system such as autophagy is believed to be the main cause for 
the accumulation of dysfunctional organelles and damaged molecules, particularly critical in post-
mitotic cells [235, 236]. The genetic and pharmacological inhibition or enhancement of autophagy is 
respectively correlated to decreased or increased longevity. Indeed, the vast majority of interventions 
found to increase longevity are autophagy-dependent, suggesting a crucial cytoprotective role of 
autophagy and the tight relation between autophagy and aging.  
In yeast, the abrogation of the conserved TOR, Ras/cAMP-dependent protein kinase A (PKA) 
or Sch9 proteins, which integrate the network of nutrient sensing pathways, is known to promote 
longevity [214-217]. These signaling pathways are negative regulators of autophagy, supporting that 
autophagy and aging are coordinately regulated. Another important aspect to consider when 
analyzing the regulation of autophagy and aging by nutrient sensing pathways is the dietary 
intervention, caloric restriction (CR). CR is the only non-genetic intervention that, until date, is the 
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best approach used to delay the onset of aging. CR consists in the reduction of calories intake while 
maintaining appropriate levels of essential nutrients such as minerals and vitamins. CR regime 
changes from glucose or amino acids limitation and incubation in water for yeast, axenic medium or 
bacterial deprivation for worms, reduced availability of yeast for flies and calories or amino acid 
restriction or alternated day feeding for rodents. It is responsible for 20% to more 100% life span 
expansion in these organisms [237-246]. Nevertheless, although in several models the CR beneficial 
in the prevention of aging, a direct effect of CR on the life span extension in human and primates is 
still under discussion [247]. Importantly, CR exerts its effects by reducing the activity of various 
signal transduction pathways either directly or through the decrease in the activity of nutrient-sensing 
pathways, such as the TOR, PKA and Sch9. The transduction pathways are able to activate a stress 
response and particularly to induce the antioxidant defenses [248], by inducing catalase activity and 
the superoxide dismutases (SODs) [249, 250]. Thus, CR restriction regulates several signaling 
pathways that are linked to autophagy regulation, suggesting that CR is also regulating autophagy. In 
this sense, it is proposed that autophagy is one of the mechanisms associated with the extension of 
life span by caloric restriction [251], since in cells where the expression of different ATG genes was 
abolished, the anti-aging effects of CR were reverted [252, 253]. 
Although TORC1 is the most studied regulator of autophagy, molecules such as the 
acetylase inhibitor, spermidine, and the deacetylase activator (Sirtuin1), resveratrol, prolong life span 
of multiple species in a TOR-independent autophagy-dependent fashion [193]. Interestingly, in yeast 
the longevity effects of CR are also associated to the sirtuins activity (reviewed in [202, 254-256]), 
particularly the yeast replicative life span, pointing to a complex and elaborated network regulating 
autophagy and aging. Sirtuins are a family of deacetylases that function either as deacetylases or as 
ADP ribosylase enzymes, which are regulated by the cofactor NAD+ and thus may serve as sensors 
of the metabolic state of the cell [257]. In yeast, while high Sir2 activity has been reported to extend 
replicative life span by inhibiting the progressive enlargement and fragmentation of the nucleoli in 
old cells resulting from the accumulation of toxic extrachromossomal ribosomal DNA circles (ERCs) 
[239], in chronological life span, Sir2 appears to have a different role. Under non-CR conditions, 
deletion or overexpression of Sir2 has no effects on the CLS, nevertheless it is described that the 
CLS extension experienced by cells under extreme CR is also dependent on the role of Sir2. In this 
sense, the findings suggest that in S. cerevisiae, Sir2 deacetylases play both pro- and anti-aging 
roles in different contexts (reviewed in [257]). 
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Mammalian cells possess seven sirtuins, in which SIRT1 is the closest to the yeast Sir2, 
nevertheless the aging phenotype associated with SIRT1 overexpression and abrogation has not yet 
been determined. However, several studies have reported that also in mammals sirtuins may affect 
aging [258]. 
Together, the accumulating findings, above described, point to the existence of an 
elaborated network signaling autophagy and aging, and pharmacological manipulation of autophagy 
appears as an attractive strategy to delay aging and has been motivating the development and the 
search for drugs that directly or indirectly, regulate autophagy activity. Nevertheless, the pleiotropic 
nature of nutrient signaling pathways regulating autophagy and the dual and opposite functions, 
cytoprotective or detrimental according to the context, of autophagy generate serious limitations. 
 
 
1.2.7 Monitoring autophagy 
 
Given the impact of autophagy in several physiological and pathological processes, it was 
necessary to establish methods to correctly identify, quantify and manipulate the autophagic 
process. Thus, in the last years, the identification of the autophagic machinery players and the 
possibility to experimentally manipulate the autophagic process allowed the development of 
innumerous techniques to monitor and modulate autophagy in order to prove its role in determined 
processes [259].  
To evaluate autophagy, it is necessary to have in attention that an increased number of 
autophagosomes is not directly related with an induction of autophagy, since autophagosome is an 
intermediated structure and the number, at determined time point, is a function of the balance 
between the rate of their generation and the rate of their conversion into autolysosomes. Therefore, 
autophagosome accumulation may denote either autophagy induction or, alternatively, inhibition if a 
blockage of the process occurs before the autophagosome formation [259].  
Microscopy, in particular electron microscopy (EM), is an old methodology, that it is still 
indispensable for the monitorization of autophagy. The EM has been used to quantify the 
autophagosomes number. Nevertheless, although the autophagosome is a double membrane 
structure that contains undigested cytoplasmic material including organelles, whereas autolysosome 
is a single membrane structure containing cytoplasmic components at various stages of 
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degradation, it is not always possible to distinguish the autophagosomes from autolysosomes, and 
there is no specific biochemical marker that distinguishes the both organelles [260]. In this sense, 
new adaptations to the EM methodology were developed, using the combination of positive and 
negative markers, such as immunogold labeling studies [118]. Since assessment of the 
autophagosome by EM techniques requires specialized expertise and is very expensive, alternative 
methodologies were developed. In the last years, it became widely used the quantification of 
autophagosomes by counting the GFP-Atg8/LC3 punctate, using fluorescence microscopy, both in 
yeast and in mammalian cells. As above referred, Atg8/LC3 is a unique autophagic marker, since 
their lipidated form remains attached to the autophagosome until the fusion with the 
lysosome/vacuole. Nevertheless, the quantification of the autophagosomes by this technique has 
several constrains. Since Atg8–PE/LC3-II is associated with all types of autophagic organelles, 
including the pre-autophagosomal phagophores, and its formation/lipidation/delipidation kinetics is 
not well established, it is almost impossible, at least with the currently available antibodies, to 
distinguish between Atg8/LC3-I and Atg8-PE/LC3-II [109]. Thus, the autophagosomes quantification 
may not be entirely correct. Surprisingly, in yeast, it is possible to assess, by light microscopy, the 
accumulation of undigested autophagic bodies in the vacuole. In this assay the cells must be treated 
with protease inhibitors such as phenylmethanesulfonyl fluoride (PMSF), to inhibit the degradation of 
autophagic bodies, or it can also be used vacuolar protease mutant strains [261]. This method 
cannot be applied to mammalian cells because the lysosome is too small.  
More recently, the measurement of autophagy flux by the LC3 turnover was introduced, 
essentially in mammalian cells. In this assay cells must be treated with lysosomal inhibitors that will 
impair the LC3-II degradation resulting in LC3-II accumulation. Therefore, the differences in the LC3-
II amount between samples in the presence and absence of lysosomal inhibitors represent the 
amount of LC3 that is delivered to lysosomes for degradation [262]. Another developed method is 
based on the disappearance of total LC3/Atg8 that will be directly correlated with autophagy flux. In 
this method, which can be applied to mammalian and yeast cells, the reduction of total LC3/Atg8 
can be quantitatively and sensitively monitored by flow cytometry [263] or by immunoblot analysis 
and is inversely correlated with autophagic flux. To perform this technique, the LC3/Atg8 must be 
fused with tag proteins, like GFP. Additionally, other autophagy substrates like p62 can be used to 
monitor autophagy flux [264].  
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Due to the different issues associated with the microscopic methodologies, biochemical 
assays to assess the autophagosome number were also developed. In mammalian cells, LC3 is also 
used in biochemical assays to assess autophagosome numbers. The conversion from endogenous 
LC3-I to LC3-II and from GFP-LC3-I to GFP-LC3-II can be detected by immunoblotting with antibodies 
against LC3 or GFP, respectively. In this assay it is established that the amount of LC3-II is 
correlated with the number of autophagosomes [109]. Nevertheless, not all LC3-II is present on 
autophagic membranes and some population of LC3-II seems to be ectopically generated in an 
autophagy-independent manner [259].  
Besides the methodologies described to assess the number of autophagosomes, the 
autophagic flux assays were also designed to reveal if the autophagosome number is correlated with 
autophagy induction or inhibition. One of the most traditional methods to evaluate autophagy flux, 
that can be a performed in yeast and mammalian cells, is the measurement of the degradation of 
long-lived proteins [265]. It is possible to measure the bulk degradation of long-lived proteins, by 
incubating cells with radioactive amino acids to label all cellular proteins. The accumulated 
radioactivity is directly correlated to the degradation of long-lived proteins. It should be noted that the 
distinction between long-lived and short-lived proteins is not always possible and that a considerable 
fraction of the long-lived proteins degradation will, therefore, reflect non-autophagic proteolysis 
[266]. In this sense, some long-lived proteins and even other macromolecules that appear to be 
exclusively degraded by autophagy, can be used to specifically measure autophagy including lactate 
dehydrogenase (LDH) and lactose [267].  
All the above described methods are based on the disappearance of a signal/protein, 
nevertheless there are inherent difficulties because the reduction of the protein levels is generally so 
small and occurs so slowly that the detection of the changes is hampered by the high background of 
the remaining protein. In this sense, to overcome this difficulty, in yeast was developed a method 
that allows the quantification of the autophagic flux based on the incremental increase of a signal, 
particularly it is based in the measurement of an enzyme activity. Yeast cells own a vacuolar alkaline 
phosphatase, Pho8, which contains a N-terminal transmembrane domain that acts as an internal 
uncleaved signal sequence allowing translocation into the ER, but as the majority of the resident 
vacuolar hydrolases, Pho8 is delivered into the vacuole through a portion of the secretory pathway 
[268]. When Pho860, which lacks the membrane spanning region and cytosolic tail, is expressed 
in cells where the endogenous Pho8 was abrogated, the modified inactive protein will be detected in 
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the cytosol. When autophagy is induced the Pho860 is transported to the vacuole via autophagy, 
where it is activated, and this conversion can be enzymatically measured, for instances through the 
alkaline phosphatase (ALP) assay [269]. 
To accomplish a more specific measurement of autophagy, it is important to execute the 
above described methodologies in the presence of autophagy modulators [259]. Actually, in 
autophagy research, one of the most severe problems is the lack of highly specific autophagy 
modulators, both inhibitors and activators. Nonetheless, some modulators are available, and it is 
also possible to perform genetic manipulation techniques, as schematized in figure 16 [270]. In 
yeast and mammalian cells, the commonly used pharmacological approaches to inhibit autophagy 
involve the use of PI3-kinase inhibitors such as wortmannin or 3-methyladenine (3-MA). These drugs, 
inhibitors of class III phosphatidylinositol 3-kinases, block the autophagosome formation, 
nevertheless, they will also interfere with a variety of cellular processes [271, 272], including DNA 
synthesis and endocytosis, being necessary a careful analysis of the results. The other class of 
pharmacological inhibitors blocks autophagy at later stages of and include bafilomycin A1, 
chloroquine (CQ), and lysosomal protease inhibitors such as E64d and pepstatin A, which raises the 
lysosomal/vacuole pH leading to the inhibition of lysosome/vacuole-autophagosome fusion and to 
lysosomal/vacuole protein degradation. One major limitation of these inhibitors is also the fact that 
they affect other cellular processes besides autophagy, such as mitosis and endocytosis [259]. A 
more specific inhibition of the autophagy pathway is achieved by the knockout or knockdown of 
different ATG genes, which as observed in figure 16, can be applied in the several autophagy steps, 
allowing the study of a specific autophagy phase. In yeast, this approach can be easily performed. In 
mammalian cells, it is possible to implement the RNAi mediated approaches to induce the 
knockdown of certain Atg proteins, nevertheless, since the protein levels are not completely 
suppressed, the results must be carefully analyzed. Furthermore, the autophagy inhibition can 
results in mild phenotype, probably due to the presence of isoforms that can compensate for the 
deficiency [259]. 
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Figure 16. Schematic representation of the most common treatments and reagents used to modulate the autophagy 
process. From [259]. 
 
 
Autophagy can also be stimulated. Like the autophagy inhibitors, the autophagy inducers 
lack specificity to the autophagic pathway. The most efficient physiological inducer of autophagy is 
starvation. Another way to activate autophagy is through the modulation of the nutrient-sensing 
signaling pathways, in which the most used target is the TOR kinase. It can be used rapamycin and 
its analogs, such as CCI-779, that will inhibit TOR and activating autophagy. However, TOR inhibition 
is not a specific inducer of autophagy, since other cellular responses, particularly protein synthesis 
and cellular metabolism, are also affected [259].  
Currently, to measure autophagy, it is available a large number of methods, however none 
of them is a perfect method to evaluate the autophagosome number and autophagy flux. Therefore, 
to perform an accurate and rigorous evaluation of the autophagic activity it is necessary to apply 
multiple approaches. 
 
 
1.4 The protein misfolding related synucleinopathies 
 
The protein misfolding related synucleinopathies, in which Parkinson disease (PD) is 
included, is the most common neurodegenerative movement disorder, affecting millions of elderly 
persons worldwide [273-275]. PD is clinically characterized by major motor difficulties including 
uncontrollable resting tremor, muscular rigidity, impaired postural reflexes, and bradykinesia, which 
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differ between patients [273, 276]. Although, PD is a prevalent degenerative illness that affects the 
central nervous system and also the peripheral and enteric systems [276], the main neuropathology 
that underlie PD motor deficits is the loss of dopaminergic neurons in the substantia nigra pars 
compacta, which results in a severe depletion of striatal dopamine (DA) [273], as well as the 
presence of cytoplasmic, Lewy bodies, (LB) and neuritic, Lewy neuritis (LN) inclusions in the 
surviving dopaminergic neurons [277]. 
The PD etiology remains poorly understood, however the pathogenesis of this disease 
appears to be converging on common contexts: aging, oxidative stress, mitochondrial dysfunction 
and protein aggregation [51, 273]. PD is mainly a sporadic neurodegenerative disease. However, 
rare monogenic familial forms of the disease, characterized by early-onset and an autosomal 
dominant or recessive pattern of inheritance have also been identified [278]. Until now, 6 genes 
have been linked to familial PD. α-Syn and LRRK2/dardarin mutations are responsible for 
autosomal dominant forms of PD, whereas mutations in Parkin, PINK1, DJ-1 and ATP13A2 are 
associated with the autosomal recessive forms of PD. Additionally, the genes that codify for the 
ubiquitin carboxy-terminal esterase L1 (UCHL1), the mitochondrial serine protease (Omi/HtrA2) or 
the synaptic protein Synphilin-1, are also associated with PD, nevertheless these associations 
remain poorly understood [279-282]. α-Syn is a small protein that contains an imperfect sequence 
(KTKEGV) repeated about 6 times throughout the N-terminal half of the protein [283], a hydrophobic 
central region and an acidic C-terminal region (Fig. 17) [284]. This protein is natively unfolded, 
however it can be found in several aberrant conformational states such as oligomer, protofibril, and 
amyloid fibril [285]. The focus on α-syn emerged at the time that α-syn was identified as the major 
constituent of the Lewy bodies (LB). In fact, three autosomal dominant mutations, A53T, A30P and 
E46K, have been identified and linked to the familial forms of PD. Additionally, the duplication and 
triplication of the α-syn locus leads to earlier disease onset and faster progression [286]. 
Furthermore, excessive posttranslational modifications including phosphorylation, ubiquitination, 
nitration, oxidation, and the increase propensity to interact with other proteins modulate the 
predisposition of α-syn to fibrillize [285]. For instance, α-syn is essentially in a non-phosphorylated 
state in normal conditions, although in disease conditions, it is extensively phosphorylated. Indeed, 
in the post-mortem brain tissue from PD patients the majority of the α-syn presents in the LB is 
phosphorylated at Ser129. Thus, it is hypothesized that the phosphorylation at Ser129 serves as the 
priming event that leads to the LB formation [287].  
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The α-syn function is poorly understood, however mounting evidence indicates that α-syn is 
able to interact with some pathways, like the vesicular trafficking, the lipid metabolism, the protein 
quality control system and with the mitochondrial homeostasis. α-Syn regulates the membrane 
trafficking via vesicle budding or turnover. Thus, overexpressed or mutated α-syn allows the efficient 
vesicles budding from the ER, however hampers the vesicles dock and fusion with Golgi membranes 
[288], resulting in vesicles accumulation. In addition, endocytosis is also impaired by α-syn, 
triggering the obstruction of post-vesicle internalization steps and defects in vacuolar fusion. It is also 
described that α-syn inhibits the phospholipase D (LPD), which is involved in the lipids metabolism, 
causing the accumulation of lipids droplets. Besides lipids, α-syn appears to interact with several 
proteins, modifying their activity, what suggests that it acts as a chaperone protein. Moreover, 
expression of a-syn was shown to induce ubiquitin accumulation, impairment of the proteasome, 
mitochondria fragmentation and accumulation of ROS (reviewed in [289-291]).  
 
 
 
Figure 17. α-Synuclein protein domains and pathogenic mutations. Adapted from [292]. 
 
 
1.4.1 Synucleinopathies and the proteolytic systems 
 
The proteolytic systems, namely UPS and autophagy, have been associated with the 
pathogenesis of PD. Depending on the α-syn conformation state, it can be degraded by the UPS 
and/or by autophagy. The α-syn soluble form is degraded by by the chaperone mediated autophagy 
(CMA) and can also been degraded by the UPS (Fig. 18a). However, the misfolded α-syn aggregates 
leads to proteosomal dysfunction, probably because α-syn aggregates sequester ubiquitinated 
proteins, Hsp and components of the proteasome [293, 294]. This is also supported by data 
showing that overexpression of α-syn in cultured cells is able to inhibit the proteosomal activity, with 
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more strong effects observed with the α-syn clinical mutants [295, 296], and that aggregated α-syn 
interacts with the 19S cap [297]. The mutant forms of α-syn, particularly α-syn A53T, impair the 
CMA. They are able to bind to the lysosomal membrane with high affinity, but they aren’t 
translocated into the lysosome. Additionally, the binding to the CMA receptor leads to the block of 
the uptake and degradation of other CMA substrates and consequently to a general CMA blockage 
[298]. In PD, the blockage of CMA by α-syn prevents also the activation of protective proteins such 
as myocyte enhancer factor 2D (MEF2D), which is a transcription factor that plays a role in the 
neuronal survival. Indeed, the blockage of the CMA induces the upregulation of UPS and some 
compensatory autophagy (macroautophagy) (Fig. 18d), which appears to contribute to neuronal cell 
death [299]. Several reports showed that autophagosomes structures accumulate in the brain of PD 
patients [300] and animal models of PD [301], leading to the question of whether autophagy is a 
cause or a protective factor of neurodegeneration. On the other hand, it is also showed that aberrant 
α-syn is also able to inhibit autophagy through RAB1A, a GTPase involved in the early secretory 
pathway, ER-to Golgi transport. Additionally, the RAB1A inhibition leads to the mislocalization of Atg9 
and to the inhibition of autophagosome formation [302].  
Altogether these findings support the hypothesis that autophagy dysfunction is an important 
mechanism of PD pathogenesis. Importantly, aging is a major risk factor for neurodegenerative 
disorders, such as PD. During aging, an inefficient function of several processes becomes evident. 
Thus, the CMA loses efficiency with downregulation of LAMP-2A receptors, and consequently the 
UPS becomes the route of α-syn elimination (Fig. 18b). Additionally, upregulation of α-syn results in 
the failure of the CMA and in the UPS, and consequently in the induction of autophagy 
(macroautophagy) [303] (Fig. 18c).  
Recently, it was observed that in cells overexpressing α-syn or expressing α-syn A53T 
mutant form occurs a colocalization between autophagosomes and normal, polarized mitochondria, 
thus these cells presented a decrease number and length of mitochondria [304], suggesting that 
mitophagy may play a role in the PD pathogenesis. Moreover, this process of clearance apparently is 
dependent of Parkin, other gene associated with PD [304].  
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Figure 18. The proteolytic systems involved in α-synuclein degradation. a) Degradation of α-synuclein normally occurs 
though chaperone-mediated autophagy (CMA) with a smaller contribution from the ubiquitin-proteasome system (UPS). 
b) During aging the CMA becomes inefficient and the UPS is induced. c) Upregulation of α-synuclein induces the CMA 
activity, but over the time leads to the failure of the CMA and UPS, and autophagy (macroautophagy) adopts a more 
important role to compensate CMA and UPS failure. d) α-synuclein A53T mutant form blocks CMA, inducing the UPS 
and autophagy (macroautophagy). From [303].  
 
 
Furthermore, Parkin plays a role in the specific recruitment and degradation of damage 
mitochondria by autophagy. The data demonstrated that the treatment of cells with the carbonyl 
cyanide m-chlorophenylhydrazone (CCCP) results in the relocation of PARKIN to mitochondria 
followed by mitochondria loss. Further observations also indicated that the PARKIN-marked 
mitochondrial fragments are LC3 positive, demonstrating that the clearance of damaged 
mitochondria occurs through autophagy [305, 306]. In this process mediated by Parkin other PD 
relate gene also interacts, PINK1. Under normal cellular conditions, PINK1 is imported to the inner 
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mitochondria, although upon mitochondrial depolarization, the import of PINK1 is blocked occurring 
its accumulation on the outer membrane of damaged mitochondria. Thus, in this scenario Parkin is 
recruited to the mitochondria and apparently PINK1/Parkin modulates mitochondrial trafficking 
[307]. Nevertheless, how the recruitment of PARKIN to damaged mitochondria can promote their 
degradation is still illusive, but it is well established that some of the disease-associated mutations 
linked to Parkin and PINK1 result in impaired mitophagy [175, 308, 309]. Furthermore, besides α-
syn, PINK1 and Parkin, the other monogenic PD-related genes, LRRK2 [310] and DJ-1 [311] 
apparently are also associated with autophagy or mitochondrial dynamics, nevertheless further 
studies are necessary to elucidate that role in mitophagy. 
Together, these findings imply that beyond autophagy, the specific degradation of 
mitochondria (mitophagy) might play a significant role or even be the convergence points for 
different monogenic PD-related mutations that give rise to similar symptoms. Nevertheless, the 
significance of the mitophagy role and if it a cause or a consequence of the PD pathogenesis is yet 
controversial. 
 
 
1.5 Yeast models for synucleinopathies 
 
Several model systems have been developed to study PD, particularly synucleinopathies, 
from high eukaryotic models, like mice, to simple organisms, like yeast. Modeling mice are 
indispensable for studying the molecular basis of neurological disorders, nevertheless this model 
entails certain limitations that include slow pace, high costs and complex intrinsic pathways. Thus, it 
is not surprising that in recent years numerous neurological diseases have been modeled in 
genetically tractable organisms, including D. melanogaster, C. elegans and yeast S. cerevisiae [312]. 
Indeed, yeast models presents advantage with respect to genome-wide experimental approaches. 
The short generation time and the cheap manutention, together with the availability of a collection of 
precise deletion mutants of every gene in the genome, and the rapidly evolving databases of yeast 
protein–protein interactions and gene expression patterns. Additionally the key cellular processes 
associated with the neurodegenerative diseases are conserved between yeast and the higher 
eukaryotic cells. In this sense, these large and easily accessible bodies of information, coupled with 
the ease with which yeast can be manipulated genetically, have led to dissection of novel molecular 
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mechanisms underlying the pathogenesis of synucleopathies, including PD. Furthermore, the yeast 
models are preferred systems for the screening of chemical libraries, identification and validation of 
novel drugs, mainly because the compounds/drugs assays are performed in a physiologically 
relevant environment and their use is cost-effective and user friendly. Nevertheless, the yeast model 
also possesses limitations. The more pronounced begins with the presence of a cell wall and the 
most obvious when thinking in neurodegenerative diseases is the lack of cell-cell interactions, like 
immune and inflammatory responses and synaptic transmission among others. Furthermore, 
several pathways are far more complex in mammalian cells than in yeast. 
For modeling human disease in yeast, it is possible to follow two different approaches. When 
the human disease-related gene has a yeast homologue, the analysis can be made by the gene 
deletion or overexpression. On the other hand, if the human disease-related gene does not have a 
yeast homologue, the human gene is heterologous expressed in yeast and screens are designed 
against any relevant phenotypes that result from this expression [313]. In fact these strategies 
already prove to be useful. For example the yeast models of synucleinopathy, which are achieved by 
the heterologous expression of different forms of human α­syn in yeast [284, 291, 314-317], 
already allowed the study of the changes in α­syn distribution in living cells. Additionally, some 
central features of mammalian cellular pathology can be recapitulated in the yeast models, such as 
defective vesicle trafficking, proteasomal degradation, ROS accumulation, mitochondrial pathology 
and lipid-droplet accumulation [284, 291, 316, 318], permitting a more detailed study of the 
complex process in a simple organism.  
The yeast S. cerevisiae is also an established model for aging study. In yeast is possible to 
evaluate aging by two different methods, by the replicative life span (RLS) or by the chronological life 
span (CLS). RLS is related with the number of daughter cells produced by a mother cell prior to 
senescence, and is thought to provide a model of aging in mitotically active cells, whereas the CLS 
corresponds to the length of time that a mother cell can survive in a non-dividing state, and is 
proposed to serve as a model for aging of post-mitotic cells in multicellular eukaryotes [257]. In a 
context of age-related diseases, this model as the advantage of being an easily manipulable model 
with a short life cycle. In fact, the only studied in which was explored the effects of the expression of 
α­syn in aged cells was performed in yeast [319].  
The humanized yeast S. cerevisiae models provides a platform to explore fundamental 
processes that induce neurodegeneration, being an important tool to disclose protein function or 
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cellular pathways that are involved in misfolding, aggregation and subsequent toxicity of related-
protein diseases, in both proliferative and aged cells.  
 
 
This chapter attempts to summarize the relevant findings on the regulation of protein quality 
control system and its connection in a proteotoxicity context associated with α-syn toxicity. However, 
how different pathways of protein quality control influence each other, how they are regulated in a 
coordinated manner, and their contribution to aging under proteotoxicity remains to be answered. 
On the next chapters, results will be presented in an attempt to get new insights on the mechanisms 
associated with the toxicity induced by α-syn, during aging through the study of the effects of 
autophagy/mitophagy modulation during yeast CLS, hoping to contribute for the continuous 
knowledge on the regulatory mechanisms associated with synucleinopathies. 
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2.1 Strains and plasmids 
 
The yeast Saccharomyces cerevisiae strains and plasmids used in this study are listed in 
Tables 1 and 2, respectively. 
 
Table 1. Yeast strains used in this study. 
Yeast Strain Genotype 
W303-1A MAT a can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 ade2-1 
BY4741 MAT a his31 leu20 met15Δ0 ura3Δ0 
BY4741 rho 0 MAT a his31 leu20 met150 ura30 
atg11pho8 MAT a his31 leu20 met150 ura3v0 atg11::kanMX4 pho8::HPH 
atg32pho8 MAT a his31 leu20 met150 ura30 atg32::kanMX4 pho8::HPH 
sir2pho8 MAT a his31 leu20 met150 ura30 sir2::kanMX4 pho8::HPH 
 
 
2.1.1 Generation of rho 0 strains   
 
The BY4741 rho 0 strain used for lifespan analysis was generated by treatment with 
ethidium bromide. In a standard experiment cells are washed with sterile 10 mM KPO4, pH 7 and 
inoculated into 10 ml of 10 mM KPO4 phosphate, pH 7 buffer containing 10 µg/ml ethidium 
bromide. After incubation for 1 hour with shaking (150 rpm) at 26ºC cells are spread on YEPD 
plates for single colonies growth. Small colonies should correspond to respiratory deficient 
mutants. Each experiment was determined for more than one rho 0 isolate in order to verify the 
observed phenotype. Absence of mitochondrial DNA was verified by fluorescence microscopy of 
log phase cells stained with DAPI and by the absence of growth on the non-fermentable carbon 
source, glycerol.  
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Table 2. Plasmids used in this study 
Plasmids Type of Plasmid Source 
pRS304GAL-SynWT-GFP Integrative This study 
pRS304 GAL-SynA53T-GFP Integrative This study 
pRS304 GAL-SSynA30P-GFP Integrative This study 
pRS306 GAL-SynWT-GFP Integrative This study 
pRS306 GAL-SynA53T-GFP Integrative This study 
pRS306 GAL-SynA30P-GFP Integrative This study 
pCM252-SynWT-GFP CEN This study 
pCM252-SynA53T-GFP CEN This study 
pYX242-SynWT 2µ Winderickx, J [320] 
pYX242-SynA53T 2µ Winderickx, J [320] 
pYX242-SynA30P 2µ Winderickx, J [320] 
pYX222-SynWT 2µ This study 
pYX222-SynA53T 2µ This study 
pYX222-SynA30P 2µ This study 
pYX242-cytPho8 2µ Reichert, AS [168] 
pYX242-mtPho8 2µ Reichert, AS [168] 
pYX222-mtDsRed 2µ Gourlay, CW 
pRS416-GFPAtg8 2µ Reggiori, F 
 
 
2.1.2 Construction of the double mutants strains: atg11pho8, atg32pho8 and 
sir2pho8   
 
The PHO8 yeast cells from the Euroscarf, disrupted with a geneticin cassette were used 
as template. Therefore it was used the plasmid pAG34, which contains the hygromycin cassette 
and homologous regions relative to the locus of interest, to perform the homologous 
recombination. Linerized pAG34 with the XhoI restriction enzyme, were introduced in PHO8 
yeast cells (Euroscarf) by transformation with the LiAc method. Cells were then plated in selective 
YEPD medium containing hygromycin, to select the positive clones. The correct integration of the 
marker at the target locus in these transformants was then verified by PCR, using the internal 
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primers (3 and 4) paired with the external primers (5 and 6) (Table 3), which allowed the 
confirmation that the hygromycin cassette is located in the correct place. 
Next, it was proceeded with the disruption of the PHO8 gene in atg11, atg32 or sir2 
mutant cells For that, first it was amplified the hygromycin selection cassette using the internal 
primers (3 and 4) paired with the external primers (1 and 2) (Table 3). Primers 1 and 2 have 
about 50 oligonucleotides from the flanking region on either side of the PHO8 gene, to allow the 
homologous recombination. The cassette was amplified in two separate PCR reactions to 
produce overlapping fragments, to minimized false positive appearance. The PHO8 gene 
disruption was achieved by co-transformation, as described before. The resulting cells were then 
plated in selective YEPD medium containing hygromycin and geneticin. Once again, the resistant 
transformants were checked for correct integration of the marker at the PHO8 locus, as above 
described.  
 
 
Table 3. Primers used to construct the double mutants atg11pho8, atg32pho8 and sir2pho8 
Number Primer name Sequence 
1 Pho8-AMP-FW 5’-GCCAGCAAGTGGCTACATAAA-3’ 
2 Pho8-AMP-RV 5’-CAGTACGTGTCATGCGGTTAG-3’ 
3 HYG-FW 5’-CGCAAGGAATCGGTCAATAC-3’ 
4 HYG-RV 5’-AAAGCATCAGCTCATCGAGA-3’ 
5 Pho8-CONF-FW 5’-CGACATGAATAGCAGCATTGA-3’ 
6 Pho8-CONF-RV 5’-TCACGCTATAGAATGCACCT-3’ 
 
 
2.2 Media and culture conditions 
 
Cells were maintained in YEPD agar medium consisting of 0.5% yeast extract, 1% 
peptone, 2% glucose and 2% agar. All experiments were performed in synthetic complete (SC) 
medium containing 0.67% (w/v) yeast nitrogen base without amino acids (Difco Laboratories, 
Detroit, MI) supplemented with the appropriate amino acids and bases for which the strains were 
300 mg/L leucine, 50 mg/L histidine, 100 mg/L adenine, 100 mg/L tryptophan, 100 mg/L 
methionine or 100 mg/L uracil. Calorie restriction (CR) was accomplished by reducing the 
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glucose concentration from 2% to 0.5 in the initial culture medium. In a standard experiment, 
overnight cultures were grown in either media and inoculated into flasks with a ratio 
volume/medium of 3:1 at 26ºC with shaking at 150 rpm. Growth was monitored by measuring 
the turbidity of the culture at 640 nm (OD640) on a spectrophotometer (Genesys 20/Thermo 
Spectronic) and viability was determined by counting colony-forming units (CFUs) after 2 d of 
incubation at 26 ºC on YEPD agar plates.  
 
 
2.3 Chronological life span 
 
Yeast chronological life span (CLS) was measured as previously described [321]. In a 
standard experiment, overnight cultures were grown in SC medium containing different 
concentrations of glucose and then inoculated into flasks containing medium with the same 
concentration of glucose at a volume ratio of 1:3. These cultures were then incubated at 26 °C 
with shaking at 150 rpm.  
Depending on the expression model used, different manipulations were performed. For 
the galactose-inducible (high toxicity) models, cells were grown until exponential, diauxic or 
stationary phases, harvested by centrifugation, washed twice with sterile water and then 
transferred to a SC medium containing 2% (w/v) galactose to induce α-syn expression. For the 
Tet-On models (low toxicity models), cells were grown at 26ºC and 150 rpm, until exponential or 
stationary phases, and then doxycycline was added to the medium at a final concentration of 2 
µg/ml in order to induce the expression of α-syn. Finally, the cells expressing α-syn under the 
control of the constitutive TPI1 promoter (moderate toxicity model) were grown until stationary 
phase.  
The survival of the cells from the inducible expression systems, Tet-On and GAL1, was 
assessed by counting colony-forming units (CFUs) after incubation of culture aliquots for 2 days 
at 30°C on YEPD agar plates. Regarding the moderate expressing system (constitutive TPI1 
promoter), cultures reached stationary phase two days later and this was considered day 0 of 
chronological life span (CLS). Survival was assessed by CFUs beginning at day 0 of CLS (when 
viability was considered to be 100%), and then again every 2-3 days until less than 0.01% of the 
cells in the culture were viable.  
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The CLS was also determined by flow cytometry, using the fluorescent probes propidium 
iodide (PI) and FUN1 beginning at the day that cultures achieved stationary phase (day 0) and is 
expressed as % survival compared to survival at day 0 (100 %). Briefly, for PI staining 106 cells 
were collected at indicated time points, washed twice, ressuspended in PBS and stained with 5 
µg/ml PI for 30 min at 30ºC in the dark. For FUN1 staining, aliquots of 106 cells were collected 
at indicated time points, washed twice and ressuspended in sterile water supplemented with 2% 
glucose and stained with 0.5 µM FUN1 for 30 minutes at 37°C. The PI and the FUN1 signals 
were measured using FACSCaliber2 flow cytometer (BD-Biosciences) with a 488 nm excitation 
laser. Signals from 30,000 cells/sample were captured at a flow rate of 1,000 cells/s. Data 
collected with the FACSCaliber2 flow cytometer was processed with Flowjo software (Tree Star) 
and quantified with WinList software (Verity Software House). 
 
 
2.3.1 Determination of maximum and minimum chronological life span  
 
Mean, which represents 50% of cell survival, and maximum, which represents 10% of cell 
survival, chronological life spans were determined from curve fitting of the survival/CLS data, 
from pair matched, pooled experiments with the statistical software Prism (GraphPad Software). 
 
 
2.4 Pharmacologic induction or inhibition of autophagy 
 
Pharmacological induction of autophagy was accomplished by treating the cells at day 0 
of CLS with 2 µg/ml of rapamycin. To perform the pharmacological autophagy inhibition assay, 
the cells were treated at day 0 of cells with 10 mM 3-methyladenine (3-MA), which inhibits the 
phosphatidylinositol 3-kinases (PI3K), blocking the autophagosome formation [322], or with 0.5 
mM chloroquine (CQ), which raises the lysosomal/vacuole pH leading to the inhibition of 
lysosome/vacuole-autophagosome fusion and lysosomal/vacuole protein degradation [229, 323-
326]. Next CLS was determined as described before, in section 2.2. 
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2.5 Index of respiratory competence (IRC) 
 
The IRC reflects the respiratory status of mitochondria and thus mitochondrial 
functionality. It can be defined as the ability of cells to grow on non-fermentable substrates such 
as glycerol. The IRC was calculated by the ratio between the number of CFUs on non-fermentable 
carbon source (yeast extract/peptone and 2% glycerol, YPG) and the colonies on a fermentable 
carbon source (YEPD) agar plates.[327] 
 
 
2.6 Superoxide dismutase (SOD) assays 
 
For determination of superoxide dismutase activities, yeast extracts were prepared in 25 
mM Tris buffer (pH 7.4) containing a cocktail of protease inhibitors. Protein content of cellular 
extracts was estimated by the method of Bradford (Bio-Rad) using bovine serum albumin (BSA) 
as a standard. Briefly, for determination of catalase activity 15 µg of proteins were separated by 
native PAGE. Then the gel was incubated in 2.5 mM nitro blue tetrazolium, during 20 min in 
dark, followed by an incubation with developed solution (36 mM phosphate potassium buffer, pH 
7.8; 28 mM Temed and 86 µM riboflavin), during 15 min in dark. Next gel were transferred to 
deionized water and exposed to light until the appearance of bands. Superoxide dismutase 
activities were measured based on their ability to inhibit reduction of nitro blue tetrazolium to 
formazan in non-denaturing polyacrylamide gels [328]. Sod2 activity was distinguished from 
Sod1 activity based on the ability of 2 mM cyanide to inhibit Sod1, but not Sod2. Quantification of 
band intensities was performed by densitometry using Quantity One Basic Software from Bio-Rad. 
 
 
2.7 RNA extraction  
 
RNA was extracted with phenol, using the following procedure: 0.8 ml of cold TRIzol LS 
reagent (Invitrogen) were added to the yeast pellet and the resulting suspension was transferred 
to a microcentrifuge tube containing 0.5 g of sterile glass beads, 0.5 mm diameter, which had 
been soaked in concentrated nitric acid, washed thoroughly with water, and dried overnight in a 
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baking oven at 200°C. The suspension was shaken for 4 min in a vortex mixer; after 5 min at 
room temperature, 0.2 ml chloroform were added and the tubes shaken vigorously by hand. After 
5 min incubation in ice, the suspension was centrifuged at 7000g for 15 min in the cold. The 
upper, aqueous phase was transferred to a new tube, 0.5 ml isopropanol were added, the 
mixture was incubated 10 min in ice and centrifuged at 11,000 g for 10 min in the cold. The 
supernatant was removed and the pellet washed with 1 ml cold 70% ethanol. After vacuum-drying 
for 5 min, the RNA pellet was dissolved in 50 µL of RNAse free water. 
The purity of the sample was checked by the ratio A260/A280 [using the ND-100 UV-
visible light spectrophotometer (NanoDrop Technologies)]. The RNA integrity was assessed by 
visual inspection, after electrophoresis on 1% agarose gel, in the presence of ethidium bromide. 
 
 
2.8 Quantitative mRNA expression  
 
The quantitative mRNA expression analysis was performed according to the MIQE 
guidelines (Minimum information for publication of quantitative real-time PCR Experiments 
[329]). First, the primers listed in Table 4 were constructed, by in silico analysis, in Beacon 
Designer 7.90 software (Premier Biosoft International). The primers were constructed in an 
attempt that all annealing temperatures were in a range between 53°C and 58°C, and 
preferentially located near the 3' terminal portion. This software includes a BLAST analysis 
against S. cerevisae genome sequence for specificity assurance, and uses Mfold server, to avoid 
positioning on risky secondary structures. To determine the optimal annealing temperature of the 
primers it was performed a quantitative real-time PCR (qPCR) at a range of around the calculated 
Tm of the primers, using a thermal gradient block. To check the specificity of the reaction, all 
melting curves were analyzed and checked the presence of one single shark peak. Also, the 
presence of a single fragment, with the expected sized of the reaction product (one sample per 
gene) was confirmed by 1% agarose gel electrophoresis. It was established the efficiency of the 
primers by a calibration curve using a sample of cDNA as template. The PCR efficiency of each 
primer pair (Eff in Table 4) was evaluated by the dilution series method using a mix of sample 
cDNAs as the template and was determined from calibration curves using the formula 10(-
1/slope). After, a regular qPCR protocol was taken to each dilution, in duplicate to all primers 
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used in this study, the corresponding quantification cycle (Cq) values were determined. Then, the 
measured Cq values were plotted against the log of the copy number of the template, creating the 
Cc which allowed the calculation of the efficiency from the slope and R2 value. 
 
 
Table 4. List of primers for quantification of mRNA expression and their efficiency (Eff) 
Gene Primer sequence Eff (%) 
ACT1 
F: GATCATTGCTCCTCCAGAA 
98.2 
R: ACTTGTGGTGAACGATAGAT 
PDA1 
F: TGACGAACAAGTTGAATTAGC 
94.8 
R: TCTTAGGGTTGGAGTTTCTG 
TDH2 
F: CCGCTGAAGGTAAGTTGA 
95.1 
R: CGAAGATGGAAGAGTTAGAGT 
ATG6 
F: TGTCTACTATGATGAGAATTTCA 
93.4 
R: TGGCTTGTTGTGAGTGTT 
ATG8 
F: AATATCTAGTTCCTGCTGACC 
98.2 
R: CCGTCCTTATCCTTGTGTT 
ATG32 
F: TTATTGTTTCCTCCAGTT 
91.8 
R: GCTTCGTCATCATTATCTTCC 
ATG33 
F: GTCTGTTTGTTTAGCCATCAC 
95.1 
R: AAAGTGGTTAAAGTGGGAGTA 
DNM1 
F: TCAACAGGAGAATGGACAA 
98.4 
R: CATCATCATCGTAGTCACTG 
 
 
To normalize the data of qPCR of our target genes we tested four putative reference 
genes: ACT1 (actin), PDA1 (alpha subunit of pyruvate dehydrogenase), TDH2 (isoform 2 of 
glyceraldehyde-3-phosphate dehydrogenase) and TUB2 (β-tubulin) in same experimental 
conditions. We used as reference, genes with Cq differences (Cq) between all the time points 
less than 0.5. Results are listed in Table 5.  
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Table 5. Quantification cycles differences (ΔCq) of the tested reference genes. 
Gene Cq 
 ACT1 0.31 
PDA1 0.36 
TDH2 0.33 
TUB2 0.63 
 
 
The qPCR was used to measure the mRNA transcripts of the ATG8, ATG6, ATG32, 
ATG33 and DNM1 genes. Three reference genes [ACT1 (actin), PDA1 (alpha subunit of pyruvate 
dehydrogenase) and TDH2 (isoform 2 of glyceraldehyde-3-phosphate dehydrogenase)] were 
selected due to their stable expression and were tested in the same experimental conditions 
allowing expression normalization. 
Total RNA (300 ng) was reverse-transcribed into cDNA in a 20 µL reaction mixture using 
the iScript™ cDNA synthesis kit (Bio-Rad). Then, 22.5 ng of cDNA of each sample were tested in 
duplicate in a 96-well plate (Bio-Rad), in a 20 µL reaction mixture using the SsoFast Evagreen 
Supermix™ kit (Bio-Rad) and processed according to the manufacturer’s instructions in a 
CFX96™ Real Time System (Bio-Rad). A blank (no template control) was also incorporated in 
each assay. The thermocycling program consisted of one hold at 95°C for 1 min, followed by 39 
cycles of 15 min at 95°C, 20 s at 57°C and 20 s at 72°C. After completion of these cycles, 
melting-curve data were collected to verify PCR specificity, contamination and the absence of 
primer dimers. Relative expression levels were determined with efficiency correction, which 
considers differences in the efficiencies between target and reference genes, using the gene 
expression module of the CFX manager Software (Bio-Rad). 
 
 
2.9 Determination of HAC1 mRNA splicing 
 
To determine the HAC1 mRNA splicing, real time reactions were carried out in the same 
manner as those used for quantification of mRNA expression (above described), using the primer 
pair: F: ATGACTGATTTTGAACTAACTAG and R: CAATTCAAATGAATTCAAACCTG (NCBI Gene ID: 
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850513). Afterward, the respective fragments were fractionated by electrophoresis on a 1% 
agarose gel.  
 
 
2.10 Determination of UPR activity 
 
Yeast strains transformed with the plasmids harboring the genes that codify to α-syn WT, A53T or 
A30P or the vector control were transformed with a second plasmid carrying UPRE-LacZ reporter 
gene. Then cells were cultured in the same conditions and collected at the specific time points. 
After cells were disrupted using glass beads in the Z-buffer [60 mM Na2HPO4.7H20, 40 mM 
NaH2PO4.H20, 10 mM KCl, 1 mM MgSO4.7H2O and 0.27% (v/v) β-mercaptoethanol] and 
assayed for β-galactosidase activity using the colorimetric substrate ONPG as previously 
described [330]. 
 
 
2.11 Autophagy and mitophagy activity 
 
The monitoring of autophagy and mitophagy was performed according to the protocol 
described by Mendl and co-authors [168] and Noda and Klionsky [269] Briefly, strains deleted for 
PHO8 gene were transformed with cytPho8- or mtPho8-expressing plasmids. At specific time 
points, 5x108 cells were collected, harvested, washed in 2 ml of ice-cold water containing 0.85% 
NaCl, 1 mM PMSF, and resuspended in 300 µL lysis buffer (20 mM PIPES, 0.5% Triton X-100, 
50 mM KCl, 100 mM potassium acetate, 10 mM MgSO4, 10 µM ZnSO4, and 1 mM PMSF). An 
equal volume of acid-washed glass beads was added and the cells were lysed by vortexing for 7 
min. To start the assay, 100 µl of extract was added to 400 µL reaction buffer [250 mM Tris-HCl, 
pH 8.5, 0.4% Triton X-100, 10 mM MgSO4, 4 mM nitrophenyl phosphate (Sigma)], and samples 
were incubated 15 min at 37°C before terminating the reaction by adding 500 µL of stop buffer 
(2 M glycine, pH 11). Generation of nitrophenol was monitored by measuring absorbance at 405 
nm using a microplate reader Model680 (Bio-Rad), and each sample was corrected with the time 
0 blank. Protein concentration in the extracts was measured with the Bradford (Bio-Rad) 
according to the manufacturer’s instructions. 
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2.12 Confocal microscopy 
 
For mitochondrial morphology and Atg8 analysis, strains expressing the α-syn or carrying 
the vector control were transformed with pYX222-mtDsRed and pRS416-GFPAtg8. At specific 
time points, cells were collected and imaged using a confocal Olympus FLUOVIEW microscope. 
To visualize the α-syn foci, the cells were collected and fixed in 4% paraformaldehyde during 15 
min. After washing, first with 100 mM cacodylate (pH 7.4) and then with TDES (100 mM Tris, pH 
7.5, 25 mM DTT, 5 mM EDTA and 1.2 M sorbitol), cells were incubated 10 min with TDES, at 
room temperature, to soften the cell wall, followed by a wash step with 100 mM phoscitrate 
buffer (100 mM K2HPO4, 100 mM citric acid): 1 M sorbitol. Cells were then incubated 30 min 
with 100 mM phoscitrate buffer: 1 M sorbitol containing 50 µl of β-glucuronidase and 25 µl of 10 
mg/ml zymolyase was added to produce spheroplasts. This was followed by a wash step with 
100 mM cacodylate: 5 mM CaCl2: 1 M sorbitol. Next, cells were permeabilized with 0.1% Triton-
X100 contained in 1X with phosphate-buffered saline (PBS), during 10 min. After 5 min rinsing 
with 0.1% BSA in PBS (137 mM NaCl, 2.7 mM KCl, 8 mM Na2HPO4, 1.8 mM KH2PO4), cells 
were incubated 2 h with the antibody anti--syn (Cell signaling) (1:400), followed by rinsing with 
0.1% BSA in PBS for 15 min. Next cells were incubated with the Pacific Blue conjugated goat 
anti-rabbit secondary antibody (1:100) for 4 h. Finally, cells were rinsed again with 0.1% BSA in 
PBS for 15 min, resuspended in PBS and visualized, at room temperature, by confocal 
microscopy. Images were acquired in a confocal Olympus FLUOVIEW microscope with an 
Olympus PLAPON 60X/oil objective, with a numerical aperture of 1.35. GFP and DsRed were 
excited with and argon laser and a helium-neon laser (GFP: 488 nm excitation; DsRed: 559 nm 
excitation). Pacific blue was excited with a UV laser (Pacific blue: 405 nm excitation). Background 
reduction was performed with appropriate saturation levels using software FV1000 (Olympus) 
and Adobe Photoshop CS. Image stacks for analysis were acquired with sequential steps of 0.25 
to 0.5 µm per plane in the z-direction and a total thickness of 4-6 µm. The acquired stacks were 
rendered with FV1000 software. 
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2.13 Assessment of ROS accumulation 
 
Free intracellular reactive oxygen species (ROS), specifically superoxide anions were 
measured using dihydroethidium (DHE) or dihydrorhodamine 123 (DHR). Aliquots of cells were 
collected at indicated time points and DHE was added to a final concentration of 5 µM from a 5 
mM stock in DMSO and cell were incubated for 10 min at 30°C. For DHR staining, aliquots were 
taken at selected time points and DHR was added to a final concentration of 15 µg/mL and cells 
were incubated for 90 min at 26 °C. After incubation, cells were washed once with PBS. The 
DHE signals were measured using FACSCaliber2 flow cytometer (BD-Biosciences) with a 488 nm 
excitation laser. The DHR signal was collected through a 488-nm blocking filter, a 550-nm long-
pass dichroic with a 525 nm band pass. Signals from 30,000 cells/sample were captured at a 
flow rate of 1,000 cells/s. Data collected with the FACSCaliber2 flow cytometer were processed 
with Flowjo software (Tree Star) and quantified with WinList software (Verity Software House). 
 
 
2.14 Preparation of protein extracts and western blot analysis  
 
For detection of protein levels by western blot, the total cellular extracts were collected at 
specific time points and extracted as previously described.[331] Briefly, cells were pre-treated 
with 2 M lithium acetate for 5 min at room temperature. After lithium acetate removal, 0.4 M 
NaOH was added for 5 min on ice. Next, the cell were resuspended in SDS-PAGE sample buffer 
and boiled for 5 min. Of total protein, 20 µg were resolved on a 12% SDS-PAGE gel and 
transferred to a nitrocellulose membrane during 7 min at 25V. The membranes were blocked 
with Tris-buffered saline (TBS) with 0.1% Tween 20 (TBST) containing 5% skim milk, followed by 
incubation with anti--syn (1:1000) primary antibody in TBST containing 1% skim milk and anti-
actin (1:5000) (kindly provide by Dr. Gourlay, C) primary antibody. After washing with TBS, the 
membranes were incubated with the respective secondary antibody, HRP-conjugated anti-rabbit 
IgG or HRP-conjugated anti-mouse IgG at a dilution of 1:5000 and detected by enhanced 
chemiluminescence (Thermo Scientific). 
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2.15 Statistical analysis  
 
The results shown are mean values and standard error of the mean of at least three 
independent assays. Statistical analyses were determined using two-way ANOVA. A p-value of less 
than 0.05 was considered as a significant difference.  
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3.1 α-Synuclein toxicity is associated with autophagy and mitophagy induction in 
yeast aged cells 
 
 
3.1.1 α-Synuclein-induced toxicity is phase growth dependent 
 
Yeast cells have been extensively used as a model to study the cytotoxic effects of α-
synuclein (α-syn) [290]. Previous data showed that α-syn mediates cell death in yeast thought an 
age- and mitochondria-dependent process [319], which is in good agreement with the late onset 
of the vast majority of Parkinson disease (PD) cases. However, it is still not clear how age traits 
potentiate the cytotoxic effects of α-syn. To address this question, we used a previous developed 
yeast model [291] displaying high toxicity and that consists on the heterologous expression of the 
human wild type α-syn (α-syn WT) gene and the clinical A53T and A30P mutant forms under the 
control of a GAL1-inducible promoter, with two copies of the construct integrated in the genome 
[291]. α-Syn expression was induced in different phases of the yeast cell growth, namely 
exponential, diauxic and stationary, and effects on cells growth and on the chronological life span 
(CLS) were monitored. As expected, growth analysis demonstrated that the expression of α-syn 
WT or A53T in yeast cells produced a strong growth defect phenotype (Fig. 19A-C). This growth 
defect was dependent on the growth phase, given that a more aggravated phenotype was 
observed when heterologous expression of α-syn was induced in stationary phase cells (Fig. 19A-
C). CLS analysis revealed that the expression of α-syn WT or the familial mutant A53T form, 
resulted in the CLS reduction, leading to only 10% of survival, compared with about 100% survival 
of cells harboring the vector control after 30 hours of induction (Fig. 20A-C). The CLS observed 
effects were also dependent on the growth phase, since it was revealed a more aggravated 
phenotype when the α-syn expression was induced in stationary phase cells (Fig. 20A-C). These 
negative effects on CLS were not related to a lower expression of α-syn in post-mitotic cells, since 
an immunoblot analysis confirmed the α-syn levels even in stationary phase cells (Fig. 20A-C). In 
addition, it was also possible to observe the presence of foci, disperse in the cytosol, in the 
stationary phase cells expressing α-syn WT or the familial A53T mutant (Fig. 21). Furthermore, 
the presence of foci, correlated to α-syn toxicity, was observed independently of the growth cells 
phase in which the expression was induced.  
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Figure 19. α-Syn WT and A53T induce growth inhibition dependent on the growth phase. Growth curves of wild 
type cells expressing α-syn WT, A53T or A30P under the control of the GAL1 promoter or harboring the vector 
control. α-Syn expression was induced at (A) exponential, (B) diauxic or (C) stationary growth phases. The data 
represents mean ± SEM of three biological independent replicas. The error bars represent the standard error of the 
mean (SEM). 
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Figure 20. Chronological longevity of cells expressing α-syn WT or A53T is dependent on the growth cells phase at 
which the expression was induced. Chronological life span of wild type cells expressing α-syn WT, A53T or A30P 
under the control of the GAL1 promoter or harboring the vector control. α-Syn expression was induced at (A) 
exponential, (B) diauxic or (C) stationary growth phases. Cell viability was measured at 6 h of intervals beginning at 
the time that was induced the α-syn and is expressed as % survival compared to survival at time 0 (100%). The data 
represents mean ± SEM of three biological independent replicas. Significance of the data was determined by two-way 
ANOVA (***p0.001). 
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Figure 21. α-Syn WT and A53T expression induces foci formation independently on the growth cells phase. Image 
of wild type cells expressing α-syn WT-GFP, A53T-GFP or A30P-GFP under the control of GAL1 promoter. α-Syn foci 
were analyzed at 24h after α-syn expression induction at exponential, diauxic or stationary growth phases. Scale 
bars: 5 µm.  
 
 
The determination of the mean (50% survival) and maximum (10% survival) CLS of cells 
expressing α-syn WT and the mutant forms, induced in the different growth cells phases (Fig. 22) 
also corroborate the data, showing that the expression of α-syn WT or A53T in stationary phase 
cells promoted a statistical significant decrease of the mean and maximum life span when 
compared to α-syn expression in exponential or diauxic phase cells (Fig. 22A and B).  
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Figure 22. α-Syn toxic variants expression reduces the mean and maximum chronological life span (CLS) in a 
growth cells phase dependent fashion. (A) Mean (50% survival) and (B) maximum (10% survival) CLS were 
determined from curve fitting of the survival data (Fig. 18A-C) (from pair matched, pooled experiments) with the 
statistical software Prism (GraphPad Software). Significance was determined between exponential, diauxic or 
stationary cells expressing vector control or α-syn variants (*). The significance determined between cells expressing 
the vector control or α-syn variants within growth phase (exponential, diauxic or stationary) was also determined 
(#).The error bars represent the standard error of the mean (SEM). Significance of the data was determined by two-
way ANOVA (#p0.001; ***p0.001). 
 
 
As previous described in the literature [291] the heterologous expression of the α-syn 
A30P mutant form resulted in a non-toxic phenotype, since the growth phenotype and the mean 
and maximum CLS were similar to the ones revealed by the cells harboring the vector control 
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(Fig. 19, 20 and 22). The reason for this phenotype is believed to be related to the fact that A30P 
mutation disrupts the first α-helical domain of α-syn blocking the unfolded to folded transition of 
α-syn that apparently is crucial for α-syn interaction with phospholipids [332]. Therefore the 
absence of A30P toxicity in yeast cells can be related to its inability to associate with the plasma 
membrane, and perhaps other membranes [291, 315]. In contrast, A30P toxicity in mammalian 
cells can result from a loss of function, leading to mistargeting, and possible sequestration of α-
syn WT in inappropriate intracellular compartments [315]. 
Together, the results suggest that the expression of the toxic form of α-syn (WT and A53T 
mutant form) induced toxicity (growth inhibition and CLS reduction) dependent on the cell growth 
phase.  
In this high toxicity yeast model, in few hours, the cells expressing α-syn WT or A53T 
mutant form lost viability (Fig. 20). Thus in an attempt to better sequentially monitor the events 
that occur in the cells promoted by the expression of toxic α-syn forms, we decided to develop a 
yeast model with lower toxicity. This low toxicity model consists in the expression of α-syn under 
the control of an inducible Tet-On system from a single integrated copy, since as described in 
literature, the toxicity of the yeast PD model is dependent on the number of gene copies inserted 
in the genome and also on the type of plasmid used [291] (see Material and Methods).  
The expression of α-syn WT was induced at the exponential and stationary growth cell 
phases. The CLS analysis demonstrated that in the yeast model with low toxicity, the expression 
of α-syn WT or the toxic familial mutant A53T resulted in a reduction of the CLS, ranging from 
25% in exponential phase cells to 41.66% in stationary phase cells (Fig. 23). The α-syn levels 
were also confirmed by an immunoblot assay during the CLS (Fig. 23). 
The determination of the mean and maximum life span of these cells also demonstrated 
that the expression of the toxic α-syn variants (WT and mutant A53T form) resulted in a statistical 
significant reduction of the mean and maximum CLS in comparison with cells harboring the 
vector control (Fig. 24), being the reduction more pronounced in stationary phase cells, 
corroborating the results described with the high toxicity yeast model.  
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Figure 23. Low expression levels of α-syn WT or A53T also induce toxicity dependent on the cells growth phase. 
Chronological life span (CLS) of wild type cells expressing α-syn WT or A53T under the control of a Tet-On promoter 
or harboring the vector control. α-Syn expression was induced at (A) exponential or (B) stationary growth phases and 
viability was measure at 2-3 day intervals beginning at the time that α-syn expression was induced and is expressed 
as % survival compared to survival at time 0 (100%). α-Syn levels during CLS of cells were also monitored by 
immoblot analysis of α-syn. The data represents mean ± SEM of three biological independent replicas. The error 
bars represent the standard error of the mean (SEM). Significance of the data was determined by two-way ANOVA 
(***p0.001). 
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Figure 24. Low levels of α-syn also reduce the mean and maximum chronological life span (CLS) of cells 
dependent on the cells growth phase. (A) Mean (50% survival) and (B) maximum (10% survival) CLS were 
determined from curve fitting of the survival data (Fig. 23) (from pair matched, pooled experiments) with the 
statistical software Prism (GraphPad Software). Significance was determined between exponential or stationary cells 
expressing vector control or α-syn variants (*). The significance determined between cells expressing the vector 
control or α-syn variants within growth phase (exponential or stationary) was also determined (#).The error bars 
represent the standard error of the mean (SEM). Significance of the data was determined by two-way ANOVA 
(#p0.001; ***p0.001). 
 
 
In these assays, α-syn was expressed as C-terminally tagged GFP fusion to allow the 
microscopic evaluation of foci (Fig. 22). Although the new developed model has low toxicity, it 
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was also possible to observe the presence of foci (Fig. 25), in cells from both exponential and 
stationary growth phases.  
 
 
 
Figure 25. Expression of α-syn WT or A53T in yeast under the control of Tet-on promoter also induces the 
appearance of foci. Image of wild type cells expressing α-syn WT-GFP or A53T-GFP under the control of Tet-on 
promoter. α-Syn foci were analyzed at 24h after α-syn expression induction. 
 
 
This new developed yeast model, with low toxicity, is extremely important because it 
allows the induction of α-syn expression, at any time of the cells growth phase, without the need 
of changing the culture medium. Additionally, with this model, it is also possible to dissect, with 
temporal sensibility, the α-syn cellular toxicity, due to the more extended CLS. 
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3.1.2 α-Synuclein-induced toxicity in yeast aged cells is associated with the unfolded 
protein response (UPR) activation 
 
The accumulation of misfolded proteins in the endoplasmic reticulum (ER) is the main 
event that activates a complex intracellular signal transduction pathway called unfolded protein 
response (UPR) [333]. Previous findings from postmortem assessment of PD patients brains 
revealed that the UPR pathway is activated in nigral dopaminergic neurons in the presence of α-
syn inclusions, suggesting that the activation of the UPR may be induced by the accumulation of 
α-syn [334]. Conversely, in a yeast model of PD, it was demonstrated that the expression of α-
syn WT or the A53T mutant form causes ER stress accompanied with alteration on the ERAD 
pathway [335]. Besides ERAD, the cells exposed to ER stress activates the UPR [22]. In yeast, 
UPR activation occurs through the inositol-requiring kinase 1 (Ire1) dissociation from its ER-
sensing domain allowing the cytosolic component of Ire1, with endonuclease activity, to splice an 
intron out of the messenger RNA coding for Hac1 (homologous to activating transcription factor 
(ATF)/CREB 1) (orthologue of mammalian XBP1). Translation of this mRNA produces active 
Hac1p, a transcriptional factor culminates in the expression of several genes [194]. 
To address the question of whether or not α-syn-induced toxicity activates the Ire1-Hac1 
signaling pathway, we assessed the splicing activation of the HAC1 mRNA after induction of the 
heterologous expression of α-syn variants under the control of a GAL1-inducible promoter, the 
high toxicity yeast model. Therefore, yeast cells were grown until the stationary phase and then 
the α-syn expression was induced by the presence of galactose in the culture medium. Next 
during specific times points of the CLS, samples were collected and the HAC1 splicing analyzed 
by quantitative real-time PCR (qPCR). The data obtained revealed that yeast aged cells expressing 
α-syn WT or the mutant A53T variant suffered a HAC1 splicing after 12h of expression induction, 
being also detected at 24h, as represented in figure 26A, by the band with a length of 687 bp, 
(splicing of the 252 bp intron in the HAC1 primary transcript). In contrast, cells harboring the 
vector control or expressing the non-toxic α-syn variant A30P showed, at 12h, both the spliced 
and unspliced forms of HAC1, revealed by the visualization of two bands with 939 and 687 bp, 
probably due to an adaptation of the cells to carbon source change in the culture medium from 
glucose to galactose. Nevertheless, at 24h it was only observed the unspliced HAC1 form (Fig. 
26A). These results indicated that Ire1-Hac1 signaling pathway is stimulated by the presence of 
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the toxic α-syn forms, corroborating the evidence already observed by studies performed in 
animal models of PD [333, 336]. 
 
 
 
Figure 26. α-Syn WT and A53T expression induced a sustained unfolded protein response (UPR). (A) The splicing 
activation of the HAC1 mRNA at 0, 12 and 24 h in cells expressing α-syn WT or the mutant forms under the control 
of the GAL1 promoter. (B) UPR activity was measured, during chronological life span (CLS), through the β-
galactosidase assay that was carried out in the stationary wild type cells expressing the vector control, the α-syn WT, 
the A53T or the A30P mutant under the control of the Tet-on promoter and co-harboring a plasmid containing lacZ 
under the control of the UPR element (UPRE). The data represent mean ± SEM of three biological independent 
replicas. The error bars represent the standard error of the mean (SEM). Significance of the data was determined by 
two-way ANOVA (*p<0.05; **p<0.01; ***p<0.001). 
 
 
To further confirm these data, we also used the low toxicity yeast model to evaluate the 
UPR activity by a different methodology. For that, yeast cells were transformed with a second 
plasmid containing lacZ under the control of the UPR element (UPRE), which is a consensus 
sequence usually present in the genes required for yeast UPR [34]. Expression of α-syn WT or 
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A53T mutant form resulted in the stimulation of the UPR activity during the CLS, as revealed by 
β-galactosidase activity, being more pronounced from day 4 of induction of α-syn expression, 
compared to cells harboring the vector control (Fig. 26B), consistently with the low toxicity of this 
yeast model. 
Together, the results obtained with the two yeast models, which result in different α-syn 
expression levels, disclosed that the heterologous expression of α-syn WT or A53T mutant variant 
resulted in the stimulation of the UPR, detected by the activation of the Ire1-Hac1 signaling 
pathway and by the indirect measurement of the UPR activity. The results indicat that the 
accumulation of misfolded α-syn causes the persistent activation of the UPR system that is likely 
to be unable to deal with α-syn accumulation. Accordingly, in mammalian cells, α-syn also leads 
to the UPR pathway [333].  
 
 
3.1.3 Autophagy modulation rescues yeast aged cells from α-synuclein-induced 
toxicity  
 
As described in the above section, in yeast, the signaling pathway that mediates the UPR, 
which is activated in response to several physiological and pathological conditions, like the 
accumulation of misfolded proteins, is ultimately responsible for the activation of several genes 
associated with the degradation of the misfolded proteins. In fact, Hac1 is capable of inducing 
the expression of several ATG genes, like ATG5, ATG7, ATG8, ATG14 and ATG19 [194, 195]. 
Furthermore, the UPR is activated to reestablish the ER homeostasis by adaptive mechanisms 
that involve the autophagy stimulation [221]. Indeed, in yeast it is described that ER proliferation 
leads to the formation of autophagosome-like structures that are densely and selectively packed 
with membrane stacks derived from the UPR-expanded ER [155]. In this sense and given the 
persistent activation of the UPR in response to the α-syn toxic variants observed, we asked 
whether or not this UPR stimulation may be linked to an autophagy induction. For that an 
evaluation of key autophagic genes expression and of autophagy activity during CLS was 
performed. 
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3.1.3.1 Heterologous expression of α-syn WT or A53T mutant leads to increased 
levels of ATG6 and ATG8 mRNA levels 
 
As above mentioned, the activation of the Ire1-Hac1 signaling pathway is intrinsically 
associated with the up-regulate expression of some genes associated with autophagy, including 
ATG8 [194, 195]. Thus, the evaluation of the mRNA expression levels of some autophagy 
regulators was accomplished. Although, it has been suggested that autophagy is mainly regulated 
at the post-translational level, the identification of transcription factors involved in the regulation 
of autophagy genes has exposed the possible transcriptome regulation of the autophagic genes 
[337]. Therefore, we started with the evaluation of the levels of two relevant autophagic 
mediators, ATG6 and ATG8. Autophagy-related protein 6 (Atg6)/vacuolar protein sorting 30 
(Vps30) is a component that is common in two distinct phosphatidylinositol 3-kinase complexes. 
In the complex I, particularly involved in the nucleation step [54], Atg14 links Atg6 to Vps34 lipid 
kinase [338], while in the complex II, Vps38 links Vps30 to Vps34 and plays a role in the 
vacuolar protein sorting [338]. On the other hand, the ATG8 gene encodes a protein that is 
predominantly associated with the autophagosome, remained attached to the autophagosomes 
membrane structures [118]. Apparently, ATG8 is the main autophagic regulator showing a strong 
transcriptional regulation [110, 189].  
To evaluate the mRNA levels, the high toxicity yeast model was used. Cells were grown 
until the stationary phase where the α-syn expression was induced. Samples were collected at 
specific time points, at 12h that represents the time at which the cells expressing the α-syn toxic 
variants (WT or A53T) start to lose viability and at 24h, representing the time where only about 
10% of cells still survive. The ATG6 and ATG8 levels were evaluated by qPCR (quantitative Real 
Time PCR), following the standard recommendations for the qPCR method [329] and as 
described in Chapter 2 (Material and Methods). 
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Figure 27. α-Syn WT and A53T lead to increased levels of ATG6 and ATG8 mRNA levels. (A) ATG6 and (B) ATG8 
mRNA relative expression levels at 0, 12 and 24 h in cells expressing the α-syn WT, A53T or A30P under the control 
of the GAL1 promoter or harboring the vector control. Three reference genes [ACT1 (actin), PDA1 (alpha subunit of 
pyruvate dehydrogenase) and TDH2 (isoform 2 of glyceraldehyde-3-phosphate dehydrogenase)] were used as 
internal standards and for the normalization of mRNA expression levels. The data represent mean ± SEM of three 
biological independent replicas. The error bars represent the standard error of the mean (SEM). Significance of the 
data was determined by two-way ANOVA (**p<0.01; ***p<0.001). 
 
 
The analysis of the relative mRNA expression levels of ATG6 revealed that only after 24h 
the mRNA levels were significantly increased in cells expressing α-syn WT or A53T compared 
with the cells expressing the non-toxic A30P variant or harboring the vector control (Fig. 27A). in 
contrast, the data showed that the relative ATG8 mRNA expression levels were already 2-fold 
increased after 12 h of α-syn WT or A53T expression when compared to cells expressing the 
vector control or the non-toxic A30P (Fig. 27B). At 24 h of α-syn WT or A53T expression the ATG8 
mRNA levels were even higher (Fig. 27B). Together these results indicated that the CLS reduction 
(Fig. 20C) promoted by the expression of α-syn WT or the clinical A53T mutant is associated with 
an increase of the ATG6 and ATG8 mRNA levels (Fig. 27). The increase in the mRNA expression 
levels of the two evaluated genes showed that both are transcriptionally regulated after α-syn 
expression, suggesting that the sustained UPR activation might be related to autophagy 
induction. 
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3.1.3.2 Heterologous expression of α-syn WT or A53T mutant leads to increased 
levels of mitophagy specific genes  
 
Oxidative stress and mitochondrial dysfunction are hallmarks of α-syn induced toxicity in 
yeast aged cells [319]. Additionally, there is also evidence that the specific mitochondria 
degradation by autophagy, called mitophagy, is the primary pathway to eliminate dysfunctional, 
aged or excessive mitochondria. Furthermore, recent evidence highlighted that two proteins 
encoded by genes linked to familiar PD forms, PARK2/PARKIN and PINK1, are important for the 
degradation of dysfunctional mitochondria (mitophagy) [306, 307]. Taking into account the 
mitochondrial importance on PD pathogenesis, we decided to assess the expression of three 
mitophagy related genes: ATG32 and ATG33, mitophagy-specific genes [339], and DNM1, a 
mitochondrial dynamic-related GTPase required for mitochondrial fission, that is through to be 
necessary for mitophagy [340]. 
By using the same yeast high toxicity model and the methodology above described, it 
was observed that the ATG32 normalized mRNA expression levels have a significant increase of 
about 2-fold, at 12 and 24 hours of induction of α-syn WT or A53T expression (Fig. 28B). Similar 
results were observed relatively to the DNM1 mRNA expression levels, however just at 24 hours 
of α-syn expression (Fig. 28A). ATG33 mRNA levels were increased in WT and A53T α-syn 
expressing cells, only at 12 hours, whereas at 24 hours the cells harboring the vector control and 
cells expressing α-syn WT or A53T mutant displayed similar ATG33 mRNA levels (Fig. 28C). 
These data revealed that there is a genetic upregulation of the studied genes linked to mitophagy 
in these conditions. 
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Figure 28. α-Syn WT and A53T lead to increased mRNA levels of proteins linked to mitophagy. (A) DNM1, (B) 
ATG32 and (C) ATG33 mRNA relative expression levels at 0, 12 and 24 h in cells expressing the α-syn WT, A53T or 
A30P under the control of the GAL1 promoter or harboring the vector control. Three reference genes [ACT1 (actin), 
PDA1 (alpha subunit of pyruvate dehydrogenase) and TDH2 (isoform 2 of glyceraldehyde-3-phosphate 
dehydrogenase)] were used as internal standards and for the normalization of mRNA expression levels. The data 
represent mean ± SEM of three biological independent replicas. The error bars represent the standard error of the 
mean (SEM). Significance of the data was determined by two-way ANOVA (*p<0.05; **p<0.01; ***p<0.001). 
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Mitophagy has been associated with mitochondria fission given the large size of 
mitochondria in comparison to autophagosome [306]. However, other authors claim that 
mitophagy occurs independently of the mitochondria fission [168]. Our data indicates that during 
CLS, cells harboring the genes that codify for the toxic α-syn variants display higher mRNA DNM1 
levels associated with elevated mRNA levels of ATG32 and ATG33, supporting a link between the 
two processes: mitochondria fission with mitophagy. Altogether, the results suggest that the 
expression of α-syn toxic variants lead to mitochondria selective degradation, which is associated 
with the stimulation of both, UPR and autophagy. 
 
 
3.1.3.3 Modulation of autophagy in yeast aged cells expressing the toxic α-syn 
variants 
 
The increase of mRNA levels of autophagic regulators, per se, does not prove that 
autophagic activity is increased, therefore to further set out whether autophagy impacts on the 
toxicity of α-syn in yeast aged cells, we have decided to pharmacologic inhibit the autophagy 
process. For such purpose, the high toxicity yeast models were used, and α-syn expression was 
induced in stationary cells phase, representing the day 0 of CLS, and at the same time 
autophagy was pharmacologically inhibited by adding 3-methyladenine (3-MA), which inhibits the 
phosphatidylinositol 3-kinases (PI3K), blocking the autophagosome formation [322]. The results 
obtained showed that autophagic inhibition in yeast aged cells completely revert the toxic α-syn 
phenotype as reflected by the CLS extension observed (Fig. 29A), suggesting that autophagy 
might play a central role in the α-syn-induced toxicity. To further confirm this data, we have also 
modulated autophagy in the low toxicity yeast model. The induction of autophagy was achieved 
through a TOR-dependent pathway, by using rapamycin [69, 73, 341-345]. For the inhibition of 
the autophagy, 3-MA was used, as described before, but we also used chloroquine (CQ) which 
raises the lysosomal/vacuole pH leading to the inhibition of lysosome/vacuole-autophagosome 
fusion and to lysosomal/vacuole protein degradation [229, 323-326]. To perform these assays, 
α-syn WT expression was induced in stationary phase cells, representing the day 0 of CLS, and at 
this point, autophagy was pharmacologically induced with rapamycin or inhibited by adding 3-MA 
or CQ.  
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The induction of autophagy by the presence of rapamycin in the medium resulted in a 
slight increase of the CLS of cells expressing the α-syn WT (Fig. 29B) as confirmed by the 
determination of the mean and maximum chronological life spans of cells in the presence or 
absence of rapamycin (Fig. 29E and F). As referred, rapamycin inhibits Tor1, and as known Tor1 
inactivation results in a pleiotropic cellular response [259] that leads to a CLS extension. These 
reasons could explain the slight increase of CLS in the presence of rapamycin independent on 
autophagy.  
The inhibition of the autophagy with 3-MA or CQ resulted in a CLS extension of cells 
(Figs. 29C and D), consistently with the results obtained with the high toxicity models in the 
presence of 3-MA (Fig. 29A). The determination of the mean and maximum CLS of wild type cells 
expressing α-syn WT with autophagy inhibition corroborated these results. In fact, the expression 
of α-syn WT in wild type cells in the presence of 3-MA or CQ promoted a statistical significance 
increase of the mean and maximum life span when compared to wild type cells expressing α-syn 
WT without any pharmacological treatment (Fig. 29E and F). 
The observation that autophagy inhibition results in a better cell fitness accompanied by 
CLS extension suggests a role for autophagy in the α-syn-induced toxicity. 
 
 
3.1.3.4 α-Synuclein-induced toxicity in yeast aged cells is associated with autophagy 
induction and selective mitochondria degradation  
 
To further elucidate the role of autophagy in α-syn-induced toxicity, a new yeast model 
with moderate toxicity, in which α-syn WT, A53T or the A30P mutant are constitutively expressed 
under the control of an endogenous triose phosphate isomerase (TPI1) promoter from a single 
integrated copy, was developed. This model was used to perform additional functional analysis, 
particularly the determination of the autophagy activity during CLS. For that purpose, PHO8 
mutant cells were transformed with a plasmid expressing an inactive Pho8 proenzyme targeted to 
the cytosol. The activation of autophagy resulted into the translocation of the inactive Pho8 
proenzyme from the cytosol to the vacuole and its consequent activation, allowing the 
determination of the autophagy activity by the alkaline phosphatase (ALP) assay [168, 269].  
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Figure 29. Autophagy inhibition rescues aged yeast cells from α-syn-induced toxicity. (A) Chronological life span 
(CLS) of stationary wild type cells expressing α-syn WT or A53T mutant under the control of the GAL1 promoter or 
harboring the vector control in the presence or absence of 3-methyladenine (3-MA), an inhibitor of autophagy. CLS of 
stationary wild type cells expressing α-syn WT under the control of the Tet-on promoter or harboring the vector 
control in the presence or absence of (B) rapamycin (inducer of autophagy), (C) 3-MA or (D) chloroquine (CQ) 
(inhibitor of autophagy). (E and F) Mean (50% survival) and maximum (10% survival) chronological life spans were 
determined from curve fitting of the survival data (B, C and D) (from pair matched, pooled experiments) with the 
statistical software Prism (GraphPad Software). Significance was determined between wild type cells expressing α-
syn WT with wild type cells expressing α-syn WT treated with 3-MA, CQ or rapamycin. The data represent mean ± 
SEM of three biological independent replicas. The error bars represent the standard error of the mean (SEM). 
Significance of the CLS curves was determined by two-way ANOVA (*p<0.05; ***p<0.001).  
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As expected, with this moderate toxicity model, the expression of α-syn WT or the familial 
mutant α-syn A53T led to a CLS reduction when compared with the CLS of cells harboring the 
vector control or the α-syn A30P non-toxic mutant [291] (Fig. 30A). An immunoblot assay 
confirmed the expression of α-syn variants during CLS (Fig. 30B). To confirm the data obtained 
by the evaluation of proliferative capacity, other viability assays, namely the plasma membrane 
integrity, assessed by the exclusion of propidium iodide (PI), and by the metabolic activity 
evaluated by FUN1 were also used (Fig. 30C and D). The results obtained with PI and FUN1 
assays also revealed a drastic CLS decrease in cells expressing the toxic α-syn variants, WT or 
mutant A53T form (Fig. 30C and D). 
The results obtained with these new moderate toxicity models are in concordance with 
the data obtained with the other two models, with low or high toxicity levels.  
 
 
 
Figure 30. Moderate toxicity yeast model. Chronological life span measured by (A) CFU, (C) PI exclusion or (D) 
FUN1 metabolic activity and (B) α-syn levels of stationary wild type cells expressing the vector control, the α-syn WT, 
the A53T or the A30P mutant under the control of the constitutive TPI1 promoter. The data represent mean ± SEM 
of six biological independent replicas. Cell viability was measured at 2-3 day intervals beginning at the day that 
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cultures achieved stationary phase (day 0) and is expressed as % survival compared to survival at day 0 (100%). The 
error bars represent the standard error of the mean (SEM). Significance of the data was determined by two-way 
ANOVA (***p<0.001). 
 
 
After the establishment of these yeast models for α-syn toxicity, the autophagy activity 
during CLS was evaluated. The data from the ALP assay showed that the heterologous expression 
of α-syn WT or A53T induced a gradual increase of the autophagic activity over time, more 
pronounced from day 3, when compared to cells harboring the vector control or expressing the 
non-toxic A30P (Fig. 31A). These results corroborate the increased mRNA levels of genes 
associated with autophagy, ATG8 and ATG6 (Fig. 27), and associate α-syn toxicity to autophagy 
induction. 
It is well established by results obtained with other animal models and also with post-
mortem analysis of PD patient brains that mitochondria and oxidative stress have a central role in 
the PD pathogenesis. These facts associated with the data from the mRNA analysis, which 
revealed increased ATG32 mRNA levels, raised the question about the role of mitophagy in the 
toxicity induced by the expression of α-syn toxic variants. To deal with this question, PHO8 
mutant cells were transformed with a plasmid expressing an inactive Pho8 proenzyme targeted to 
the mitochondrial matrix. The activation of mitophagy resulted into the translocation of the 
inactive Pho8 proenzyme within the mitochondria to the vacuole and its consequent activation, 
allowing the determination of the mitophagy activity by the ALP assay [168, 269]. The data 
resultant from the analysis of the mitophagy activity revealed a similar profile to the one obtained 
by the autophagic activity analysis, which demonstrated sustained mitophagy activation, more 
evident after day 3 of CLS in the cells expressing α-syn WT or the familial A53T mutant form 
compared with cells harboring the vector control or expressing the non-toxic A30P (Fig. 31B). 
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Figure 31. α-Syn-induced toxicity in aged yeast cells is associated with autophagy induction and selective 
degradation of mitochondria. Autophagy and mitophagy activity were measured through the alkaline phosphatase 
(ALP) assay that was carried out in the wild type cells expressing the vector control, the α-syn WT, the A53T or the 
A30P mutant and co-harboring a plasmid expressing the inactive Pho8 proenzyme targeted to (A) the cytosol or (B) 
to the mitochondrial matrix, during chronological life span. The data represent mean ± SEM of three biological 
independent replicas. The error bars represent the standard error of the mean (SEM). Significance of the data was 
determined by two-way ANOVA (*p<0.05; **p<0.01; ***p<0.001). 
 
 
The results described in this section and obtained with the different α-syn expression and 
toxicity systems suggest that the expression of α-syn WT or A53T variant results in a sustained 
UPR response due to the presence of misfolded α-syn that accumulate originating foci. This UPR 
response is correlated with an activation of autophagy with selective degradation of mitochondria, 
as demonstrated by the mitophagy ALP assay and the increased ATG32 mRNA levels.  
 
 
3.1.4 The contribution of mitophagy to the α-synuclein-induced toxicity  
 
As mentioned before, mitochondria are organelles essentials for energy production, 
regulation of cell signaling and apoptosis [346-348]. Nevertheless, mitochondria are the major 
source of reactive oxygen species (ROS), which may oxidize mitochondrial lipids, proteins and 
DNA [349]. Due this dual function, the cell has mechanisms of mitochondrial quality control to 
maintain the overall fitness. In this sense, mitophagy has emerged as a key mechanism in this 
quality control system, responsible of the elimination of superfluous or damaged mitochondria 
97 
[350]. In fact, oxidative stress and mitochondria dysfunction have long been recognized as 
central players that operate in the PD pathogenesis [351]. Indeed dysfunctional mitochondria are 
observed in the substantia nigra of PD patients, and it was recently proposed that this could be a 
consequence of the loss of mitochondria due to the overactivation of autophagy [304]. However, 
little is known about the factors that predispose mitochondria for degradation by mitophagy. As 
referred in chapter 1, studies on genes associated with autosomal recessive forms of PD 
demonstrate that PINK1 and PARK2 collaborate in mitochondrial quality control systems [179]. 
Hence, defects in mitophagy have recently emerged as a central pathogenic hypothesis in PD 
[51, 352]. Nevertheless, the precise role of autophagy and mitophagy in the pathogenesis of PD 
still remains controversial [353]. 
To get new insights into the role of mitophagy in α-syn-induced toxicity we extended our 
analysis to the evaluation of the CLS in cells lacking genes associated with specific types of 
autophagy, namely, ATG11 and ATG32. Atg11 is a scaffold protein that directs receptor (Atg19)-
bound cargo to the phagophore assembly site and that participates in all specific types of 
autophagy [140]. Atg32 is an outer mitochondrial membrane protein essential for mitophagy, but 
not for autophagy or other types of selective autophagy. In yeast, the selective autophagy requires 
a receptor and an adaptor protein: Atg32 acts as a receptor protein that interacts with the 
adaptor protein Atg11, most likely to sequester mitochondria to the phagophore assembly site 
(PAS) [161, 166]. Additionally, an evolutionary conserved motif (WXXI/L) is present in Atg32, 
which is a pre-requisite for the interaction with Atg8. Furthermore, this interaction, Atg32 and 
Atg8, is essential for mitochondrial recruitment [161].  
The CLS results analysis demonstrated that in atg11 cells the expression of α-syn WT 
or A53T no longer had an effect on longevity, since the CLS curves overlapped with the curve 
obtained for vector control cells (Fig. 32A and B). These results were also confirmed with 
different viability assays, namely the propidium iodide (PI) exclusion, and the metabolic activity 
evaluated by FUN1 (Fig. 32C and D). 
Interestingly, expression of the non-toxic α-syn A30P induced a slight decrease of 
longevity, compared to atg11 cells expressing the vector control, particularly when viability was 
evaluated by propidium iodide exclusion or FUN1 processing (Fig. 32C and D). This most likely 
relates to the previously made observations that the A30P mutant is predominantly cytoplasmic 
[354] and subject to vacuolar degradation, in contrast to α-syn WT and A53T [355]. It is 
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conceivable that the increased toxicity of the A30P mutant in ATG11 deleted cells is associated 
with a general defect in cargo recognition given the role of Atg11 in connecting the cargo 
molecules with components of the vesicle-forming machinery [91, 156]. 
 
 
 
Figure 32. ATG11 deletion increases longevity in aged yeast cells expressing the toxic α-syn variants. Chronological 
life span measure by (A) CFU, (C) PI exclusion or (D) FUN1 metabolic activity and (B) α-syn levels of stationary 
atg11 cells expressing the vector control, the α-syn WT, the A53T or the A30P mutant under the control of the 
constitutive TPI1 promoter. Cell viability was measured at 2-3 day intervals beginning at the day that cultures 
achieved stationary phase (day 0) and is expressed as % survival compared to survival at day 0 (100%). The data 
represents mean ± SEM of three biological independent replicas. The error bars represent the standard error of the 
mean (SEM). Significance of the data was determined by two-way ANOVA. 
 
 
Next, we addressed the effect of α-syn heterologous expression in the CLS of atg32 
cells. Similarly to what we observed for the atg11 cells, the chronological longevity of atg32 
cells harboring the vector control or expressing A30P was reduced when compared to wild type 
cells, and the expression of α-syn WT or A53T no longer triggered a toxic effect (Fig. 33A and B). 
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To confirm these results we used other different viability assays, namely the PI exclusion, and the 
metabolic activity evaluated by FUN1 (Fig. 33C and D). The results obtained with these assays 
also revealed the lack of an effect of α-syn WT or A53T expression in atg32 cell survival (Fig. 
33C and D). 
 
 
 
Figure 33. ATG32 deletion increases longevity in aged cells expressing the toxic α-syn variants. Chronological life 
span measure by (A) CFU, (C) PI exclusion or (D) FUN1 metabolic activity and (B) α-syn levels of stationary atg32 
cells expressing the vector control, the α-syn WT, the A53T or the A30P mutant under the control of the constitutive 
TPI1 promoter. Cell viability was measured at 2-3 day intervals beginning at the day that cultures achieved stationary 
phase (day 0) and is expressed as % survival compared to survival at day 0 (100%). The data represents mean ± 
SEM of three biological independent replicas. The error bars represent the standard error of the mean (SEM). 
Significance of the data was determined by two-way ANOVA (***p<0.001). 
 
 
The determination of the mean (50% survival) and maximum (10% survival) chronological 
life spans of wild type and the mutant strains also confirmed the absence of effects on CLS by 
the expression of α-syn toxic variants (Fig. 34). Consistently, the results showed that the 
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expression of α-syn WT or A53T in atg11 and atg32 cells promoted a statistically significant 
increase of the mean and maximum life span when compared to wild type cells (Fig. 32A and B).  
 
 
 
Figure 34. ATG11 or ATG32 deletion increases mean and maximum CLS of aged cells expressing the toxic α-syn 
variants. (A) Mean (50% survival) and (B) maximum (10% survival) chronological life spans were determined from 
curve fitting of the survival data (Figs. 30, 32 and 33) (from pair matched, pooled experiments) with the statistical 
software Prism (GraphPad Software). Significance was determined between wild type cells and atg11 or atg32 
cells expressing vector control or α-syn variants (*). The significance determined between cells expressing the vector 
control or α-syn variants within each strain (wild type, atg11 or atg32) was also determined (#).The error bars 
represent the standard error of the mean (SEM). Significance of the data was determined by two-way ANOVA 
(#p<0.01; *p<0.05; ***p<0.001). 
 
 
To evaluate whether or not the lack of α-syn effects on the CLS of cells with impaired 
mitophagy were related to lower α-syn aggregation, the foci formation was evaluated by 
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immunostaining against α-syn and analyzed by confocal microscopy. The analysis showed that 
cells expressing α-syn WT or A53T displayed the typical formation of α-syn foci (Fig. 35A), and 
the number of foci seemed to be independent of the abrogation of mitophagy by the deletion of 
the ATG11 or ATG32 genes, since we observed similar number of foci in wild type cells and in 
atg11 and atg32 cells. Therefore, the foci formation apparently is not linked to the decreased 
toxicity of α-syn cells in ATG11 or ATG32 mutant cells (Fig. 35A and B). 
 
 
 
Figure 35. Foci formation is not linked to the abrogation of α-syn toxicity observed in ATG11 or ATG32 mutant 
cells. (A) -Syn was analyzed after incubation with antibody against -syn as the primary and the Pacific Blue 
conjugated goat anti-rabbit secondary antibody. Single confocal planes are shown. Scale bars: 5 µm. (C) Foci 
number was quantified in wild type, atg11 and atg32 cells expressing -syn WT. The error bars represent the 
standard error of the mean (SEM). 
 
 
Next the autophagy and mitophagy activities in the atg11 or atg32 mutant cells were 
evaluated as previously described. For that we applied the ALP assay, as described. The ALP 
assay indicated that atg11 cells expressing the vector control displayed slightly higher levels of 
autophagic activity (Fig. 36A), when compared to vector control wild type cells (Fig. 31A). 
Nevertheless, the observed induction of autophagy in wild type cells upon expression of the 
102 
different α-syn variants was abrogated to basal levels in atg11 cells (Fig. 36A). Importantly, 
mitophagy upon expression of the different α-syn variants was abrogated in atg11 cells (Fig. 
36B). This clearly demonstrated that selective autophagy, the process abolished in atg11 cells, 
is associated with the toxicity of α-syn in aged yeast cells. 
Due to the inhibition of mitophagy, atg32 cells displayed a higher autophagic activity 
and these levels decreased during aging both in vector control and in cells expressing the 
different α-syn variants (Fig. 36C). Furthermore, and as expected, the ALP assay indicated that 
the expression of the different α-syn variants in atg32 cells no longer induced mitophagy (Fig. 
36D).  
 
 
 
Figure 36. Deletion of ATG11 or ATG32 almost abolishes the autophagy and mitophagy induced by the expression 
of α-syn toxic variants. Autophagy and mitophagy activity were measured through the alkaline phosphatase (ALP) 
assay that was carried out to assess (A and C) autophagy and (B and D) mitophagy in atg11 or atg32 cells, 
respectively. The data represent mean ± SEM of three biological independent replicas. The error bars represent the 
standard error of the mean (SEM). Significance of the data was determined by two-way ANOVA (*p<0.05; **p<0.01; 
***p<0.001). 
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Buttner and collaborators [319] identified that mitochondrial function and oxidative 
phosphorylation are key players in α-syn-induced toxicity in yeast cells, since deletion of mtDNA 
completely abrogates the α-syn-induced toxicity. These observations were also confirmed by us, 
since the expression of α-syn WT or A53T mutant variant in cells where the mtDNA was deleted, 
the rho 0 cells, promoted a CLS similar to that of cells harboring the vector control or expressing 
the non-toxic A30P variant (Fig. 37). 
 
 
 
Figure 37. α-Syn-induced toxicity is dependent on the mitochondrial function. Chronological life span of rho 0 cells 
expressing the vector control, the α-syn WT, the A53T or the A30P mutant under the control of the constitutive TPI1 
promoter. Cell viability was measured at 2-3 day intervals beginning at the day that cultures achieved stationary 
phase (day 0) and is expressed as % survival compared to survival at day 0 (100%). The data represents mean ± 
SEM of three biological independent replicas. 
 
 
In this context, and to test the hypothesis that the lower toxicity of α-syn WT or A53T may 
be not detected due to an inherent mitochondrial dysfunction of atg11 and atg32 cells, we 
decided to determine the index of respiratory competence (IRC) [327] of these mutant cells. The 
IRC is defined by the percentage of yeast cells that have the ability to grow in both fermentable 
(glucose) and non-fermentable (glycerol or ethanol) carbon sources, and, additionally it can 
reflect the respiration status of mitochondria [327]. The results obtained showed that atg32 
cells are able to grow on glycerol and present an IRC similar to wild type cells (Table 6). atg11 
cells also displayed an IRC similar to wild type cells, nevertheless, mitochondrial functionality of 
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these mutant cells started to be affected at 7 days of CLS (Table 6). Moreover, the data also 
revealed that α-syn WT and A53T expression did not negatively affect the IRC of atg11 and 
atg32 cells but, instead, increased their IRC when compared to wild type cells (Table 6). 
Altogether, the results strongly suggest that the lack of α-syn WT and A53T toxicity is not 
associated with mitochondrial dysfunction of atg11 and atg32 cells.  
When combined, the data described in this section confirmed that the toxicity of α-syn 
WT and the A53T mutant as observed in wild type cells was dependent on Atg11 and Atg32, two 
factors required for the induction of mitophagy. To further validate the biochemical data obtained 
with the ALP assay, we assessed mitophagy by microscopy visualization of the process. Wild 
type, atg11∆ and atg32∆ mutant cells expressing α-syn toxic forms, GFP-Atg8 and mtDsRed 
(mitochondrially-targeted DsRed) were analyzed by confocal microscopy. In wild type cells 
harboring the vector control, GFP-Atg8 was distributed in the cytosol with a punctate pattern, and 
mtDsRed labeled a typical mitochondrial network (Fig. 38). The expression of α-syn WT resulted 
in the accumulation of GFP in the vacuole in the vast majority of the cells, indicating that GFP-
Atg8 was shuttled to the vacuole and that autophagy was induced. Furthermore, the vast majority 
of the cells did not present the mitochondrial mtDsRed signal, and in those cases where red 
fluorescence was observed, the typical mitochondrial network was abolished (Fig. 38). In 
contrast, in atg11 and atg32 cells expressing the α-syn toxic forms, the GFP-Atg8 was 
essentially distributed in the cytosol, and the mitochondrial network remained detectable 
although we observed some mitochondrial fragmentation (Fig. 38). The same results were 
obtained for yeast cells expressing the A53T mutant (data not shown). The cells expressing the 
non-toxic A30P mutant produced similar results as those obtained with the cells harboring the 
vector control (data no shown).  
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Table 6. Index of respiratory competence (IRC) of stationary phase wild type, ATG11 and ATG32 mutant cells 
during chronological lifespan. Wild type and mutants cells were grown in selective SC medium and at the indicated 
time points cells were plated onto YPG (Yeast Peptone with 2% Glycerol) and also on YEPD (Yeast Peptone with 2% 
Glucose) plates. The IRC was calculated as the number of colonies formed on YPG divided by the number of colonies 
formed on YEPD times 100%. Data represents mean ± SEM of three independent samples. Significance was 
determined between wild type cells and atg11 or atg32 cells expressing vector control or -syn variants by two-
way ANOVA (*p0.05; **p0.01; ***p0.001. 
 
 
 Time 
(days) 
Vector 
Control 
Syn WT Syn A53T Syn A30P 
Wild 
type 
0 
83.2±4.99 74.6±5.49 76.4±10.51 75.9±2.26 
3 77.1±4.91 99.1±14.36 66.5±3.76 76.6±4.93 
7 61.3±6.58 23.8±1.19 14.6±3.49 73.4±6.34 
10 81.40±9.8 10.3±6.34 3.25±0.86 91.9±6.91 
atg11 
0 87.1±8.62 91.9±6.01 98.5±2.37 *** 87.9±9.01 
3 84.8±5.59 65.6±1.03 * 97.9±2.02 *** 85.8±9.32 
7 20.4±5.71 *** 8.6±4.33 ** 53.4±6.51 *** 61.2±0.31 * 
10 26.7±6.78 *** 1.31±0.30 ** 24.3±7.79 * 31.9±4.47 *** 
atg32 
0 74.24±3.97 93.6±7.86 94.8±6.93 *** 82.7±3.84 
3 95.6±5.83 ** 99.2±9.51 74.5±2.38 *** 91.3±5.48 
7 83.2±4.28 75.2±0.96 ** 75.1±4.62 *** 84.4±2.00 
10 95.5±3.98 96.9±13.42 *** 91.7±10.48 *** 60.1±5.48 * 
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Figure 38. α-Syn-induced toxicity is associated with mitophagy induction. Wild type, atg11 and atg32 cells expressing, mitochondrially-targeted DsRed (mtDsRed) and GFP-Atg8. Single 
confocal planes are shown. Scale bars: 5 µm.  
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Hence, the results indicate that in control conditions mitophagy is important to maintain 
the homeostasis of aged cells. In contrast, under conditions of α-syn toxicity, mitophagy appears 
to result in increased toxicity rather than in cellular protection for the aged cells. Thus, mitophagy 
mediates α-syn-induced toxicity contributing to the reduction of CLS, which could be related with 
the fact that aged cells have a reduced ability to simultaneously upregulate anabolic processes in 
order to compensate for the loss of cellular material by increased mitophagy. On the other hand, 
it is possible that the selectivity of various types of autophagy, like mitophagy, is lost some 
factors, commonly required for various types of autophagy, may become limiting when mitophagy 
is upregulated. Additionally, the loss of selectivity could also result in the degradation of 
functional competent mitochondria, crucial to sustain cell survival of post-mitotic cells, 
contributing to the toxicity observed. The question that arises is how α-syn is stimulating 
autophagy/mitophagy? 
ROS, particularly superoxide anions, are crucial signaling molecules implicated in the 
control and regulation of autophagy and aging progression [225]. Additionally, both mammalian 
SIRT1 and its yeast homologue sirtuins 2 (Sir2) were recently described as inducers of autophagy 
under starvation conditions [356], and indeed, Sir2 was already associated with α-syn-induced 
toxicity [320]. Therefore, the next steps in this study were to evaluate the contribution of ROS and 
Sir2 to the induction of autophagy/mitophagy under α-syn-induced toxicity. 
 
 
3.1.5 Superoxide anion accumulation under α-synuclein-induced toxicity is 
decreased in cells with impaired mitophagy 
 
In yeast models, it was also shown that α-syn expression triggers intracellular 
accumulation of ROS and mitochondrial dysfunction [319]. Recent findings established a role for 
superoxide anion (O2
2-), in the regulation of autophagy [349], particularly in conditions of 
prolonged starvation [225].  
In order to unravel whether ROS may mediate the induction of autophagy/mitophagy, 
due to expression of α-syn variants, we examined the accumulation of ROS, the O2
2- levels and 
total ROS levels, particularly hydrogen peroxide (H2O2), during cells CLS. The accumulation of O2
2- 
was assessed by the fluorescent probe dihydroethidium (DHE) [357] and the accumulation of 
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total ROS levels by the use of the fluorescent probe dihydrorhodamine 123 (DHR) [358]. Flow 
cytometry analysis revealed that wild type cells expressing α-syn WT or A53T mutant form 
displayed a significant increase of DHE fluorescence intensity over time, as compared to the wild 
type cells harboring the vector control or expressing the non-toxic A30P mutant (Fig. 39A). In 
contrast, the expression of α-syn WT or A53T in cells lacking either the ATG11 or ATG32 gene did 
not result in such increased accumulation of O2
2- (Fig. 39B and C). The same results were 
observed when the accumulation of total ROS levels, by DHR, was analyzed (Fig. 39D-F). In fact, 
the accumulation of ROS was higher in wild type cells expressing α-syn WT or A53T mutant form 
compared with the same cells harboring the vector control or expressing the non-toxic A30P 
mutant (Fig. 39D). Consistently, the absence of the ATG11 or ATG32 gene abrogated the 
accumulation of total ROS levels under the expression of α-syn WT or A53T (Fig. 39E and F).  
High levels of DHE and DHR fluorescence were observed in the atg11∆ mutant cells 
expressing the non-toxic A30P (Fig. 39B and E), in accordance with the reduced CLS of these 
cells (Fig. 32). The data also showed that independently of background, wild type, atg11∆ or 
atg32∆, vector control cells, grown in 2% glucose, a condition known to induce the accumulation 
of O2
2-, resulted in increased accumulation of O2
2-, as expected. 
To further explore the reasons underlying the decrease in O2
2- and H2O2 accumulation 
displayed by cells with an impairment of mitophagy expressing toxic α-syn, we have determined 
the activity of superoxide dismutases, both cytosolic Cu/Zn-dependent (Sod1) and the 
mitochondrial Mn-dependent superoxide dismutases (Sod2), known to inhibit the accumulation of 
ROS. 
 
. 
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Figure 39. Reactive oxygen species (ROS) accumulation under α-syn-induced toxicity is decreased in cells with impaired mitophagy. During chronological life span of (A and D) wild type, (B 
and E) atg11 and (C and F) atg32 cells, expressing the vector control, the α-syn WT, the A53T or the A30P mutant forms under the control of the constitutive TPI1 promoter, the 
accumulation of superoxide anion and hydrogen peroxide were evaluated by flow cytometry, using the fluorescent probes (A-C) dihydroethidium (DHE) and (D-F) dihydrorhodamine 123 (DHR), 
respectively. The error bars represent the standard error of the mean (SEM). Values indicate mean ± SEM from three independent experiments. Significance of the values between yeast strains 
was determined by two-way ANOVA (*p0.05; **p0.01; ***p0.001). 
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The results showed that while atg11 cells expressing the vector control displayed Sod1 
activity comparable to wild type cells, atg32 cells presented a significant increase in Sod1 
activity (Fig. 40A). Nevertheless, both atg11 and atg32 cells had lower basal levels of Sod2 
activity, which do not increase over the CLS (Fig. 40B). The expression of α-syn A53T in wild type 
cells led to a decrease of Sod1 and a maintenance of Sod2 activity over the CLS time evaluated 
(Fig. 40C and D). In contrast, the expression of α-syn A53T did not affect the activity of Sod1 in 
atg32 cells, and promoted a slight increase of this activity in atg11 cells, while it increased the 
Sod2 activity (Fig. 40D). Hence, the ability of atg11 and atg32 cells to maintain Sod1 activity 
and to increase Sod2 over the CLS when expressing α-syn WT (data not shown) or A53T (Fig. 
40C and D) could be responsible for the decreased accumulation of ROS observed, since it is 
described that reduction of O2
2- is controlled by the SODs [359].  
The maintenance and increased in the Sods activities observed over CLS in atg11∆ or 
atg32∆ mutant cells could be the mechanism behind the decreased superoxide anion levels 
displayed by these cells. Additionally, these data on the oxidative status these mutant cells are in 
agreement with the respiratory competence displayed by these cells (Table 6). Furthermore, the 
ROS levels apparently are also correlated with the stimulation of autophagy. In conditions of 
starvation, the ROS accumulation is induced and consequently leads to induction of autophagy 
due to the interaction with Atg4, which enables the conversion of Atg8 to Atg8-PE and vice versa 
[224]. Probably, in wild type cells expressing α-syn WT or A53T that accumulate elevated ROS 
levels, the autophagy will be partially stimulated. 
Thus, our work does not rule out superoxide anions as inducers of autophagy/mitophagy 
due to the α-syn expression of the toxic variants [360]. Nevertheless, we decided to study other 
molecules that might be implicated in autophagy stimulation. 
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Figure 40. Superoxide dismutases (SODs) activity under α-syn-induced toxicity is increased in cells with impaired 
mitophagy. Bands corresponding to Sod1 activity of cells expressing vector control (A) or α-syn A53T mutant (C) and 
Sod2 activity of cells expressing vector control (B) or α-syn A53T mutant (D) were measured with a densitometer and 
the relative intensities calculated (Quantitaty One software, BioRad). Values indicate mean ± SEM from three 
independent experiments. Significance of the values between yeast strains was determined by two-way ANOVA 
(*p0.05; **p0.01; ***p0.001). 
 
 
3.1.6 SIR2 mediates the induction of autophagy/mitophagy under α-synuclein-
induced toxicity  
 
Autophagy induction can be mediated by several pathways. Recently, it was 
demonstrated the ability of the human homologue of yeast sirtuin 2 (Sir2), SIRT1, to induce 
autophagy [202]. In fact, different studies confirmed the induction of autophagy by SIRT1 in 
different models and in both normal growth and starvation conditions [201]. Furthermore, SIRT1, 
is required to sustain autophagy in response to nutrient starvation through deacetylation of 
autophagic regulators, including ATG5, ATG7, ATG8 and ATG12, suggesting that SIRT1 can 
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adjust autophagy activity to match the metabolic status [55, 201]. In addition, recent studies 
have also shown that in yeast cells, α-syn toxicity is Sir2 dependent [320]. Altogether, these 
findings led us to hypothesize a possible role of Sir2 in the induction of autophagy/mitophagy in 
response to α-syn toxicity.  
 
 
 
Figure 41. Abrogation of SIR2 reduces the α-syn toxicity in yeast aged cells. Chronological life span measure by (A) 
CFU, (C) PI exclusion or (D) FUN1 metabolic activity and (B) α-syn levels of stationary sir2 cells expressing the 
vector control, the α-syn WT, the A53T or the A30P mutant under the control of the constitutive TPI1 promoter. Cell 
viability was measured at 2-3 day intervals beginning at the day that cultures achieved stationary phase (day 0) and 
is expressed as % survival compared to survival at day 0 (100%). The data represents mean ± SEM of three biological 
independent replicas. The error bars represent the standard error of the mean (SEM). Significance of the data was 
determined by two-way ANOVA (***p<0.001). 
 
 
Thereby, using the moderate α-syn toxicity model, we expressed the human α-syn WT, 
the clinical A53T or A30P mutants in SIR2 cells, and grown the cultures until the stationary 
phase, about 2 days, representing this time the day 0 of CLS, and then the CLS and the 
autophagic activity were evaluated. In agreement with observations previously made [320], the 
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results showed a CLS extension of sir2 cells expressing α-syn WT or A53T as compared to wild 
type cells expressing the same proteins (Fig. 41A and B). The CLS extension of sir2 cells 
expressing α-syn WT or A53T was also validated by the analysis of cells viability by PI exclusion 
and FUN1 metabolic processing (Fig. 41C and D). Interestingly, the deletion of SIR2 in cells 
expressing the A30P non-toxic mutant resulted in a shorter CLS, which is in accordance with the 
data obtained with the atg11 cells. For the cells carrying the vector control, the SIR2 deletion 
did not alter the CLS in comparison to the wild type cells. These results are in agreement with the 
previous report showing that SIR2 deletion suppresses the toxicity induced by α-syn [320]. 
Consistently, this data was corroborated by the determined mean and maximum CLS (Fig. 42). 
 
 
 
Figure 42. SIR2 deletion increases mean and maximum CLS of aged cells expressing the toxic α-syn variants. (A) 
Mean (50% survival) and (B) maximum (10% survival) chronological life spans were determined from curve fitting of 
the survival data (Figs. 30 and 41) (from pair matched, pooled experiments) with the statistical software Prism 
(GraphPad Software). Significance was determined between wild type cells and sir2 cells expressing vector control 
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or α-syn variants (*). The significance determined between cells expressing the vector control or α-syn variants within 
each strain (wild type, sir211) was also determined (#).The error bars represent the standard error of the mean 
(SEM). Significance of the data was determined by two-way ANOVA (#p<0.05; *p<0.05; **p<0.01; ***p<0.001). 
 
 
The reduction of the α-syn toxicity by the abrogation of the SIR2 gene supports a role for 
Sir2 in controlling autophagy/mitophagy induction upon α-syn expression. To elucidate the 
validity of this hypothesis, the autophagic and mitophagic activities were evaluated by the ALP 
assay, above described, during CLS. The results showed that SIR2 deletion inhibits the 
autophagy and mitophagy activities in cells expressing the α-syn toxic variants, as reflected by the 
abolishment of the ALP activity in sir2 cells (Fig. 43A and B). Once again, these results support 
the hypothesis that α-syn toxicity is dependent of the autophagy and mitophagy sustained 
induction, which in turn seems to be mainly regulated by Sir2. 
 
 
 
Figure 43. Sir2 is associated with autophagy induction and selective degradation of mitochondria under α-syn-
induced toxicity. Autophagy (A) and mitophagy (B) activities were measured through the alkaline phosphatase (ALP) 
assay, in sir2 cells. The data represent mean ± SEM of three biological independent replicas. The error bars 
represent the standard error of the mean (SEM). Significance of the data was determined by two-way ANOVA 
(*p<0.05; **p<0.01). 
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Figure 44. Sir2 abrogation reduces mitophagy induced by α-syn expression. Wild type and sir2 cells expressing, mitochondrially-targeted DsRed (mtDsRed) and GFP-Atg8. Single confocal 
planes are shown. Scale bars: 5 µm 
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Next, to further corroborate the biochemical data obtained with the ALP assay, we 
assessed the mitophagy by microscopic visualization of the process. Therefore, in wild type and 
sir2∆ cells expressing α-syn toxic forms, the GFP-Atg8 and mtDsRed (mitochondrially-targeted 
DsRed) were expressed. The cell visualization by confocal microscopy revealed that in sir2 cells 
the GFP-Atg8 was essentially found distributed in the cytosol independently of the expression of 
α-syn variants. In addition, mitochondrial mtDsRed marked a mitochondrial network (Fig. 44) 
suggesting the abolishment of the mitophagy as revealed in wild type cells expressing α-syn WT, 
corroborating the absence of mitophagy activity determined in sir2∆ cells.  
 
 
 
Figure 45. Sir2 regulates the mRNA levels of ATG8 and ATG32 in stationary phase cells expressing α-syn toxic 
variants. Relative ATG8 and ATG32 mRNA levels in stationary phase wild type and sir2 cells expressing α-syn at 
day 0, 3, 7 and 10. Three reference genes [ACT1 (actin), PDA1 (alpha subunit of pyruvate dehydrogenase) and 
TDH2 (isoform 2 of glyceraldehyde-3-phosphate dehydrogenase)] were used as internal standards and for the 
normalization of mRNA expression levels. The data represent mean ± SEM of three biological independent replicas. 
The error bars represent the standard error of the mean (SEM). Significance of the data was determined by two-way 
ANOVA (*p<0.05; **p<0.01; ***p<0.001). 
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As described before, in wild type cells the expression of α-syn WT or A53T mutant is 
responsible for the induction of higher mRNA levels of ATG8 and ATG32 (Fig. 27B and 28B), and 
consequently associated with the autophagy/mitophagy stimulation. In this sense, since we 
observed an abrogation of the autophagy and mitophagy activities in sir2 cells, we decided to 
perform the analysis of the ATG8 and ATG32 relative mRNA levels in sir2 cells, expressing α-
syn WT or A53T, during CLS. The mRNA analysis revealed that the expression of ATG8 (Fig. 45A 
and B) and ATG32 (Fig. 45C and D) is strongly dependent on Sir2 in stationary phase cells under 
α-syn toxic conditions, particularly the expression of ATG32, since the deletion of SIR2 gene 
strongly reduces the ATG32 mRNA levels (Fig. 45).  
Recently it was demonstrated that the mammalian SIRT1 has the capacity to induce 
autophagy, in both normal and starved conditions (reviewed in [202]), however to the yeast 
SIRT1 homologue, Sir2, this link to autophagy was never showed. This work clearly proved that, 
during the yeast CLS, Sir2 is involved not only in the modulation of autophagy but also in the 
regulation of mitophagy.  
Thus, our data strongly supports the hypothesis that α-syn toxicity is dependent on Sir2, 
an essential mediator of autophagy/mitophagy through the transcriptional regulation of ATG8 and 
ATG32 in stationary phase cells expressing α-syn toxic variants, during aging. Altogether, these 
innovative findings open new insights to the study of the mechanism associated with PD 
pathogenesis in higher eukaryote organisms.  
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Caloric restriction mitigates α-synuclein toxicity aged 
cells 
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3.2 Caloric restriction mitigates α-synuclein toxicity in yeast aged cells 
 
Caloric restriction (CR) increases life span in multiple organisms including yeast, worm, 
flies and mammalian, nevertheless, the molecular mechanisms by which CR slows aging remains 
yet poorly understood. CR promotes several physiological changes that may underlie its effects 
on longevity, including decreased activity of nutrient and signaling pathways, increased resistance 
to stress, altered translation and ribosome biogenesis, and increased autophagy. In this sense 
CR is a promising intervention that is able to attenuate aging and ultimately to decrease the risk 
of age-related neurodegenerative disorders [361]. Based on the perspective that CR is able to 
delay aging, age-related neurodegenerative disorders, and to modulate autophagy, our aim in this 
section was to contribute for a better comprehension of the effects of CR on α-syn toxicity and 
correlate them with the autophagy/mitophagy activity during aging. For that, we tested whether 
reducing the glucose concentration in the medium (CR) impacts on the autophagy/mitophagy in 
aged cells expressing α-syn. 
 
 
3.2.1 Reduced glucose uptake extends CLS of yeast cells expressing α-synuclein 
 
Although CR in worms, flies and mammals usually requires a complex food source 
limitation, in yeast, moderate CR is commonly achived by reducing the glucose concentration in 
the culture medium from 2% to 0.5% [239, 362, 363]. In this study, we used the moderate 
toxicity yeast model, consisting in the constitutive expression of α-syn WT, A53T or the A30P 
mutant under the control of the endogenous TPI1 promoter. Therefore, cells were grown under 
CR, specifically, in culture medium with 0.5% of glucose, until the stationary phase, representing 
the day 0 of the CLS. As expected the CLS, measured by the survival of non-dividing stationary 
phase cells harboring the vector control and expressing the non-toxic mutant α-syn A30P was 
clearly extended in comparison with the same cells under non-CR conditions (2% glucose)(Fig. 
46). Cells expressing the toxic α-syn variants (WT or A53T mutant form) grown under CR 
condition also displayed CLS extension of two times comparatively to non-CR conditions (Fig. 46A 
and B ). Nevertheless, α-syn WT or A53T mutant form expression also induced a shortening of 
CLS when cells were under CR conditions in comparison with the cells harboring the vector 
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control or expressing the non-toxic mutant α-syn A30P under the same conditions (Fig. 46B). 
These results showed that although CR increases CLS of cells expressing α-syn toxic variants, it 
does not abolished α-syn toxicity, it only ameliorates the toxicity in comparison with non-CR 
conditions.  
 
 
 
Figure 46. Caloric restriction (CR) ameliorates α-syn-induced toxicity in aged yeast cells. Chronological life span of 
(A) non-CR (Fig. 30A), (B) CR and (C) CR-α-syn levels of stationary wild type cells expressing the vector control, α-syn 
WT, A53T or A30P mutant forms under the control of the constitutive TPI1 promoter, a moderate toxicity model. The 
data represent mean ± SEM of three biological independent replicas. Cell viability was measured at 2-3 day intervals 
beginning at the day that cultures achieved stationary phase (day 0) and is expressed as % survival compared to 
survival at day 0 (100%). The error bars represent the standard error of the mean (SEM). Significance of the data 
was determined by two-way ANOVA (***p<0.001). 
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The analysis of the mean and maximum CLS of control cells and cells expressing the α-
syn variants under CR intervention revealed a significant increase (about two folds) of mean and 
maximum CLS when compared with the same cells grown under 2% glucose (non-CR conditions) 
(Fig. 47). Summing up, our data showed that CR intervention alleviates the α-syn-induced toxicity, 
allowing an extension of CLS. 
As above described, one of the physiological changes that underlie the chronological 
longevity promoted by CR is based on the stimulation of autophagy [364]. Thus, whether the 
capacity of CR to ameliorate the α-syn-induced toxicity is associated with the regulation of 
autophagy was investigated.  
 
 
 
Figure 47. Caloric restriction (CR) increases mean and maximum CLS of wild type cells expressing α-syn toxic 
variants. (A) Mean (50% survival) and (B) maximum (10% survival) chronological life spans were determined from 
curve fitting of the survival data from (Figure 46A and B). Significance was determined between wild type cells grown 
under non-CR or CR conditions expressing vector control or α-syn variants (*).The significance determined between 
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cells expressing the vector control or α -syn variants within each condition (normal or CR conditions) was also 
determined (#). The data represent mean ± SEM of three biological independent replicas. The error bars represent 
the standard error of the mean (SEM). Significance of the chronological life span curves was determined by two-way 
ANOVA (#p<0.001; ***p<0.001). 
 
 
The determination of autophagy activity, by the ALP assay (as already described), during 
CLS under CR conditions was performed. The data showed that CR statistically significantly 
stimulates autophagy in cells harboring the vector control in comparison with the same cells 
grown under non-CR conditions (Fig. 48A and C). The increase in autophagy activity of CR cell 
versus non-CR cells expressing vector control was found to be statistical significant by two-way 
ANOVA (**p<0.01; ***p<0.001; § p<0.001). Furthermore, in cells harboring the vector control 
under CR, a regulated increased of the autophagic activity, which was maintained at similar levels 
during CLS, in comparison with the levels observed under non-CR conditions. The same profile 
was also observed for the mitophagy activity, nevertheless, the statistical significance induction 
was only observed at 10 days of CLS (Fig. 48B and D). The heterologous expression of α-syn WT 
or the A53T mutant form in wild type cells grown under CR conditions resulted in autophagy 
levels similar to the ones presented by the cells harboring the vector control, and significantly 
lower than the levels presented by the cells expressing the α-syn toxic variants when grown under 
non-CR conditions (Fig. 48A and C). The same results were observed for mitophagy activity in 
cells expressing α-syn WT or the A53T mutant form (Fig. 48B and D). The data suggests that the 
physiological CR intervention results in the induction of autophagy/mitophagy, but maintains the 
autophagy/mitophagy levels at a physiological threshold in cells expressing the toxic variants of 
α-syn. 
 
 
 
 
125 
 
Figure 48. Caloric restriction (CR) regulates the autophagy and mitophagy activities. (A, C) Autophagic and (B, D) 
mitophagic activities were measured through the alkaline phosphatase (ALP) assay, during the chronological life 
span of wild type cells grown under non-CR (Fig. 31) and CR conditions, respectively. The data represent mean ± 
SEM of three biological independent replicas. The error bars represent the standard error of the mean (SEM). 
Significance was determined between wild type cells expressing the vector control or α-syn variants within each 
growth condition (non-CR or CR) (*). The significance determined between wild type cells grown under non-CR or CR 
conditions expressing the vector control or α-syn variants (§). Significance of the data was determined by two-way 
ANOVA (**p<0.01; ***p<0.001; § p<0.001). 
 
 
3.2.2 Caloric restriction increases chronological life span (CLS) of α-syn expressing 
cells independently of mitophagy 
 
As described in previous sections, the expression of α-syn WT or the A53T mutant form 
induces an increase of autophagy/mitophagy, and apparently CR manipulation attenuates these 
activities to a more physiological threshold, avoiding the generation of autophagic stress. To 
further elucidate the effects of CR in preventing α-syn toxicity, we decided to evaluate if CR also 
extends the CLS of cells with impaired mitophagy, namely in atg11 and atg32 cells. 
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The CLS data demonstrated that atg11 cells harboring the vector control submitted to 
CR presented an extension of the longevity compared to the same cells grown in non-CR 
conditions (Fig. 49A and B). Expression of α-syn toxic variants in atg11 cells submitted to CR 
conditions resulted in CLS extension, either when compared to non-CR cells expressing the α-syn 
toxic variants (Fig 49A and B) or to non-CR cells harboring the vector control (Fig. 49B).  
 
 
 
Figure 49. Caloric restriction (CR) promotes a CLS extension in cells with impaired mitophagy. Chronological life 
span of (A, D) non-CR (Fig. 32A and Fig. 33A), (B, E) CR interventions and (C, F) CR-α-syn levels of atg11 and 
atg32 cells, respectively, expressing the vector control, the α-syn WT, the A53T or the A30P mutant under the 
control of the constitutive TPI1 promoter. Cell viability was measured at 2-3 day intervals beginning at the day that 
cultures achieved stationary phase (day 0) and is expressed as % survival compared to survival at day 0 (100%). The 
data represents mean ± SEM of three biological independent replicas. The error bars represent the standard error of 
the mean (SEM). Significance of the data was determined by two-way ANOVA (*p<0.05; ***p<0.001). 
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ATG32 deleted cells harboring the vector control and under CR also displayed an 
extension of the chronological longevity, which was even higher in the cells expressing the toxic α-
syn variants (Fig. 49D and E). Summing up, in all the studied conditions, the cells with impaired 
mitophagy submitted to CR revealed a chronological longevity extension, independently of the α-
syn expression, in comparison to the same cells grown in non-CR conditions (Fig. 49A-F).  
 
 
 
Figure 50. Caloric restriction (CR) increases mean and maximum CLS of cells with impaired mitophagy. (A, C) 
Mean (50% survival) and (B, D) maximum (10% survival) chronological life spans were determined from curve fitting 
of the survival data (Figure 46 and 49) of cells gown under CR or non-CR (Fig. 34) conditions, respectively (from pair 
matched, pooled experiments) with the statistical software Prism (GraphPad Software). Significance was determined 
between wild type cells and atg11 or atg32 cells expressing vector control or α-syn variants (*). The significance 
determined between cells expressing the vector control or α-syn variants within each strain (wild type, atg11 or 
atg32) was also determined (#). (#p<0.001; *p<0.05; **p<0.01; ***p<0.001). 
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The determination of mean and maximum CLS also supports the CLS extension and the 
loss of toxicity by the expression of α-syn WT or the A53T in cells where mitophagy was 
abrogated and submitted to CR. The generated data showed that CR promoted a statistically 
significant increase of the mean and maximum CLS of wild type cells, atg11 and atg32 cells 
expressing the α-syn variants when compared with cells cultivated under non-CR conditions (Fig. 
50). The CR was unable to overpass the decreased longevity experienced by the atg11 cells 
expressing the non-toxic α-syn A30P, although the cells grown under CR presented a slight 
extension of CLS (Fig. 50). 
Given the previous results showing that CR mediates CLS extension of cells expressing α-
syn toxic variants by regulating autophagy/mitophagy to physiological levels below the ones 
observed in non-CR cells, we decided to evaluate autophagy/mitophagy activities in the ATG11 
and ATG32 mutant cells grown under CR conditions (Fig. 51). The ALP assay indicated that the 
mutant cells display autophagy/mitophagy levels similar to the ones presented by wild type cells 
under CR conditions (Fig. 48), although, as expected, the atg32 cells presented lower 
mitophagy levels (Fig. 51D). This data showed that CR-mediated life span extension of cells 
expressing α-syn toxic variants is independent of selective autophagy, particularly mitophagy. 
The data presented in this section indicates that in cells with impaired mitophagy 
expressing the α-syn toxic variants, CR increases CLS by pathways independent, or at least 
partially independent, of autophagy/mitophagy. Nevertheless, CR is also able to regulate 
autophagy/mitophagy, and consequently this regulation is ameliorating the α-syn-induced toxicity 
as demonstrated in wild type cells subjected to CR conditions.  
CR promotion of longevity extension is associated with decreased mitochondrial free 
radical generation and Sir2 activation, however the role of sir2 in CLS is still matter of debate 
[365]. In fact, during yeast replicative life span (RLS), CR induces the activation of Sir2 leading to 
a RLS extension. In contrast, during chronological longevity, overexpression or deletion of SIR2 
has no effect on the CLS, except when deleted cells are submitted to severe CR, such as 
incubation in water [257]. Given the identified role of Sir2 on autophagy/mitophagy regulation 
under proteotoxic stress created by α-syn expression, we decided to evaluate the contributions of 
ROS accumulation and Sir2 in the CR amelioration of α-syn-induced toxicity, during CLS. 
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Figure 51. Caloric restriction (CR) does not affect autophagy and mitophagy activities in aged atg11 or atg32 
cells under α-syn-induced toxicity. Autophagy and mitophagy activities were measured through the alkaline 
phosphatase (ALP) assay that was carried out to assess (A and B) autophagy or (C and D) mitophagy in atg11 or 
atg32 cells, respectively, grown under CR conditions. The data represent mean ± SEM of three biological 
independent replicas. The error bars represent the standard error of the mean (SEM). Significance of the data was 
determined by two-way ANOVA (*p<0.05; **p<0.01; ***p<0.001). 
 
 
3.2.3 Caloric restriction regulates superoxide anion levels in aged yeast cells 
expressing α-syn toxic variants 
 
As above described, in an attempt of understand the CR extension of cells under 
conditions of α-syn-induced toxicity, the ROS levels were measured [358]. The accumulation of 
superoxide anion (O2
2-) and total ROS levels during CLS was evaluated by flow cytometry, using 
the fluorescent probes DHE and DHR, respectively. As expected, the flow cytometry analysis 
revealed that CR resulted in the decrease of the O2
2- levels in wild type cells harboring the vector 
control (Fig. 52A). The same phenotype was observed in cells expressing the toxic α-syn variants, 
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since these cells displayed a significant decrease in the DHE fluorescence intensity over time, as 
compared to the wild type cells under non-CR conditions (Fig. 52A shadow bars versus bars and 
Fig. 39A). Conversely, the expression of α-syn WT or A53T in cells lacking either the ATG11 or 
ATG32 genes grown under CR conditions (Fig. 52B and C shadow bars versus bars) presented 
similar levels of O2
2- in comparison with the wild type cells in same conditions (Fig. 37A-C). 
Nevertheless, those mutant cells showed a lower DHE fluorescence intensity over time in 
comparison with the same cells submitted to non-CR conditions (Fig. 52B and C shadow bars 
versus bars and Fig. 39B and C). Striking, expression of the non-toxic α-syn A30P mutant form 
led to increased accumulation of O2
2- levels in ATG11 mutant cells (Fig. 52B shadow bars versus 
bars), consistently with the shorter CLS observed even under non-CR conditions (Fig. 49B). 
The analysis of the accumulation of total ROS levels, particularly H2O2, showed that wild 
type cells (Fig. 53A bars versus non-shadow bars) displayed higher total ROS levels in 
comparison with the atg11 and atg32 cells (Fig. 53B and C bars versus non-shadow bars), 
independently of the expression of toxic α-syn variants. In addition, the total ROS levels under CR 
conditions were higher than under non-CR conditions (Fig. 52 bars versus non-shadow bars and 
Fig. 37D-F). This data is in agreement with our previous report study on the pro-longevity effects 
of H2O2 [358]. Thus under CR conditions the mutant cells presented similar levels of ROS 
independently of the proteotoxic stress promoted by the expression of α-syn WT or A53T (Fig. 
53B and C bars versus non-shadow bars).  
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Figure 52. Caloric restriction (CR) decreases O22- accumulation. During chronological life span of (A) wild type, (B) atg11 and (C) atg32 cells, expressing the vector control, the α-syn WT, 
the A53T or the A30P mutant forms under the control of the constitutive TPI1 promoter. The accumulation of superoxide anion was evaluated by flow cytometry, using the fluorescent probe 
dihydroethidium. Shadows on the bars represent the values obtained for cells submitted to CR conditions. Bars represent cells submitted to non-CR conditions. The error bars represent the 
standard error of the mean (SEM). Values indicate mean ± SEM from three independent experiments. Significance of the values between yeast strains only submitted to CR conditions was 
determined by two-way ANOVA. 
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Figure 53. Caloric restriction (CR) increases accumulation of total ROS levels. During chronological life span of (A) wild type, (B) atg11 and (C) atg32 cells, expressing the vector control, 
the α-syn WT, the A53T or the A30P mutant forms under the control of the constitutive TPI1 promoter. The accumulation of total ROS levels, particularly hydrogen peroxide, was evaluated by 
flow cytometry, using the fluorescent probe dihydrorhodamine 123 (DHR). Bars represent cells submitted to CR conditions. Non-shadow bars represent the cells submitted to non-CR 
conditions. The error bars represent the standard error of the mean (SEM). Values indicate mean ± SEM from three independent experiments. Significance of the values between yeast strains 
only submitted to CR conditions was determined by two-way ANOVA. 
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α-Syn toxic variants expression triggers intracellular accumulation of ROS and 
mitochondrial dysfunction in yeast [319]. Nevertheless, under CR conditions a decrease in the 
accumulation of O2
2- associated with the regulation/decrease of autophagy/mitophagy activity 
and lack of α-syn toxicity was observed. Furthermore, the data showed that even under 
proteotoxic stress, CR is able to activate a pathway dependent on H2O2 and independent of Rim 
15 [358, 366]. These conclusions are supported by the increase DHR fluorescence levels of CR 
cells (Fig. 53). 
 
 
3.2.4 Caloric restriction (CR)-increased chronological life span (CLS) extension is 
independent of Sir2 under proteotoxic stress  
 
Given the results obtained (section 3.1) concerning the crucial role of Sir2 on the 
transcriptional regulation of autophagy, particularly mitophagy in cells expressing toxic α-syn 
variants under non-CR conditions, we decided to evaluate if the same mechanism is operating 
under CR conditions. Furthermore, we wondered if the regulation/decrease of 
autophagy/mitophagy observed in wild type cells expressing the toxic α-syn variants under CR 
conditions was due to Sir2 functions. For that, CLS of sir2 cells submitted to CR was evaluated 
and compared with wild type cells submitted to CR and non-CR conditions. 
SIR2 deleted cells harboring the vector control cultivated in CR conditions presented a 
CLS extension in comparison with the same cells grown in non-CR conditions (Fig. 54). The same 
phenotype was observed for the sir2 cells expressing the α-syn variants. Thus, CR intervention 
increased the CLS of cells expressing α-syn independently of Sir2 (Fig. 54). Furthermore, the 
determination of mean and maximum CLS demonstrated that sir2 cells expressing the toxic α-
syn variants, WT or mutant A53T form, grown under CR conditions presented an increased mean 
and maximum CLS in comparison with the wild type cells expressing the same variants and 
submitted to the same conditions (Fig. 55). In contrast, sir2 cells harboring the vector control 
showed a similar CLS CR-dependent extension to the one displayed by wild type cells (Fig. 55). 
These results indicate that CR is still able to increase the CLS of the long-lived sir2 cells under 
proteotoxic stress (Fig. 55).  
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Figure 54. Caloric restriction (CR) increases CLS of sir2 cells expressing toxic α-syn variants. Chronological life 
span (A) under non-CR (Fig. 41A) and (B) CR conditions and (C) CR-α-syn levels of sir2 cells expressing the vector 
control, the α-syn WT, A53T or A30P mutant forms under the control of the constitutive TPI1 promoter. Cell viability 
was measured at 2-3 day intervals beginning at the day that cultures achieved stationary phase (day 0) and is 
expressed as % survival compared to survival at day 0 (100%). The error bars represent the standard error of the 
mean (SEM). Significance of the data was determined by two-way ANOVA (***p<0.001). 
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Figure 55. Caloric restriction (CR) increases the mean and maximum life span of sir2 cells expressing toxic α-syn 
variants. (A, C) Mean (50% survival) and (B, D) maximum (10% survival) chronological life spans of cells grown under 
CR or non-CR (Fig. 42) conditions, respectively, were determined from curve fitting of the survival data (Figure 46B 
and 54B) (from pair matched, pooled experiments) with the statistical software Prism (GraphPad Software). 
Significance was determined between wild type cells and sir2 cells expressing vector control or α-syn variants (*). 
The significance determined between cells expressing the vector control or α-syn variants within each strain (wild 
type or sir2) was also determined (#) (#p<0.001; ** p<0.01). 
 
 
As described in section 3.1, Sir2 is regulating autophagy and mitophagy by the 
transcriptional control of the ATG8, and particularly ATG32 mRNA levels, in cells expressing the 
α-syn toxic variants. Thus, given the Sir2 increasing of autophagy/mitophagy activity in cells 
expressing the α-syn variants under non-CR conditions, we wondered if CR is also able to regulate 
the autophagy/mitophagy activity in cells where Sir2 is abolished. The data demonstrated that 
SIR2 deletion statistically significantly reduces the autophagy and mitophagy activity in cells 
expressing α-syn toxic variants and also in the cells harboring the vector control (Fig. 56) in 
comparison with the wild type cells also grown under CR conditions (Fig. 48). Furthermore the 
autophagy and mitophagy levels were similar to the ones presented by the SIR2 cells grown 
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under non-CR conditions (Fig. 56). In these sense, the data suggests that CR is not promoting life 
span extension of sir2 cells by the modulation of autophagy/mitophagy. 
 
 
 
Figure 56. CR is not promoting life span extension of sir2 cells by the modulation of autophagy/mitophagy. (A, C) 
Autophagy and (B, D) mitophagy activity were measured through the alkaline phosphatase (ALP) assay in sir2 cells 
grown under CR or non-CR (Fig. 43) conditions, respectively. The data represent mean ± SEM of three biological 
independent replicas. The error bars represent the standard error of the mean (SEM). Significance of the data was 
determined by two-way ANOVA. 
 
 
To complete this study further work needs to be performed such as the evaluation of the 
ATG8 and ATG32 mRNA levels to determine if CR is transcriptionally regulating 
autophagy/mitophagy and consequently alleviating α-syn toxicity. Additionally, to define the 
possible O2
2- involvement in the abolishment of α-syn toxicity under CR, the SODs activity must be 
also monitored. Furthermore, the evaluation of α-syn foci under CR intervention needs also to be 
assessed in an attempt to define the foci role in the α-syn toxicity. 
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Summing up, our data demonstrated that CR is associated with the maintenance of 
autophagy/mitophagy that consequently ameliorates the toxicity induced by α-syn toxic variants. 
Nevertheless the CR-mediated extension of CLS in cells expressing the α-syn toxic variants is 
independent of mitophagy and Sir2.  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
           CHAPTER 4 
CONCLUDING REMARKS AND FUTURE PROSPECTIVES
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It has long been puzzling why protein aggregation and neurotoxicity develop late in life, 
even in familial forms of neurodegenerative disease where mutant proteins are present 
throughout life. In this context, aging is, by far, the strongest risk factor associated with the late-
onset diseases. Indeed, aging is associated with a general and progressive decline of 
fundamental cellular housekeeping processes that are crucial for maintaining cellular 
homeostasis, such as autophagy [367, 368], which contributes to the accumulation of misfolded 
proteins [369], particularly in post-mitotic cells. In fact, the genetic and pharmacological 
inhibition or enhancement of autophagy is respectively correlated to decreased or increased 
longevity [345]. Moreover, the vast majority of interventions found to increase longevity are 
autophagy-dependent, supporting the crucial cytoprotective role of autophagy and the tight 
relation between autophagy and aging. To address the interplay between autophagy and aging 
under a proteotoxic context, the yeast Saccharomyces cerevisiae heterologous expressing human 
α-synuclein (α-syn) variants was used [290]. The yeast is a powerful model for investigating the 
cellular and molecular basis of α-syn toxicity and has several advantages such as the well 
characterized autophagy machinery and the fact of being an established system for aging 
research [370]. Herein, data is presented showing that the expression of α-syn WT or A53T 
mutant form in yeast cells results in shortening of chronological life span and increased α-syn 
toxicity. Furthermore, aging proved to be a major risk factor associated with α-syn toxicity, since 
the harmful phenotype was more pronounced when α-syn was expressed in stationary phase 
(aged) cells. These observations were made by using three distinct yeast models with different 
toxicity levels, from low to high toxicity, which highlighted that the modulation of the toxicity 
induced by α-syn depends on the physiological state of the cells.  
The accumulation of misfolded proteins in the cells triggers the activation of the cellular 
protein quality control system. One of the major pathways of this system is the unfolded protein 
response (UPR). Our findings demonstrate that a sustained UPR activation is being elicited by the 
heterologous expression of the toxic α-syn variants. In yeast the UPR is mediated by the Ire1-
Hac1 signaling pathway, which is ultimately responsible for the activation of several genes 
associated with the degradation of the misfolded proteins, particularly the ATG genes, like ATG5, 
ATG7, ATG8, ATG14 and ATG19 [194, 195]. Mounting evidence established that when UPR is 
unable to restore the endoplasmic reticulum homeostasis, the misfolded proteins are driven to 
proteolytic degradation, particularly autophagy [37]. Our findings confirmed that the UPR 
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activation was accompanied with the upregulation of at least two autophagic genes, ATG6, which 
participates in the formation of the autophagosome [54], and ATG8, which codifies for a protein 
that is predominantly associated with the autophagosome structure [118], suggesting that 
autophagy plays an important role in the α-syn-induced toxicity in yeast aged cells. Our data 
obtained by pharmacological manipulation of autophagy confirmed the association between 
autophagy induction and α-syn toxicity. The pharmacological inhibition of autophagy, with 
chloroquine or 3-methyladenine, rescues aged yeast cells from α-syn-induced toxicity. The 
pharmacological induction of autophagy with rapamycin also resulted in a slight reduction of the 
α-syn-induced toxicity. Nevertheless, this autophagy induction is mediated by the inhibition of 
TOR pathway that participates in a wide range of cellular response, namely proteins synthesis 
and cellular metabolism [259], and in yeast, its pharmacological or genetic abrogation is always 
associated with a strong chronological life span extension [244]. Thus, further conclusions 
cannot be drawn by the experiments with rapamycin.  
Autophagy is a process that is present at basal levels, contributing to the turnover of 
cytoplasmic components and crucial to maintain cell homeostasis, particularly important in post-
mitotic cells, such as neurons, since aged cells do not have the capacity to get rid of their waste 
through cell division [226, 227]. However, an imbalance on autophagy levels, either too much or 
too little, can be injurious to the cells [230]. Our findings confirmed that cells expressing PD-
causing variants of α-syn displayed increased autophagic activity, which strongly supports our 
hypothesis and establishes an association between increased autophagic activity and α-syn-
induced toxicity in aged cells. Notably, it was demonstrated that α-syn expression in mammalian 
cells impairs chaperone-mediated autophagy and induces the upregulation of autophagy 
(macroautophagy), which seems to contribute to neuronal cell death [299]. Although increased 
autophagic activity can mediate α-syn clearance in functionally competent cells [371] and 
thereby have anti-aging effects [372], it might also affect autophagy efficiency and selectivity in 
aged cells [373]. The controversial role of autophagy is also associated with oxidative stress and 
mitochondrial dysfunction, which play a central role in α-syn-induced toxicity [317, 319]. 
Although the relevance of mitophagy, induced by mitochondria-damaging agents, for the etiology 
of PD remains debatable [353], accumulating evidence on the key role of the PD-associated 
proteins PINK1 and PARK2, in targeting specific dysfunctional mitochondria for degradation by 
mitophagy [373], supports the interconnection of these cellular processes and their involvement 
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in the pathogenesis of PD. Based on those findings, we wondered if dysfunctional mitochondria 
were being targeted for degradation by the autophagic machinery. The performed gene analysis 
also demonstrated that genes specifically associated with mitophagy, ATG32 and ATG33, were 
upregulated under α-syn-induced toxicity. Additionally, the DNM1 gene, which codifies to a 
mitochondrial dynamic-related GTPase required for mitochondrial fission, that is through to be 
necessary for mitophagy [340], was also found overexpressed suggesting that probably before be 
engulfed by the autophagosome, mitochondria undergo fission to prepare them to fit into 
autophagosome [161]. Further findings showed that α-syn expression induces mitophagy and 
that deletion of ATG11 or ATG32, both required for mitophagy, prevents α-syn-induced toxicity as 
revealed by the increased mean and maximum chronological life spans. A precondition 
associated with the α-syn-induced toxicity is the presence of functional mitochondria, as 
demonstrated by the resistance of rho 0 cells (lacking mitochondrial DNA) to α-syn-induced 
toxicity [319]. Our data showed that the decreased α-syn toxicity observed in cells with an 
impairment of mitophagy was not due to an inherent mitochondria dysfunction of ATG11 or 
ATG32 mutant cells, although these mutant cells display mitochondria dysfunction when 
subjected to severe nitrogen starvation [374]. 
To elucidate the pathways/molecules associated with α-syn-induced 
autophagy/mitophagy activation during aging, reactive oxygen species (ROS) were investigated. 
ROS, particularly superoxide anion, are crucial signaling molecules implicated in the control and 
regulation of autophagy and aging progression. Data herein presented suggests that the 
sustained superoxide dismutase (SOD) activities observed over CLS in atg11∆ or atg32∆ mutant 
cells could be the mechanism behind the decreased superoxide anion levels displayed by these 
cells. In fact, under certain scenarios, it is described that the H2O2 detoxifying enzymes, catalase, 
are degraded by autophagy, suggesting that the specific removal of catalases by autophagy 
creates a loop, in which the increase in the H2O2 production further stimulates an autophagy 
overactivation culminating in cell death [225]. In this sense, it is possible that the expression of 
α-syn induces autophagy that will degrade the superoxide anion detoxifying enzymes, SODs, 
since we found that wild type cells expressing the toxic α-syn variants display a decrease in the 
SODs activity. Thus, this event leads to an enhancement of the superoxide anion accumulation 
that consequently upregulates the autophagic activity, contributing to the cell death due to α-syn. 
Contrariwise, the mutant ATG11 and ATG32 cells expressing the toxic α-syn variants experience a 
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reduction in the autophagic/mitophagic activity that consequently will neither induce the SODs 
degradation nor the superoxide anion accumulation. Therefore, our results do not rule out 
superoxide anions as mediators of autophagy/mitophagy due to α-syn accumulation [360] and 
aging [375]. 
Mammalian SIRT1 was recently described as an inducer of autophagy under starvation 
conditions [356]. Here, we investigated such a role for the yeast homologue, Sir2. Our findings 
revealed that deletion of the SIR2 gene not only alleviated α-syn toxicity, as previously described 
[320], and as evidenced by the increased CLS, but also that this phenomenon is linked to a 
drastic inhibition of autophagy and mitophagy as demonstrated by the ALP assay. Notably, Sir2 
was shown to be essential for the regulation of ATG8, and particularly, ATG32 mRNA levels in 
stationary phase cells expressing α-syn toxic variants. Our findings further reveal that autophagy 
and mitophagy are mainly regulated through Sir2, in agreement with the role that alterations on 
the acetylproteome have on the regulation of autophagy [203, 255]. 
It is well established that caloric restriction (CR) is able to increase life span in multiple 
organisms including yeast, worm, flies and mammalian, nevertheless, the molecular 
mechanisms by which CR slows aging remains still poorly understood. CR promotes several 
physiological changes that may underlie its effects on longevity, including decreased activity of 
nutrient and growth factor pathways, increased resistance to stress, altered translation and 
ribosome biogenesis, and increased autophagy. In this context, CR has the capacity to delay 
aging and age-related neurodegenerative disorders. Our data suggests that CR ameliorates the α-
syn-induced toxicity in aged cells. This is confirmed by the results obtained under CR conditions 
where the α-syn toxicity is reduced, resulting in a CLS extension that was accompanied by 
physiological levels of autophagy/mitophagy activity, preventing the generation of autophagic 
stress. CR-mediates CLS extension was also observed in cells with impaired mitophagy 
expressing α-syn, even when compared with the wild type cells submitted to the same conditions, 
suggesting that CR-mediated life span extension of cells expressing α-syn is independent, or at 
least partially independent, of selective autophagy, particularly mitophagy, pointing to other 
protective pathways elicited by CR. However, CR is able to regulate autophagy/mitophagy, and 
consequently this regulation ameliorates the α-syn-induced toxicity in wild type cells. 
In contrast to non-CR conditions, CR intervention is linked to a decrease in the 
accumulation of superoxide anion that consequently is associated with the regulation/decrease of 
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autophagy/mitophagy activity and lack of α-syn toxicity. Furthermore, the data showed that even 
under proteotoxic stress, CR is able to activate a pathway involving H2O2 accumulation but 
independent of Rim 15 [358, 366], revealed by the increased DHR fluorescence levels of CR 
cells.  
In yeast, it is well recognized that CR induces the activity of Sir2 and consequently 
extends the replicative life span [257]. It is also described that either overexpression or deletions 
of Sir2 do not result in CLS extension under moderated CR [257]. Our results contradict this 
observation, since in our experimental conditions with moderate CR, the abrogation of SIR2 
harboring the vector control resulted in higher CLS compared to the same cells submitted to non-
CR conditions. Furthermore, under CR interventions the absence of SIR2 in cells expressing α-
syn toxic variants led to a higher CLS extension in comparison to the wild type cells submitted to 
the same conditions, suggesting that probably, under CR, Sir2 transcriptionally regulates 
autophagy and mitophagy by controlling the ATG8, and particularly ATG32 mRNA levels. 
However, the further CLS extension observed in the absence of SIR2 indicates that possibly CR is 
alleviating α-syn toxicity due to mechanisms independently of Sir2. To further understand the 
phenomenon of CR-alleviating of α-syn toxicity, additional work must be performed, like the 
evaluation of the ATG8 and ATG32 mRNA levels to determine if CR is transcriptionally regulating 
autophagy/mitophagy, the study of the possible O2
2- involvement in the regulation of 
autophagy/mitophagy under CR, by the SODs activity monitorization, and the evaluation of α-syn 
foci under CR intervention. 
In summary, our data shows that increased autophagy/mitophagy, promoted by α-syn 
WT and A53T mutant, has a deleterious effect in yeast aged cells. This appears counterintuitive 
as autophagy and mitophagy are considered to represent pro-survival processes. Nevertheless, 
several explanations could be envisioned to explain how impaired mitophagy due to the presence 
of toxic α-syn may extend CLS. One possible explanation is that aged cells have a reduced ability 
to simultaneously upregulate anabolic processes in order to compensate for the loss of cellular 
material by increased mitophagy. Another conceivable hypothesis is that the selectivity of various 
types of autophagy, such as mitophagy, is lost and one or more factors, commonly required for 
various types of autophagy, may become limiting when mitophagy is upregulated. The loss of 
selectivity could also result in the degradation of functional competent mitochondria, crucial to 
sustain cell survival of post-mitotic cells, contributing to the toxicity observed.  
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Future studies are necessary to be done in an attempt to dissect how different pathways 
of cellular quality control system influence each other and how they are regulated in a 
coordinated manner. 
 
 
5.1 Future prospectives 
 
Autophagy is a highly conserved proteolytic mechanism of protein quality control system 
essential for the maintenance of metabolic and cellular homeostasis and for an efficient cellular 
response to stress. It declines with aging and is believed to contribute to diverse aspects of aging 
phenotype. The results presented in this thesis yield new insights into the role of 
autophagy/mitophagy in the α-syn-induced toxicity, but raised several question on the regulation 
of autophagy/mitophagy during aging.  
One of the primordial events associated with aging is the DNA replication stress that is 
sensed by different signaling pathways and has the capacity to regulate different cellular 
processes, modulating the expression of diverse genes and ultimately impairing the cells entry 
into mitosis. DNA replication stress is also responsible for the induction of autophagy, however 
the mechanism(s) underlying this event remain poorly understood. The yeast sucrose non-
fermenting protein (Snf1) kinase, the homologue of the mammalian AMP activated protein kinase 
(AMPK), functions as an energy sensor that is able to reprogram the cellular metabolism in 
response to DNA replication stress, in order to restore the normal energy levels essential to 
sustain cell metabolism and to support a stress response. In fact, Snf1 participates in the cell 
cycle metabolic checkpoint activated by DNA replication stress regulating the G1/S transition and 
also controls S-phase entrance by regulating CLB5 transcription [8]. Notably, Snf1 activity 
increases in aged cells even when glucose is abundant. In contrast to AMPK, Snf1 is negatively 
regulated by TORC1, but Snf1 can positively regulate autophagy. The molecular mechanisms 
underlying Snf1 regulation of autophagy are still elusive, but appear to be partially dependent on 
the inactivation of TOR kinases and on the direct Atg1 phosphorylation. Accumulating evidence 
suggests a strong interconnection between DNA replication stress, autophagy and nutrient 
signaling pathways. This axis has strong impact on aging regulation and progression. In fact, it 
was demonstrated that low α-syn levels protect yeast cells from growth inhibition and ROS 
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accumulation induced by the presence of hydroxyurea, a DNA damage inducer [19]. Apparently, 
α-syn modulates S-phase checkpoint, by up-regulating histone acetylation and ribonucleotide 
reductase levels [19]. Furthermore, the proteotoxic stress is able to modulate autophagy during 
aging [20]. Thus, in this context, the chronological life span, cell cycle, autophagy, DNA damage 
and phosphorylation state of Snf1 pathway regulatory proteins can be assessed. In this sense, 
the expression of α-syn, condition with implications both in cell cycle progression and autophagy 
can be explored to further understand the coordinated regulation of DNA replication stress and 
autophagy during aging. The identification of the mechanisms underlying the connection between 
DNA replication stress and autophagy in the aging context and even under proteotoxic conditions 
is of great importance for the continuous expansion on the knowledge of the growth signaling, 
DNA replication stress and autophagy impact in aging, providing a new paradigm for investigating 
how these pathways contribute to aging and to age-related diseases. 
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